BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-1820. [PMID: 23075143 DOI: 10.1056/nejmoa1211721] [Cited by in Crossref: 3813] [Cited by in F6Publishing: 3953] [Article Influence: 346.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang TY, Meng FD, Sang GJ, Zhang HL, Tian ZJ, Zheng H, Cai XH, Tang YD. A novel viral vaccine platform based on engineered transfer RNA. Emerg Microbes Infect 2023;12:2157339. [PMID: 36482724 DOI: 10.1080/22221751.2022.2157339] [Reference Citation Analysis]
2 Zhou Z, Ali A, Walelign E, Demissie GF, El Masry I, Abayneh T, Getachew B, Krishnan P, Ng DYM, Gardner E, Makonnen Y, Miguel E, Chevalier V, Chu DK, So RTY, Von Dobschuetz S, Mamo G, Poon LLM, Peiris M. Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020. Emerg Microbes Infect 2023;12:e2164218. [PMID: 36620913 DOI: 10.1080/22221751.2022.2164218] [Reference Citation Analysis]
3 Xu S, Niu Z, Zhang J, Ren L, Liu X, Zhang S, Zou H, Hu X, Wang J, Zhang L, Zhou Y, Song Z. Bioinformatic analysis of the S protein of human respiratory coronavirus. Mol Phylogenet Evol 2023;181:107704. [PMID: 36657625 DOI: 10.1016/j.ympev.2023.107704] [Reference Citation Analysis]
4 Sartaj Sohrab S, Aly El-Kafrawy S, Mirza Z, Hassan AM, Alsaqaf F, Ibraheem Azhar E. Delivery of siRNAs against MERS-CoV in Vero and HEK-293 cells: A comparative evaluation of transfection reagents. J King Saud Univ Sci 2023;35:102540. [PMID: 36624781 DOI: 10.1016/j.jksus.2023.102540] [Reference Citation Analysis]
5 Rong Y, Zhang C, Gao WC, Zhao C. Optimization of the expression of the main protease from SARS-CoV-2. Protein Expr Purif 2023;203:106208. [PMID: 36403706 DOI: 10.1016/j.pep.2022.106208] [Reference Citation Analysis]
6 Gao H, Dai R, Su R. Computer-aided drug design for the pain-like protease (PL(pro)) inhibitors against SARS-CoV-2. Biomed Pharmacother 2023;159:114247. [PMID: 36689835 DOI: 10.1016/j.biopha.2023.114247] [Reference Citation Analysis]
7 Zamzami MA. Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase. J Biomol Struct Dyn 2023;41:1846-58. [PMID: 35037842 DOI: 10.1080/07391102.2021.2025147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 He Z, Hu Y, Niu Z, Zhong K, Liu T, Yang M, Ji L, Hu W. A review of pharmacokinetic and pharmacological properties of asiaticoside, a major active constituent of Centella asiatica (L.) Urb. Journal of Ethnopharmacology 2023;302:115865. [DOI: 10.1016/j.jep.2022.115865] [Reference Citation Analysis]
9 Dwyer DE. The Origins of Severe Acute Respiratory Syndrome-Coronavirus-2. Semin Respir Crit Care Med 2023;44:3-7. [PMID: 36646081 DOI: 10.1055/s-0042-1759564] [Reference Citation Analysis]
10 Azhar EI, Hui DS, McCloskey B, El-Kafrawy SA, Sharma A, Maeurer M, Lee SS, Zumla A. The Qatar FIFA World Cup 2022 and camel pageant championships increase risk of MERS-CoV transmission and global spread. Lancet Glob Health 2023;11:e189-90. [PMID: 36525983 DOI: 10.1016/S2214-109X(22)00543-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chu K, Quan F. Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced? Viruses 2023;15:392. [DOI: 10.3390/v15020392] [Reference Citation Analysis]
12 Yamada T, Takaoka A. Innate immune recognition against SARS-CoV-2. Inflamm Regen 2023;43:7. [PMID: 36703213 DOI: 10.1186/s41232-023-00259-5] [Reference Citation Analysis]
13 Cable J, Denison MR, Kielian M, Jackson WT, Bartenschlager R, Ahola T, Mukhopadhyay S, Fremont DH, Kuhn RJ, Shannon A, Frazier MN, Yuen KY, Coyne CB, Wolthers KC, Ming GL, Guenther CS, Moshiri J, Best SM, Schoggins JW, Jurado KA, Ebel GD, Schäfer A, Ng LFP, Kikkert M, Sette A, Harris E, Wing PAC, Eggenberger J, Krishnamurthy SR, Mah MG, Meganck RM, Chung D, Maurer-Stroh S, Andino R, Korber B, Perlman S, Shi PY, Bárcena M, Aicher SM, Vu MN, Kenney DJ, Lindenbach BD, Nishida Y, Rénia L, Williams EP. Positive-strand RNA viruses-a Keystone Symposia report. Ann N Y Acad Sci 2023. [PMID: 36697369 DOI: 10.1111/nyas.14957] [Reference Citation Analysis]
14 Li P, Hu J, Liu Y, Ou X, Mu Z, Lu X, Zan F, Cao M, Tan L, Dong S, Zhou Y, Lu J, Jin Q, Wang J, Wu Z, Zhang Y, Qian Z. Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses. PLoS Pathog 2023;19:e1011116. [PMID: 36689489 DOI: 10.1371/journal.ppat.1011116] [Reference Citation Analysis]
15 Liu MQ, Lin HF, Li J, Chen Y, Luo Y, Zhang W, Hu B, Tian FJ, Hu YJ, Liu YJ, Jiang RD, Gong QC, Li A, Guo ZS, Li B, Yang XL, Tong YG, Shi ZL. A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice. J Virol 2023;:e0171922. [PMID: 36688655 DOI: 10.1128/jvi.01719-22] [Reference Citation Analysis]
16 Chen J, Li Y, Liu Z. Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection. Cell Rep Phys Sci 2023;:101249. [PMID: 36714073 DOI: 10.1016/j.xcrp.2023.101249] [Reference Citation Analysis]
17 Sharma D, Joshi M, Apparsundaram S, Goyal RK, Patel B, Dhobi M. Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate. Mol Cell Biochem 2023;:1-20. [PMID: 36689040 DOI: 10.1007/s11010-022-04654-3] [Reference Citation Analysis]
18 Feng Y, Yuan M, Powers JM, Hu M, Munt JE, Arunachalam PS, Leist SR, Bellusci L, Adams LE, Sundaramurthy S, Shirreff LM, Mallory ML, Scooby TD, Moreno A, O'Hagan DT, Kleanthous H, Villinger FJ, Veesler D, King NP, Suthar MS, Khurana S, Baric RS, Wilson IA, Pulendran B. Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2. bioRxiv 2023:2023. [PMID: 36711543 DOI: 10.1101/2023.01.19.524784] [Reference Citation Analysis]
19 Fantini J, Azzaz F, Chahinian H, Yahi N. Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era. Viruses 2023;15:284. [DOI: 10.3390/v15020284] [Reference Citation Analysis]
20 Cui X, Zhang XF, Jagota A. Penetration of Cell Surface Glycocalyx by Enveloped Viruses Is Aided by Weak Multivalent Adhesive Interaction. J Phys Chem B 2023;127:486-94. [PMID: 36598427 DOI: 10.1021/acs.jpcb.2c06662] [Reference Citation Analysis]
21 Argano C, Mallaci Bocchio R, Natoli G, Scibetta S, Lo Monaco M, Corrao S. Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis. Pharmaceuticals (Basel) 2023;16. [PMID: 36678627 DOI: 10.3390/ph16010130] [Reference Citation Analysis]
22 Ahmad N, Joji RM, Shahid M. Evolution and implementation of One Health to control the dissemination of antibiotic-resistant bacteria and resistance genes: A review. Front Cell Infect Microbiol 2022;12:1065796. [PMID: 36726644 DOI: 10.3389/fcimb.2022.1065796] [Reference Citation Analysis]
23 Honrubia JM, Gutierrez-Álvarez J, Sanz-Bravo A, González-Miranda E, Muñoz-Santos D, Castaño-Rodriguez C, Wang L, Villarejo-Torres M, Ripoll-Gómez J, Esteban A, Fernandez-Delgado R, Sánchez-Cordón PJ, Oliveros JC, Perlman S, McCray PB Jr, Sola I, Enjuanes L. SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators. mBio 2023;:e0313622. [PMID: 36625656 DOI: 10.1128/mbio.03136-22] [Reference Citation Analysis]
24 Jeong WJ, Bu J, Mickel P, Han Y, Rawding PA, Wang J, Kang H, Hong H, Král P, Hong S. Dendrimer-Peptide Conjugates for Effective Blockade of the Interactions between SARS-CoV-2 Spike Protein and Human ACE2 Receptor. Biomacromolecules 2023;24:141-9. [PMID: 36562668 DOI: 10.1021/acs.biomac.2c01018] [Reference Citation Analysis]
25 Moza A, Duica F, Antoniadis P, Bernad ES, Lungeanu D, Craina M, Bernad BC, Paul C, Muresan C, Nitu R, Dumache R, Iacob D. Outcome of Newborns with Confirmed or Possible SARS-CoV-2 Vertical Infection-A Scoping Review. Diagnostics (Basel) 2023;13. [PMID: 36673058 DOI: 10.3390/diagnostics13020245] [Reference Citation Analysis]
26 Li Q, Shah T, Wang B, Qu L, Wang R, Hou Y, Baloch Z, Xia X. Cross-species transmission, evolution and zoonotic potential of coronaviruses. Front Cell Infect Microbiol 2022;12:1081370. [PMID: 36683695 DOI: 10.3389/fcimb.2022.1081370] [Reference Citation Analysis]
27 Hu Y, Liu K, Han P, Xu Z, Zheng A, Pan X, Jia Y, Su C, Tang L, Wu L, Bai B, Zhao X, Tian D, Chen Z, Qi J, Wang Q, Gao GF. Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs. EMBO J 2022;:e111737. [PMID: 36519268 DOI: 10.15252/embj.2022111737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Nicollete DRP, Benedetti R, Valença BA, Kuniyoshi KK, de Jesus TCS, Gevaerd A, Santiago EB, de Almeida BMM, Júnior SRR, Figueredo MVM. Cost aware strategies for sensitivity enhancement in a SARS-CoV-2 antigen test prototype: insertion of a cotton intermembrane doubles analytical sensitivity.. [DOI: 10.21203/rs.3.rs-2350797/v1] [Reference Citation Analysis]
29 Aguilar-Bretones M, Fouchier RA, Koopmans MP, van Nierop GP. Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity. J Clin Invest 2023;133. [PMID: 36594464 DOI: 10.1172/JCI162192] [Reference Citation Analysis]
30 Nejadghaderi SA, Rezaei N. Health Crisis and Cancer Prevention: Friend or Foe. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_321-1] [Reference Citation Analysis]
31 Jeong K, Chang J, Park SM, Kim J, Jeon S, Kim DH, Kim YE, Lee JC, Im S, Jo Y, Min JY, Lee H, Yeom M, Seok SH, On DI, Noh H, Yun JW, Park JW, Song D, Seong JK, Kim KC, Lee JY, Park HJ, Kim S, Nam TG, Lee W. Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay. Antiviral Res 2023;209:105473. [PMID: 36435212 DOI: 10.1016/j.antiviral.2022.105473] [Reference Citation Analysis]
32 Poutanen SM. Human Coronaviruses. Principles and Practice of Pediatric Infectious Diseases 2023. [DOI: 10.1016/b978-0-323-75608-2.00222-6] [Reference Citation Analysis]
33 Beltz LA. Introduction. Pathogenic Coronaviruses of Humans and Animals 2023. [DOI: 10.1016/b978-0-323-98809-4.00005-x] [Reference Citation Analysis]
34 Louten J. Coronaviruses. Essential Human Virology 2023. [DOI: 10.1016/b978-0-323-90565-7.00014-9] [Reference Citation Analysis]
35 Brown JA, Amir M, Zeng MY. Epigenetic modifications and regulation in infection. Epigenetics in Organ Specific Disorders 2023. [DOI: 10.1016/b978-0-12-823931-5.00002-5] [Reference Citation Analysis]
36 Mercier A, Méheut A, Alidjinou EK, Lazrek M, Faure K, Hober D, Engelmann I. Respiratory virus detection in returning travelers and pilgrims from the Middle East. Travel Med Infect Dis 2023;51:102482. [PMID: 36280020 DOI: 10.1016/j.tmaid.2022.102482] [Reference Citation Analysis]
37 Vogel PUB. Introduction, Background and Properties of Coronaviruses. essentials 2023. [DOI: 10.1007/978-3-658-38931-4_1] [Reference Citation Analysis]
38 Raja RK, Nguyen-Tri P, Balasubramani G, Alagarsamy A, Hazir S, Ladhari S, Saidi A, Pugazhendhi A, Samy AA. SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. Appl Nanosci 2023;13:65-93. [PMID: 34131555 DOI: 10.1007/s13204-021-01900-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
39 Bellinati L, Campalto M, Mazzotta E, Ceglie L, Cavicchio L, Mion M, Lucchese L, Salomoni A, Bortolami A, Quaranta E, Magarotto J, Favarato M, Squarzon L, Natale A. One-Year Surveillance of SARS-CoV-2 Exposure in Stray Cats and Kennel Dogs from Northeastern Italy. Microorganisms 2022;11. [PMID: 36677401 DOI: 10.3390/microorganisms11010110] [Reference Citation Analysis]
40 Hkiri S, Mekni-Toujani M, Üstün E, Hosni K, Ghram A, Touil S, Samarat A, Sémeril D. Synthesis of Novel 1,3,4-Oxadiazole-Derived α-Aminophosphonates/α-Aminophosphonic Acids and Evaluation of Their In Vitro Antiviral Activity against the Avian Coronavirus Infectious Bronchitis Virus. Pharmaceutics 2022;15. [PMID: 36678743 DOI: 10.3390/pharmaceutics15010114] [Reference Citation Analysis]
41 Loginova SY, Shhukina VN, Savenko SV, Borisevich SV, Filin KN, Berzin IA, Gladkikh VD. Antiviral Activity of The Preparation Meflokhin® Against COVID-19. A&Ch 2022;67:49-54. [DOI: 10.37489/0235-2990-2022-67-9-10-49-54] [Reference Citation Analysis]
42 Cantoni D, Siracusano G, Mayora-Neto M, Pastori C, Fantoni T, Lytras S, Di Genova C, Hughes J, On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco L, Temperton N. Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines (Basel) 2022;11. [PMID: 36679903 DOI: 10.3390/vaccines11010058] [Reference Citation Analysis]
43 Faye MN, Barry MA, Jallow MM, Wade SF, Mendy MP, Sy S, Fall A, Kiori DE, Ndiaye NK, Goudiaby D, Diamanka A, Niang MN, Dia N. Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020. Viruses 2022;15. [PMID: 36680061 DOI: 10.3390/v15010020] [Reference Citation Analysis]
44 Mayet AM, Shukla NK, Raja MR, Ahmad I, Aiesh Qaisi RM, Al-qahtani AA, Taparwal A, Tirth V, Al-dossary R. Experimental Analysis to Detect Corona COVID-19 Virus Symptoms in Male Patients through Breath Pattern Using Machine Learning Algorithms. Electronics 2022;12:10. [DOI: 10.3390/electronics12010010] [Reference Citation Analysis]
45 Šimičić P, Židovec-Lepej S. A Glimpse on the Evolution of RNA Viruses: Implications and Lessons from SARS-CoV-2. Viruses 2022;15. [PMID: 36680042 DOI: 10.3390/v15010001] [Reference Citation Analysis]
46 Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, Junjie Xu, Wei Chen. Challenges and developments in universal vaccine design against SARS-CoV-2 variants. NPJ Vaccines 2022;7:167. [PMID: 36535982 DOI: 10.1038/s41541-022-00597-4] [Reference Citation Analysis]
47 Brackenborough K, Ellis H, Flight WG. Respiratory Viruses and Cystic Fibrosis. Semin Respir Crit Care Med 2022. [DOI: 10.1055/s-0042-1758728] [Reference Citation Analysis]
48 Flynn J, Ahmadi M, Mcfarland C, Kubal M, Taylor M, Cheng Z, Torchia EC, Edwards M. Crowdsourcing Temporal Transcriptomic Coronavirus Host Infection Data: resources, guide, and novel insights.. [DOI: 10.1101/2022.12.14.520483] [Reference Citation Analysis]
49 Ragusa R, Masotti S, Musetti V, Rocchiccioli S, Prontera C, Perrone M, Passino C, Clerico A, Caselli C. Cardiac troponins: Mechanisms of release and role in healthy and diseased subjects. BioFactors 2022. [DOI: 10.1002/biof.1925] [Reference Citation Analysis]
50 Chinnamadhu A, Ramakrishnan J, Suresh S, Ramadurai P, Poomani K. Dynamics and binding affinity of nucleoside and non-nucleoside inhibitors with RdRp of SARS-CoV-2: a molecular screening, docking, and molecular dynamics simulation study. J Biomol Struct Dyn 2022;:1-15. [PMID: 36510678 DOI: 10.1080/07391102.2022.2154844] [Reference Citation Analysis]
51 Tsakanyan AV, Khachatryan TS, Margaryan AV, Melik-andreasyan GG, Keshishyan АS, Nikolyan SA, Andreasyan NA, Martirosyan ST. Assessment of Humoral Immune Response to SARS CoV-2 Virus among Work Staff. Medical Science of Armenia 2022. [DOI: 10.54503/0514-7484-2022-62.4-39] [Reference Citation Analysis]
52 Xiao R, Zhang A. Involvement of the STING signaling in COVID-19. Front Immunol 2022;13:1006395. [PMID: 36569928 DOI: 10.3389/fimmu.2022.1006395] [Reference Citation Analysis]
53 Muaygil R, Aldekhyyel R, AlWatban L, Almana L, Almana RF, Barry M. Ethical uncertainty and COVID-19: exploring the lived experiences of senior physicians at a major medical centre. J Med Ethics 2022:medethics-2022-108369. [PMID: 36600609 DOI: 10.1136/jme-2022-108369] [Reference Citation Analysis]
54 Wei N, Xu Y, Wang H, Jia Q, Shou X, Zhang X, Zhang N, Li Y, Zhai H, Hu Y. Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research. Front Public Health 2022;10:1022810. [PMID: 36568760 DOI: 10.3389/fpubh.2022.1022810] [Reference Citation Analysis]
55 Dastjerdi A, Floyd T, Swinson V, Davies H, Barber A, Wight A. Parainfluenza and corona viruses in a fallow deer (Dama dama) with fatal respiratory disease. Front Vet Sci 2022;9:1059681. [PMID: 36561391 DOI: 10.3389/fvets.2022.1059681] [Reference Citation Analysis]
56 Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol 2022;:1-15. [PMID: 36460930 DOI: 10.1038/s41579-022-00822-w] [Reference Citation Analysis]
57 Moran TE, Hammers DE, Lee SW. The Role of Host-Cellular Responses in COVID-19 Endothelial Dysfunction. Curr Drug Targets 2022;23:1555-66. [PMID: 35748550 DOI: 10.2174/1389450123666220624094940] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Hartman WR. An Executed Plan to Combat COVID-19 in the United States. Adv Anesth 2022;40:45-62. [PMID: 36333051 DOI: 10.1016/j.aan.2022.07.002] [Reference Citation Analysis]
59 Dinda B, Dinda M, Dinda S, Chakraborty M. Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19. European Journal of Medicinal Chemistry Reports 2022;6:100079. [DOI: 10.1016/j.ejmcr.2022.100079] [Reference Citation Analysis]
60 Ng RWY, Boon SS, Chen Z, Ho WCS, Fung KSC, Wong BKC, Yeung ACM, Wong MCS, Chan PKS. Cross-Clade Memory Immunity in Adults Following SARS-CoV-1 Infection in 2003. JAMA Netw Open 2022;5:e2247723. [PMID: 36538327 DOI: 10.1001/jamanetworkopen.2022.47723] [Reference Citation Analysis]
61 Wang B, Zhao J, Liu S, Feng J, Luo Y, He X, Wang Y, Ge F, Wang J, Ye B, Huang W, Bo X, Wang Y, Xi JJ. ACE2 decoy receptor generated by high-throughput saturation mutagenesis efficiently neutralizes SARS-CoV-2 and its prevalent variants. Emerg Microbes Infect 2022;11:1488-99. [PMID: 35587428 DOI: 10.1080/22221751.2022.2079426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Wang F, Suo XG, Wang C, Wang JN, He XY, Wang FC, Jin J, Wen JG, Ni WJ, Shen BX, Meng XM. Highly pathogenic coronaviruses and the kidney. Biomed Pharmacother 2022;156:113807. [PMID: 36242850 DOI: 10.1016/j.biopha.2022.113807] [Reference Citation Analysis]
63 Chopra A, Shukri AH, Adhikary H, Lukinović V, Hoekstra M, Cowpland M, Biggar KK. A peptide array pipeline for the development of Spike-ACE2 interaction inhibitors. Peptides 2022;158:170898. [PMID: 36279985 DOI: 10.1016/j.peptides.2022.170898] [Reference Citation Analysis]
64 Dos S Ribeiro C, van Roode M, Farag E, Nour M, Moustafa A, Ahmed M, Haringhuizen G, Koopmans M, van de Burgwal L. A framework for measuring timeliness in the outbreak response path: lessons learned from the Middle East respiratory syndrome (MERS) epidemic, September 2012 to January 2019. Euro Surveill 2022;27. [PMID: 36695460 DOI: 10.2807/1560-7917.ES.2022.27.48.2101064] [Reference Citation Analysis]
65 Christofferson RC, Cormier SA. Beyond the Unknown: A Broad Framing for Preparedness for Emerging Infectious Threats. Am J Trop Med Hyg 2022;107:1159-61. [PMID: 36191876 DOI: 10.4269/ajtmh.22-0341] [Reference Citation Analysis]
66 Zeng S, Peng O, Hu F, Xia Y, Geng R, Zhao Y, He Y, Xu Q, Xue C, Cao Y, Zhang H. Metabolomic analysis of porcine intestinal epithelial cells during swine acute diarrhea syndrome coronavirus infection. Front Cell Infect Microbiol 2022;12:1079297. [PMID: 36530441 DOI: 10.3389/fcimb.2022.1079297] [Reference Citation Analysis]
67 McCann N, Castellino FJ. Cell Entry and Unusual Replication of SARS-CoV-2. Curr Drug Targets 2022;23:1539-54. [PMID: 36239725 DOI: 10.2174/1389450124666221014102927] [Reference Citation Analysis]
68 Rani R, Long S, Pareek A, Dhaka P, Singh A, Kumar P, McInerney G, Tomar S. Multi-target direct-acting SARS-CoV-2 antivirals against the nucleotide-binding pockets of virus-specific proteins. Virology 2022;577:1-15. [PMID: 36244310 DOI: 10.1016/j.virol.2022.08.008] [Reference Citation Analysis]
69 Alshehri A, Mir NA, Miled N. Detection of Middle East Respiratory Syndrome Coronavirus-Specific RNA and Anti-MERS-Receptor-Binding Domain Antibodies in Camel Milk from Different Regions of Saudi Arabia. Viral Immunol 2022;35:673-80. [PMID: 36534466 DOI: 10.1089/vim.2022.0045] [Reference Citation Analysis]
70 Karami H, Karimi Z, Karami N. SARS-CoV-2 in brief: from virus to prevention. Osong Public Health Res Perspect 2022;13:394-406. [PMID: 36617546 DOI: 10.24171/j.phrp.2022.0155] [Reference Citation Analysis]
71 Campagna R, Mazzuti L, Guerrizio G, Nonne C, Migliara G, De Vito C, Mezzaroma I, Chiaretti S, Fimiani C, Pistolesi V, Morabito S, Turriziani O. Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations. Vaccine X 2022;12:100246. [PMID: 36506461 DOI: 10.1016/j.jvacx.2022.100246] [Reference Citation Analysis]
72 Lim H, Kok B, Lim C, Abdul Majeed A, Leow C, Leow C. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses. Biomedical Engineering Advances 2022;4:100054. [DOI: 10.1016/j.bea.2022.100054] [Reference Citation Analysis]
73 Babaeimarzangou SS, Zaker H, Soleimannezhadbari E, Gamchi NS, Kazeminia M, Tarighi S, Seyedian H, Tsatsakis A, Spandidos DA, Margina D. Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families (Review). Exp Ther Med 2023;25:42. [PMID: 36569444 DOI: 10.3892/etm.2022.11741] [Reference Citation Analysis]
74 D'arco A, Fabrizio MD, Mancini T, Mosetti R, Macis S, Tranfo G, Ventura GD, Marcelli A, Petrarca M, Lupi S. Secondary conformation of MERS-CoV, SARS-CoV and SARS-CoV-2 Spike Proteins revealed by Infrared Vibrational Spectroscopy.. [DOI: 10.21203/rs.3.rs-2245843/v1] [Reference Citation Analysis]
75 Gao N, Rezaee F. Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy. Pharmaceutics 2022;14. [PMID: 36559113 DOI: 10.3390/pharmaceutics14122619] [Reference Citation Analysis]
76 Gonçalves RL, de Souza GAP, de Souza Terceti M, de Castro RFG, de Mello Silva B, Novaes RD, Malaquias LCC, Coelho LFL. Integrative transcriptome analysis of SARS-CoV-2 human-infected cells combined with deep learning algorithms identifies two potential cellular targets for the treatment of coronavirus disease. Braz J Microbiol 2022. [DOI: 10.1007/s42770-022-00875-2] [Reference Citation Analysis]
77 Jade D, Alzahrani A, Critchley W, Ponnambalam S, Harrison MA. Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening. Struct Chem 2022. [DOI: 10.1007/s11224-022-02072-1] [Reference Citation Analysis]
78 Wang X, Tang G, Liu Y, Zhang L, Chen B, Han Y, Fu Z, Wang L, Hu G, Ma Q, Sheng S, Wang J, Hu X, Shao S. The role of IL-6 in coronavirus, especially in COVID-19. Front Pharmacol 2022;13:1033674. [PMID: 36506506 DOI: 10.3389/fphar.2022.1033674] [Reference Citation Analysis]
79 Parmar M, Thumar R, Patel B, Athar M, Jha PC, Patel D. Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by Molecular Dynamics Simulations. Struct Chem 2022. [DOI: 10.1007/s11224-022-02089-6] [Reference Citation Analysis]
80 G LRE, Weber A, Kocher A, Kühnert D. Recombination-aware phylogenetic analysis sheds light on the evolutionary origin of SARS-CoV-2.. [DOI: 10.21203/rs.3.rs-2189993/v1] [Reference Citation Analysis]
81 Moossavi M, Rastegar M, Moossavi SZ, Khorasani M. Molecular Function of cGAS-STING in SARS-CoV-2: A Novel Approach to COVID-19 Treatment. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/6189254] [Reference Citation Analysis]
82 Kabbara A, Vialet B, Marquevielle J, Bonnafous P, Mackereth CD, Amrane S. RNA G-quadruplex forming regions from SARS-2, SARS-1 and MERS coronoviruses. Front Chem 2022;10. [DOI: 10.3389/fchem.2022.1014663] [Reference Citation Analysis]
83 Inchingolo AD, Gargiulo CI, Malcangi G, Ciocia AM, Patano A, Azzollini D, Piras F, Barile G, Settanni V, Mancini A, Garofoli G, Palmieri G, Di Pede C, Rapone B, Inchingolo AM, Jones M, Corriero A, Brienza N, Parisi A, Bianco A, Capozzi L, Del Sambro L, Simone D, Bordea IR, Tartaglia GM, Scarano A, Lorusso F, Macchia L, Migliore G, Pham VH, Dipalma G, Inchingolo F. Diagnosis of SARS-CoV-2 during the Pandemic by Multiplex RT-rPCR hCoV Test: Future Perspectives. Pathogens 2022;11:1378. [DOI: 10.3390/pathogens11111378] [Reference Citation Analysis]
84 Prasad V, Bartenschlager R. A snapshot of protein trafficking in SARS-CoV-2 infection. Biol Cell 2022. [PMID: 36314261 DOI: 10.1111/boc.202200073] [Reference Citation Analysis]
85 Sayama Y, Okamoto M, Saito M, Saito-obata M, Tamaki R, Joboco CD, Lupisan S, Oshitani H. Seroprevalence of four endemic human coronaviruses antibodies among Filipino children and their cross-reactivity and neutralization capacity against SARS-CoV-2.. [DOI: 10.21203/rs.3.rs-2214727/v1] [Reference Citation Analysis]
86 Kassaw M, Mohammed MH, Mohammed OA. Attitude of health care professionals in integrating traditional and modern medicine to control COVID-19-19 epidemics in Northeast Ethiopia.. [DOI: 10.21203/rs.3.rs-2214780/v1] [Reference Citation Analysis]
87 F. Alhetheel A, A. Alhetheel F. Middle East Respiratory Syndrome Coronavirus Outbreaks. Viral Outbreaks - Global Trends and Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.108574] [Reference Citation Analysis]
88 Corrêa-junior D, Andrade IBD, Alves V, Araújo GRDS, Frases S. Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic. Microorganisms 2022;10:2223. [DOI: 10.3390/microorganisms10112223] [Reference Citation Analysis]
89 Kuchinski KS, Loos KD, Suchan DM, Russell JN, Sies AN, Kumakamba C, Muyembe F, Mbala Kingebeni P, Ngay Lukusa I, N’kawa F, Atibu Losoma J, Makuwa M, Gillis A, Lebreton M, Ayukekbong JA, Lerminiaux NA, Monagin C, Joly DO, Saylors K, Wolfe ND, Rubin EM, Muyembe Tamfum JJ, Prystajecky NA, Mciver DJ, Lange CE, Cameron AD. Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats. eLife 2022;11. [DOI: 10.7554/elife.79777] [Reference Citation Analysis]
90 Goldstein SA, Brown J, Pedersen BS, Quinlan AR, Elde NC. Extensive Recombination-driven Coronavirus Diversification Expands the Pool of Potential Pandemic Pathogens. Genome Biol Evol 2022;14. [PMID: 36477201 DOI: 10.1093/gbe/evac161] [Reference Citation Analysis]
91 Alaofi AL, Shahid M, Raish M, Ansari MA, Syed R, Kalam MA. Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro. Molecules 2022;27:7553. [DOI: 10.3390/molecules27217553] [Reference Citation Analysis]
92 Shehu IA, Musa MK, Datta A, Verma A. Application of Nanotechnology in COVID-19 Infection: Findings and Limitations. JNT 2022;3:203-232. [DOI: 10.3390/jnt3040014] [Reference Citation Analysis]
93 Maidana-kulesza MN, Poma HR, Sanguino-jorquera DG, Reyes SI, del Milagro Said-adamo M, Mainardi-remis JM, Gutiérrez-cacciabue D, Cristóbal HA, Cruz MC, Aparicio González M, Rajal VB. Tracking SARS-CoV-2 in rivers as a tool for epidemiological surveillance. Science of The Total Environment 2022;848:157707. [DOI: 10.1016/j.scitotenv.2022.157707] [Reference Citation Analysis]
94 Yi Y, Fang J, Liu Y, Gao Y, Lin W, Hao D, Zhang X, Zhang M. Clinical Characteristics of 254 COVID-19 Inpatients in Yichang, Hubei, China, and Efficacy of Integrated Chinese and Western Medicine Treatment. IJGM 2022;Volume 15:8191-8200. [DOI: 10.2147/ijgm.s391024] [Reference Citation Analysis]
95 Ramdani H, Benelhosni K, Billah NM, Nassar I. Chest CT in covid-19 pneumonia's follow-up: A 30 patients case series. Annals of Medicine and Surgery 2022. [DOI: 10.1016/j.amsu.2022.104835] [Reference Citation Analysis]
96 Alhetheel A, Albarrag A, Shakoor Z, Somily A, Barry M, Altalhi H, Bakhrebah M, Nassar M, Alfageeh M, Assiri A, Alfaraj S, Memish ZA. Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase-4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in peripheral blood. J Infect Public Health 2022;15:1315-20. [PMID: 36279687 DOI: 10.1016/j.jiph.2022.10.008] [Reference Citation Analysis]
97 Zhang X, Zhang X, Xu A, Yu M, Xu Y, Xu Y, Wang C, Yang G, Song C, Wu X, Lu Y. Aptamer-Gated Mesoporous Silica Nanoparticles for N Protein Triggered Release of Remdesivir and Treatment of Novel Coronavirus (2019-nCoV). Biosensors 2022;12:950. [DOI: 10.3390/bios12110950] [Reference Citation Analysis]
98 Kim N, Lee T, Lee H, Yang J, Kim K, Lee J, Kim H. Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice. Vaccines 2022;10:1843. [DOI: 10.3390/vaccines10111843] [Reference Citation Analysis]
99 Al-wahaibi LH, Rehman MT, Al-saleem MSM, Basudan OA, El-gamal AA, Abdelkader MSA, Alajmi MF, Abdel-mageed WM. Virtual screening and molecular dynamics simulation study of abyssomicins as potential inhibitors of COVID‐19 virus main protease and spike protein. Journal of Biomolecular Structure and Dynamics 2022. [DOI: 10.1080/07391102.2022.2139295] [Reference Citation Analysis]
100 Chiem K, Park JG, Morales Vasquez D, Plemper RK, Torrelles JB, Kobie JJ, Walter MR, Ye C, Martinez-Sobrido L. Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus. Microbiol Spectr 2022;10:e0237922. [PMID: 35980204 DOI: 10.1128/spectrum.02379-22] [Reference Citation Analysis]
101 Palanisamy K, Maiyelvaganan KR, Kamalakannan S, Thilagavathi R, Selvam C, Prakash M. In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease. Molecular Simulation 2022. [DOI: 10.1080/08927022.2022.2136392] [Reference Citation Analysis]
102 Daniels A, Fletcher S, Kerr H, Kratzel A, Kriplani N, Craig N, Hastie J, Digard P, Davies P, Thiel V, Tait-burkard C. One for all – Human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses.. [DOI: 10.1101/2022.10.25.513760] [Reference Citation Analysis]
103 Diniz LRL, Elshabrawy HA, Souza MTS, Duarte ABS, Madhav N, de Sousa DP. Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries. Biomolecules 2022;12:1544. [DOI: 10.3390/biom12111544] [Reference Citation Analysis]
104 Pires De Souza GA, Le Bideau M, Boschi C, Wurtz N, Colson P, Aherfi S, Devaux C, La Scola B. Choosing a cellular model to study SARS-CoV-2. Front Cell Infect Microbiol 2022;12:1003608. [DOI: 10.3389/fcimb.2022.1003608] [Reference Citation Analysis]
105 Otter CJ, Fausto A, Tan LH, Cohen NA, Weiss SR. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses. bioRxiv 2022:2022. [PMID: 36299422 DOI: 10.1101/2022.10.17.512617] [Reference Citation Analysis]
106 Ma S, Damfo S, Lou J, Pinotsis N, Bowler MW, Haider S, Kozielski F. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening. IJMS 2022;23:12448. [DOI: 10.3390/ijms232012448] [Reference Citation Analysis]
107 Wang X, Rimal S, Tantray I, Geng J, Bhurtel S, Khaket TP, Li W, Han Z, Lu B. Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1. Proc Natl Acad Sci U S A 2022;119:e2202322119. [PMID: 36170200 DOI: 10.1073/pnas.2202322119] [Reference Citation Analysis]
108 Gullberg RC, Frydman J. SARS-CoV2 associated secretion of nanoLuciferase reports on virus and Virus-Like Particle production.. [DOI: 10.1101/2022.10.11.511764] [Reference Citation Analysis]
109 Lebeau G, El Safadi D, Paulo-ramos A, Hoareau M, Desprès P, Krejbich-trotot P, Chouchou F, Roche M, Viranaicken W. The Efficient Antiviral Response of A549 Cells Is Enhanced When Mitochondrial Respiration Is Promoted. Pathogens 2022;11:1168. [DOI: 10.3390/pathogens11101168] [Reference Citation Analysis]
110 Chingtham S, Kulkarni DD, Sumi T, Mishra A, Pateriya AK, Singh VP, Raut AA. Novel triplex nucleic acid lateral flow immuno-assay (NALFIA) for rapid detection of Nipah virus, Middle East respiratory syndrome coronavirus and Reston ebolavirus.. [DOI: 10.1101/2022.10.06.511237] [Reference Citation Analysis]
111 Dal H, Karabulut Keklik ES, Yilmaz H, Avcil M, Yaman E, Dağtekin G, Diker S, Can S. Estimation of biochemical factors affecting survival in intensive care COVID-19 patients undergoing chest CT scoring: A retrospective cross-sectional study. Medicine (Baltimore) 2022;101:e30407. [PMID: 36221408 DOI: 10.1097/MD.0000000000030407] [Reference Citation Analysis]
112 Gontier N, Sukhoverkhov A. Reticulate evolution underlies synergistic trait formation in human communities. Evol Anthropol 2022. [PMID: 36205197 DOI: 10.1002/evan.21962] [Reference Citation Analysis]
113 Zhou J, Liu Z, Zhang G, Xu W, Xing L, Lu L, Wang Q, Jiang S. Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines. J Med Virol 2023;95:e28172. [PMID: 36161303 DOI: 10.1002/jmv.28172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Moore KA, Osterholm MT, Lackritz EM, Poland GA. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: Setting a path to address coronavirus threats. Vaccine 2022;40:6001-3. [PMID: 36109277 DOI: 10.1016/j.vaccine.2022.08.071] [Reference Citation Analysis]
115 Nagarajan S, Priyadharsini G, Pattabiraman K. QSPR Modeling of Status-Based Topological Indices with COVID-19 Drugs. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2127803] [Reference Citation Analysis]
116 Bonyah E, Hammouch Z, Koksal ME. Mathematical Modeling of Coronavirus Dynamics with Conformable Derivative in Liouville–Caputo Sense. Journal of Mathematics 2022;2022:1-12. [DOI: 10.1155/2022/8353343] [Reference Citation Analysis]
117 Quinteros JA, Noormohammadi AH, Lee SW, Browning GF, Diaz-Méndez A. Genomics and pathogenesis of the avian coronavirus infectious bronchitis virus. Aust Vet J 2022;100:496-512. [PMID: 35978541 DOI: 10.1111/avj.13197] [Reference Citation Analysis]
118 Abdizadeh T, Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Efficacy Evaluation of Quercetin and Its Analogues on the Main Protease Enzyme of the COVID-19 Using Molecular Docking Studies. sjimu 2022;30:66-85. [DOI: 10.52547/sjimu.30.4.66] [Reference Citation Analysis]
119 Chatterjee S, Zaia J. Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples. Mass Spectrom Rev 2022;:e21813. [PMID: 36177493 DOI: 10.1002/mas.21813] [Reference Citation Analysis]
120 Lee SJ, Kim YJ, Ahn DG. Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2. J Microbiol Biotechnol 2022;32:1073-85. [PMID: 36039385 DOI: 10.4014/jmb.2206.06064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Amman BR, Cossaboom CM, Wendling NM, Harvey RR, Rettler H, Taylor D, Kainulainen MH, Ahmad A, Bunkley P, Godino C, Tong S, Li Y, Uehara A, Kelleher A, Zhang J, Lynch B, Behravesh CB, Towner JS. GPS Tracking of Free-Roaming Cats (Felis catus) on SARS-CoV-2-Infected Mink Farms in Utah. Viruses 2022;14:2131. [DOI: 10.3390/v14102131] [Reference Citation Analysis]
122 Lampova B, Doskocil I, Kourimska L, Kopec A. N-3 polyunsaturated fatty acids may affect the course of COVID-19. Front Immunol 2022;13:957518. [DOI: 10.3389/fimmu.2022.957518] [Reference Citation Analysis]
123 Mhlekude B, Postmus D, Weiner J, Stenzel S, Zapatero-belinchón FJ, Olmer R, Jansen J, Richter A, Heinze J, Heinemann N, Mühlemann B, Schroeder S, Jones TC, Müller MA, Drosten C, Pich A, Thiel V, Martin U, Niemeyer D, Gerold G, Beule D, Goffinet C. Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism.. [DOI: 10.1101/2022.09.22.508962] [Reference Citation Analysis]
124 Fielding BC. Editorial: Human coronavirus research: 20 years since the SARS-CoV outbreak. Front Microbiol 2022;13:1035267. [DOI: 10.3389/fmicb.2022.1035267] [Reference Citation Analysis]
125 Alzahrani OR, Hawsawi YM, Alanazi AD, Alatwi HE, Rather IA. In Vitro Evaluation of Leuconostoc mesenteroides Cell-Free-Supernatant GBUT-21 against SARS-CoV-2. Vaccines 2022;10:1581. [DOI: 10.3390/vaccines10101581] [Reference Citation Analysis]
126 Kotani N, Nakano T, Kuwahara R. Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis. J Biol Chem 2022;:102500. [PMID: 36152751 DOI: 10.1016/j.jbc.2022.102500] [Reference Citation Analysis]
127 Tahir ul Qamar M, Zhu X, Chen L, Alhussain L, Alshiekheid MA, Theyab A, Algahtani M. Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development. IJMS 2022;23:11003. [DOI: 10.3390/ijms231911003] [Reference Citation Analysis]
128 Hu X, Lin C, Xu Q, Zhou X, Zeng P, McCormick PJ, Jiang H, Li J, Zhang J. Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor. Viruses 2022;14:2075. [PMID: 36146880 DOI: 10.3390/v14092075] [Reference Citation Analysis]
129 Margiana R, Sharma SK, Khan BI, Alameri AA, Opulencia MJC, Hammid AT, Hamza TA, Babakulov SK, Abdelbasset WK, Jawhar ZH. The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study. Pathol Res Pract 2022;238:154128. [PMID: 36137396 DOI: 10.1016/j.prp.2022.154128] [Reference Citation Analysis]
130 Sokary S, Ouagueni A, Ganji V. Intravenous Ascorbic Acid and Lung Function in Severely IllCOVID-19 Patients. Metabolites 2022;12:865. [DOI: 10.3390/metabo12090865] [Reference Citation Analysis]
131 Ma C, Xiong Q, Gu M, Wang C, Shi L, Liu C, Si J, Tong F, Liu P, Huang M, Yan H. Determinants restricting ACE2 recognition of MERS-related coronaviruses in bats.. [DOI: 10.1101/2022.09.11.507506] [Reference Citation Analysis]
132 Rajamanickam K, Rathinavel T, Periyannan V, Ammashi S, Marimuthu S, Nasir Iqbal M. Molecular insight of phytocompounds from Indian spices and its hyaluronic acid conjugates to block SARS-CoV-2 viral entry. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2121757] [Reference Citation Analysis]
133 Luo J, Klett J, Gabert J, Lipp T, Karbach J, Jäger E, Borte S, Hoffmann R, Milkovska-Stamenova S. A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals. Microorganisms 2022;10:1812. [PMID: 36144414 DOI: 10.3390/microorganisms10091812] [Reference Citation Analysis]
134 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022;8:1758-814. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
135 Abu-Zaied MA, Elgemeie GH, Halaweish FT, Hammad SF. Synthesis of novel pyridine and pyrimidine thioglycoside phosphoramidates for the treatment of COVID-19 and influenza A viruses. Nucleosides Nucleotides Nucleic Acids 2022;41:851-77. [PMID: 35737369 DOI: 10.1080/15257770.2022.2085293] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Khemiri H, Ayouni K, Triki H, Haddad-Boubaker S. SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era. Virol J 2022;19:144. [PMID: 36076271 DOI: 10.1186/s12985-022-01873-4] [Reference Citation Analysis]
137 Peng L, Gao L, Wu X, Fan Y, Liu M, Chen J, Song J, Kong J, Dong Y, Li B, Liu A, Bao F. Lung Organoids as Model to Study SARS-CoV-2 Infection. Cells 2022;11:2758. [PMID: 36078166 DOI: 10.3390/cells11172758] [Reference Citation Analysis]
138 Te N, Rodon J, Creve R, Pérez M, Segalés J, Vergara-Alert J, Bensaid A. Evaluation of alpaca tracheal explants as an ex vivo model for the study of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vet Res 2022;53:67. [PMID: 36056449 DOI: 10.1186/s13567-022-01084-3] [Reference Citation Analysis]
139 Morales-Hernández S, Ugidos-Damboriena N, López-Sagaseta J. Self-Assembling Protein Nanoparticles in the Design of Vaccines: 2022 Update. Vaccines (Basel) 2022;10:1447. [PMID: 36146525 DOI: 10.3390/vaccines10091447] [Reference Citation Analysis]
140 Biswas A, Rajan C, Samajdar DP. A Novel HM-HD-RFET Biosensor for Label-Free Biomolecule Detection. J Electron Mater . [DOI: 10.1007/s11664-022-09872-5] [Reference Citation Analysis]
141 Sharma N, Kulkarni GT, Bhatt AN, Satija S, Singh L, Sharma A, Dua K, Karwasra R, Khan AA, Ahmad N, Raza K. Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine? Natural Product Communications 2022;17:1934578X2211263. [DOI: 10.1177/1934578x221126303] [Reference Citation Analysis]
142 Barry M, Muayqil T. RT-PCR Ct values combined with age predicts invasive mechanical ventilation and mortality in hospitalized COVID-19 patients in a MERS-CoV-endemic country. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e10525] [Reference Citation Analysis]
143 Alduraywish SA. Covid-19 Transmission, Risks Factors and Disease Characteristics in Asthmatics Patients. Postępy Mikrobiologii - Advancements of Microbiology 2022;61:125-132. [DOI: 10.2478/am-2022-011] [Reference Citation Analysis]
144 Garg P, Vanamamalai VK, Jali I, Sharma S. In silico prediction of the animal susceptibility and virtual screening of natural compounds against SARS-CoV-2: Molecular dynamics simulation based analysis. Front Genet 2022;13:906955. [DOI: 10.3389/fgene.2022.906955] [Reference Citation Analysis]
145 Yan Q, Wu K, Zeng W, Yu S, Li Y, Sun Y, Liu X, Ruan Y, Huang J, Ding H, Yi L, Zhao M, Chen J, Fan S. Historical Evolutionary Dynamics and Phylogeography Analysis of Transmissible Gastroenteritis Virus and Porcine Deltacoronavirus: Findings from 59 Suspected Swine Viral Samples from China. IJMS 2022;23:9786. [DOI: 10.3390/ijms23179786] [Reference Citation Analysis]
146 Sun Q, Li X, Kuang E. Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses. Autophagy 2022. [PMID: 36005882 DOI: 10.1080/15548627.2022.2116677] [Reference Citation Analysis]
147 Barozi V, Edkins AL, Tastan Bishop Ö. Evolutionary progression of collective mutations in Omicron sub-lineages towards efficient RBD-hACE2: Allosteric communications between and within viral and human proteins. Comput Struct Biotechnol J 2022;20:4562-78. [PMID: 35989699 DOI: 10.1016/j.csbj.2022.08.015] [Reference Citation Analysis]
148 Chen Y, Jiang RD, Wang Q, Luo Y, Liu MQ, Zhu Y, Liu X, He YT, Zhou P, Yang XL, Shi ZL. Lethal Swine Acute Diarrhea Syndrome Coronavirus Infection in Suckling Mice. J Virol 2022;:e0006522. [PMID: 35993737 DOI: 10.1128/jvi.00065-22] [Reference Citation Analysis]
149 Keyoumu T, Guo K, Ma W. Periodic oscillation for a class of in-host MERS-CoV infection model with CTL immune response. Math Biosci Eng 2022;19:12247-59. [PMID: 36653995 DOI: 10.3934/mbe.2022570] [Reference Citation Analysis]
150 Bi D, Chen Z, Wei S, Xie Z, Zang N, Mo L, Liu Z, Wang Y, Cao L, Zhao F, Lin Y, Qin Y, Tang X, Su H, Zhou J, Liang J, Lan Z, Lin L, Xi S, Luo X, Ma Q, Pang X, Luo X, Singh R. Viral Dynamic Surveillance in COVID-19 Patients: A Cohort Study. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/1399268] [Reference Citation Analysis]
151 Zhou Y, Zheng R, Liu D, Liu S, Disoma C, Li S, Liao Y, Chen Z, Du A, Dong Z, Zhang Y, Liu P, Razzaq A, Chen D, Chen X, Zhong X, Liu S, Tao S, Liu Y, Xu L, Deng X, Li J, Jiang T, Zhao J, Li S, Xia Z. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b. J Virol 2022;:e0074122. [PMID: 35980206 DOI: 10.1128/jvi.00741-22] [Reference Citation Analysis]
152 Alharbi NK, Aljamaan F, Aljami HA, Alenazi MW, Albalawi H, Almasoud A, Alharthi FJ, Azhar EI, Barhoumi T, Bosaeed M, Gilbert SC, Hashem AM. Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels. Vaccines 2022;10:1330. [DOI: 10.3390/vaccines10081330] [Reference Citation Analysis]
153 Okonofua FE, Ntoimo LFC, Onoh VI, Omonkhua AA, Alex-ojei CA, Balogun J. Lived experiences of recovered COVID-19 persons in Nigeria: A phenomenological study. PLoS ONE 2022;17:e0268109. [DOI: 10.1371/journal.pone.0268109] [Reference Citation Analysis]
154 Gutiérrez LJ, Tosso RD, Zarycz MNC, Enriz RD, Baldoni HA. Epitopes mapped onto SARS-CoV-2 receptor-binding motif by five distinct human neutralising antibodies. Molecular Simulation. [DOI: 10.1080/08927022.2022.2111421] [Reference Citation Analysis]
155 Alsafi RT. Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far. Canadian Journal of Infectious Diseases and Medical Microbiology 2022;2022:1-13. [DOI: 10.1155/2022/1156273] [Reference Citation Analysis]
156 Kandeel M, Al-mubarak AIA. Camel viral diseases: Current diagnostic, therapeutic, and preventive strategies. Front Vet Sci 2022;9:915475. [DOI: 10.3389/fvets.2022.915475] [Reference Citation Analysis]
157 Barozi V, Edkins AL, Bishop ÖT. Evolutionary progression of collective mutations in Omicron sub-lineages towards efficient RBD-hACE2: allosteric communications between and within viral and human proteins.. [DOI: 10.1101/2022.08.06.503019] [Reference Citation Analysis]
158 Ahmad T. Global research trends in MERS-CoV: A comprehensive bibliometric analysis from 2012 to 2021. Front Public Health 2022;10:933333. [DOI: 10.3389/fpubh.2022.933333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Patial S, Nazim M, Khan AAP, Raizada P, Singh P, Hussain CM, Asiri AM. Sustainable solutions for indoor pollution abatement during COVID phase: A critical study on current technologies & challenges. Journal of Hazardous Materials Advances 2022;7:100097. [DOI: 10.1016/j.hazadv.2022.100097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Wu Y, Shi Z, Chen J, Zhang H, Li M, Zhao Y, Shi H, Shi D, Guo L, Feng L. Porcine deltacoronavirus E protein induces interleukin-8 production via NF-κB and AP-1 activation. Veterinary Microbiology 2022. [DOI: 10.1016/j.vetmic.2022.109553] [Reference Citation Analysis]
161 Solomon M, Liang C. Human coronaviruses: the emergence of SARS-CoV-2 and management of COVID-19. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
162 Chen H, Liu H, Peng X. Reverse genetics in virology: A double edged sword. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.08.001] [Reference Citation Analysis]
163 Lan J, Chen P, Liu W, Ren W, Zhang L, Ding Q, Zhang Q, Wang X, Ge J. Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2. Structure 2022:S0969-2126(22)00274-X. [PMID: 35917815 DOI: 10.1016/j.str.2022.07.005] [Reference Citation Analysis]
164 Zamani Rarani F, Zamani Rarani M, Hamblin MR, Rashidi B, Hashemian SMR, Mirzaei H. Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions. Cell Mol Biol Lett 2022;27:63. [PMID: 35907817 DOI: 10.1186/s11658-022-00363-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
165 Li Y, Zheng P, Liu T, Shi C, Wang B, Xu Y, Jin T. Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike. Front Mol Biosci 2022;9:930931. [PMID: 35903152 DOI: 10.3389/fmolb.2022.930931] [Reference Citation Analysis]
166 Kakkanas A, Karamichali E, Koufogeorgou EI, Kotsakis SD, Georgopoulou U, Foka P. Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus—Host Interactions. Biomolecules 2022;12:1052. [DOI: 10.3390/biom12081052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth PM. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Front Immunol 2022;13:889372. [PMID: 35967361 DOI: 10.3389/fimmu.2022.889372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Rebendenne A, Roy P, Bonaventure B, Chaves Valadão AL, Desmarets L, Arnaud-Arnould M, Rouillé Y, Tauziet M, Giovannini D, Touhami J, Lee Y, DeWeirdt P, Hegde M, Urbach S, Koulali KE, de Gracia FG, McKellar J, Dubuisson J, Wencker M, Belouzard S, Moncorgé O, Doench JG, Goujon C. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. Nat Genet 2022. [PMID: 35879413 DOI: 10.1038/s41588-022-01110-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Jitsuk NC, Chadsuthi S, Modchang C. Vaccination strategies impact the probability of outbreak extinction: a case study of COVID-19 transmission.. [DOI: 10.1101/2022.07.23.22277952] [Reference Citation Analysis]
170 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223 [DOI: 10.5662/wjm.v12.i4.200] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
171 Sinha S, Castillo V, Espinoza CR, Tindle C, Fonseca AG, Dan JM, Katkar GD, Das S, Sahoo D, Ghosh P. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. EBioMedicine 2022;82:104185. [PMID: 35870428 DOI: 10.1016/j.ebiom.2022.104185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
172 Wright LR, Wright DL, Weller SK. Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery. Viruses 2022;14:1557. [PMID: 35891537 DOI: 10.3390/v14071557] [Reference Citation Analysis]
173 Vassilaki N, Papadimitriou K, Ioannidis A, Papandreou NC, Milona RS, Iconomidou VA, Chatzipanagiotou S. SARS-CoV-2 Amino Acid Mutations Detection in Greek Patients Infected in the First Wave of the Pandemic. Microorganisms 2022;10:1430. [PMID: 35889149 DOI: 10.3390/microorganisms10071430] [Reference Citation Analysis]
174 Arnaboldi S, Mangeri L, Galuppini E, Righi F, Tilola M, Scarazzato A, Bertasi B, Finazzi G, Varisco G, Filipello V, Losio M. Is SARS-CoV-2 a Concern for Food Safety? A Very Low Prevalence from a Food Survey during the COVID-19 Pandemic in Northern Italy. Foods 2022;11:2096. [DOI: 10.3390/foods11142096] [Reference Citation Analysis]
175 Dutta S, Panthi B, Chandra A. All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes. J Phys Chem B 2022. [PMID: 35833966 DOI: 10.1021/acs.jpcb.2c00833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
176 Lo VT, Yoon SW, Noh JY, Jang SS, Na W, Song D, Jeong DG, Kim HK. Characterization of replication and variations in genome segments of a bat reovirus, BatMRV/B19-02, by RNA-seq in infected Vero-E6 cells. Arch Virol 2022. [PMID: 35821149 DOI: 10.1007/s00705-022-05534-3] [Reference Citation Analysis]
177 Mas M, García-vicente JA, Estrada-gelonch A, Pérez-mañá C, Papaseit E, Torrens M, Farré M. Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence. JCM 2022;11:4038. [DOI: 10.3390/jcm11144038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Shi W, Wang L, Zhou T, Sastry M, Yang ES, Zhang Y, Chen M, Chen X, Choe M, Creanga A, Leung K, Olia AS, Pegu A, Rawi R, Schön A, Shen CH, Stancofski ED, Talana CA, Teng IT, Wang S, Corbett KS, Tsybovsky Y, Mascola JR, Kwong PD. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability. Structure 2022:S0969-2126(22)00235-0. [PMID: 35841885 DOI: 10.1016/j.str.2022.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Al-daghri NM, Almiman AA, Wani K, Khattak MNK, Aljohani NJ, Alfawaz H, Al-hameidi A, Aldisi D, Alkhaldi G, Sabico S. COVID-19 Lockdown and Lifestyle Changes in Saudi Adults With Types 1 and 2 Diabetes. Front Public Health 2022;10:912816. [DOI: 10.3389/fpubh.2022.912816] [Reference Citation Analysis]
180 Condé L, Allatif O, Ohlmann T, de Breyne S. Translation of SARS-CoV-2 gRNA Is Extremely Efficient and Competitive despite a High Degree of Secondary Structures and the Presence of an uORF. Viruses 2022;14:1505. [PMID: 35891485 DOI: 10.3390/v14071505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
181 Fan C, Wu Y, Rui X, Yang Y, Ling C, Liu S, Liu S, Wang Y. Animal models for COVID-19: advances, gaps and perspectives. Signal Transduct Target Ther 2022;7:220. [PMID: 35798699 DOI: 10.1038/s41392-022-01087-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
182 Wang X, Chen Y, Shi H, Zou P. Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle. Front Cell Infect Microbiol 2022;12:905248. [DOI: 10.3389/fcimb.2022.905248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Battulin NR, Serov OL. Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines. Vestn VOGiS 2022;26:402-408. [DOI: 10.18699/vjgb-22-49] [Reference Citation Analysis]
184 Bagde H, Dhopte A. Effects of Plant Metabolites on the Growth of COVID-19 (Coronavirus Disease-19) Including Omicron Strain. Cureus 2022. [DOI: 10.7759/cureus.26549] [Reference Citation Analysis]
185 Andola P, Pagag J, Laxman D, Guruprasad L. Fragment-based inhibitor design for SARS-CoV2 main protease. Struct Chem. [DOI: 10.1007/s11224-022-01995-z] [Reference Citation Analysis]
186 Weskamm LM, Fathi A, Raadsen MP, Mykytyn AZ, Koch T, Spohn M, Friedrich M, Haagmans BL, Becker S, Sutter G, Dahlke C, Addo MM, Bartels E, Gundlach S, Hesterkamp T, Krähling V, Lassen S, Ly ML, Pötsch JH, Schmiedel S, Volz A, Zinser ME. Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine. Cell Reports Medicine 2022;3:100685. [DOI: 10.1016/j.xcrm.2022.100685] [Reference Citation Analysis]
187 Samy MN, Gomaa AA, Attia EZ, Ibrahim MA, Desoukey SY, Kamel MS. Flavonoids of Zinnia elegans: Chemical profile and, in vitro antioxidant and in silico anti-COVID-19 activities. South African Journal of Botany 2022;147:576-85. [DOI: 10.1016/j.sajb.2022.02.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Held A, Dellweg D, Köhler D, Pfaender S, Scheuch G, Schumacher S, Steinmann E, Weingartner E, Weinzierl B, Asbach C. [Interdisciplinary Perspectives on the Role of Aerosol Transmission in SARS-CoV-2 Infections]. Gesundheitswesen 2022;84:566-74. [PMID: 35835094 DOI: 10.1055/a-1808-0086] [Reference Citation Analysis]
189 Sun X, Yi C, Zhu Y, Ding L, Xia S, Chen X, Liu M, Gu C, Lu X, Fu Y, Chen S, Zhang T, Zhang Y, Yang Z, Ma L, Gu W, Hu G, Du S, Yan R, Fu W, Yuan S, Qiu C, Zhao C, Zhang X, He Y, Qu A, Zhou X, Li X, Wong G, Deng Q, Zhou Q, Lu H, Ling Z, Ding J, Lu L, Xu J, Xie Y, Sun B. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2. Nat Microbiol 2022;7:1063-74. [PMID: 35773398 DOI: 10.1038/s41564-022-01155-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
190 Aein A, Khanpara S, Samant R, Cai Y, Nunez L, Savitz S, Romero J, Riascos R. Neuroimaging Findings of SARS-CoV-2 Infection. neurograph 2022;12:117-130. [DOI: 10.3174/ng.2100021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Bayati M, Hsieh H, Hsu S, Li C, Rogers E, Belenchia A, Zemmer SA, Blanc T, Lepage C, Klutts J, Reynolds M, Semkiw E, Johnson H, Foley T, Wieberg CG, Wenzel J, Lyddon T, Lepique M, Rushford C, Salcedo B, Young K, Graham M, Suarez R, Ford A, Lei Z, Sumner L, Mooney BP, Wei X, Greenlief CM, Johnson MC, Lin C. Identification and Quantification of Bioactive Compounds Suppressing SARS-CoV-2 Signals in Wastewater-based Epidemiology Surveillance. Water Research 2022. [DOI: 10.1016/j.watres.2022.118824] [Reference Citation Analysis]
192 Tang G, Liu Z, Chen D. Human coronaviruses: Origin, host and receptor. Journal of Clinical Virology 2022;155:105246. [DOI: 10.1016/j.jcv.2022.105246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Chakrabartty I, Khan M, Mahanta S, Chopra H, Dhawan M, Choudhary OP, Bibi S, Mohanta YK, Emran TB. Comparative overview of emerging RNA viruses: Epidemiology, pathogenesis, diagnosis and current treatment. Ann Med Surg (Lond) 2022;79:103985. [PMID: 35721786 DOI: 10.1016/j.amsu.2022.103985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Lin Q, Lu C, Hong Y, Li R, Chen J, Chen W, Chen J. Animal models for studying coronavirus infections and developing antiviral agents and vaccines. Antiviral Res 2022;203:105345. [PMID: 35605699 DOI: 10.1016/j.antiviral.2022.105345] [Reference Citation Analysis]
195 Sheta SM, El-Sheikh SM. Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses. Anal Biochem 2022;648:114680. [PMID: 35429447 DOI: 10.1016/j.ab.2022.114680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
196 Kurt B. SARS-CoV-2 Spike Glikoproteinlerinin Farklı Ülkelerde Karşılaştırmalı Biyoinformatik Analizleri. Comm J Biol 2022. [DOI: 10.31594/commagene.1079045] [Reference Citation Analysis]
197 Asif M, Amir M, Hussain A, Achakzai NM, Natesan Pushparaj P, Rasool M. Role of tyrosine kinase inhibitor in chronic myeloid leukemia patients with SARS-CoV-2 infection: A narrative Review. Medicine (Baltimore) 2022;101:e29660. [PMID: 35777011 DOI: 10.1097/MD.0000000000029660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Rovito R, Augello M, Ben-Haim A, Bono V, d'Arminio Monforte A, Marchetti G. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors. Front Immunol 2022;13:912336. [PMID: 35757770 DOI: 10.3389/fimmu.2022.912336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Rozehkhani SM, Mohammadzad M. Rule Extraction for Screening of COVID-19 Disease Using Granular Computing Approach. Comput Math Methods Med 2022;2022:8729749. [PMID: 35756426 DOI: 10.1155/2022/8729749] [Reference Citation Analysis]
200 Malbec L, Celerier M, Bizet M, Calonne E, Hofmann-winkler H, Boeckx B, Abdelnabi R, Putmans P, Hassabi B, Naesens L, Lambrechts D, Pöhlmann S, Deplus R, Delang L, Jeschke J, Fuks F. The RNA demethylase FTO controls m6A marking on SARS-CoV-2 and classifies COVID-19 severity in patients.. [DOI: 10.1101/2022.06.27.497749] [Reference Citation Analysis]
201 Moga E, Lynton-pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol 2022;13:904686. [DOI: 10.3389/fimmu.2022.904686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
202 Lo VT, Yoon SW, Choi YG, Jeong DG, Kim HK. Genomic Comparisons of Alphacoronaviruses and Betacoronaviruses from Korean Bats. Viruses 2022;14:1389. [DOI: 10.3390/v14071389] [Reference Citation Analysis]
203 Ahn SH, Kim JL, Lee SH, Park HY, Lee JJ, Lee H. Associations of health-related quality of life with depression and stigma in MERS-CoV survivors during the recovery period. Medicine (Baltimore) 2022;101:e29440. [PMID: 35758380 DOI: 10.1097/MD.0000000000029440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Yao W, Tan L, Liu L. Visualization and analysis of mapping knowledge domains for coronavirus research. Medicine (Baltimore) 2022;101:e29508. [PMID: 35758392 DOI: 10.1097/MD.0000000000029508] [Reference Citation Analysis]
205 Chiem K, Park J, Vasquez DM, Plemper RK, Torrelles JB, Kobie JJ, Walter MR, Ye C, Martinez-sobrido L. Monitoring SARS-CoV-2 infection using a double reporter-expressing virus.. [DOI: 10.1101/2022.06.23.497376] [Reference Citation Analysis]
206 Agarwal D, Zafar I, Ahmad SU, Kumar S, Ain QU, Sundaray JK, Rather MA. Structural, genomic information and computational analysis of emerging coronavirus (SARS-CoV-2). Bull Natl Res Cent 2022;46:170. [PMID: 35729950 DOI: 10.1186/s42269-022-00861-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Fischer M, Müller P, Scheidt HA, Luck M. Drug-Membrane Interactions: Effects of Virus-Specific RNA-Dependent RNA Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers. Biochemistry 2022. [PMID: 35731976 DOI: 10.1021/acs.biochem.2c00042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Yang KS, Leeuwon SZ, Xu S, Liu WR. Evolutionary and Structural Insights about Potential SARS-CoV-2 Evasion of Nirmatrelvir. J Med Chem 2022. [PMID: 35731933 DOI: 10.1021/acs.jmedchem.2c00404] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
209 Shaqra AM, Zvornicanin SN, Huang QYJ, Lockbaum GJ, Knapp M, Tandeske L, Bakan DT, Flynn J, Bolon DNA, Moquin S, Dovala D, Kurt Yilmaz N, Schiffer CA. Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance. Nat Commun 2022;13:3556. [PMID: 35729165 DOI: 10.1038/s41467-022-31210-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
210 Zou L, Moch C, Graille M, Chapat C. The SARS-CoV-2 protein NSP2 impairs the silencing capacity of the human 4EHP-GIGYF2 complex. iScience 2022;:104646. [PMID: 35756894 DOI: 10.1016/j.isci.2022.104646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Balloux F, Tan C, Swadling L, Richard D, Jenner C, Maini M, van Dorp L. The past, current and future epidemiological dynamic of SARS-CoV-2. Oxf Open Immunol 2022;3:iqac003. [PMID: 35872966 DOI: 10.1093/oxfimm/iqac003] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
212 Dutta D, Naiyer S, Mansuri S, Soni N, Singh V, Bhat KH, Singh N, Arora G, Mansuri MS. COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2. Diagnostics 2022;12:1503. [DOI: 10.3390/diagnostics12061503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Proia E, Ragno A, Antonini L, Sabatino M, Mladenovič M, Capobianco R, Ragno R. Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal. J Comput Aided Mol Des 2022. [PMID: 35716228 DOI: 10.1007/s10822-022-00460-7] [Reference Citation Analysis]
214 Ortega MA, García-montero C, Fraile-martinez O, Colet P, Baizhaxynova A, Mukhtarova K, Alvarez-mon M, Kanatova K, Asúnsolo A, Sarría-santamera A. Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths. JPM 2022;12:995. [DOI: 10.3390/jpm12060995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Yamamoto M, Gohda J, Kobayashi A, Tomita K, Hirayama Y, Koshikawa N, Seiki M, Semba K, Akiyama T, Kawaguchi Y, Inoue JI. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein. mBio 2022;:e0051922. [PMID: 35708281 DOI: 10.1128/mbio.00519-22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
216 Yavuz Baskiran D, Bayir B, Pehlivan E. Determination of COVID-19 Phobia Level in Health Care Workers. Soc Work Public Health 2022;:1-10. [PMID: 35702763 DOI: 10.1080/19371918.2022.2085836] [Reference Citation Analysis]
217 Qiao S, Zhang S, Ge J, Wang X. The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition. FEBS Open Bio 2022. [PMID: 35689514 DOI: 10.1002/2211-5463.13454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Dolunay A, Elyeli K, Kasap F. Unethical Practices and Effects of Digital Journalism in the COVID-19 Era: The Case of TRNC. SAGE Open 2022;12:215824402210852. [DOI: 10.1177/21582440221085266] [Reference Citation Analysis]
219 Ghimire D, Han Y, Lu M. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants. Viruses 2022;14:1255. [PMID: 35746726 DOI: 10.3390/v14061255] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
220 Judson SD, Munster VJ. Editorial: Ecology and Evolution of Coronaviruses: Implications for Human Health. Front Public Health 2022;10:926677. [PMID: 35669756 DOI: 10.3389/fpubh.2022.926677] [Reference Citation Analysis]
221 Alhabbab RY, Algaissi A, Mahmoud AB, Alkayyal AA, Al-Amri S, Alfaleh MA, Basabrain M, Alsubki RA, Almarshad IS, Alhudaithi AM, Gafari OAA, Alshamlan YA, Aldossari HM, Alsafi MM, Bukhari A, Bajhmom W, Memish ZA, Alsalem W, Hashem AM. MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals. Clin Infect Dis 2022:ciac456. [PMID: 35675306 DOI: 10.1093/cid/ciac456] [Reference Citation Analysis]
222 Kurrey R, Saha A. An Overview of SARS-CoV-2 and Technologies for Detection and Ongoing Treatments: A Human Safety Initiative. COVID 2022;2:731-51. [DOI: 10.3390/covid2060055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Hafezi R, Asemi P. Global scenarios under crises: the case of post COVID-19 era. FS 2022. [DOI: 10.1108/fs-12-2021-0248] [Reference Citation Analysis]
224 Silva SJRD, Kohl A, Pena L, Pardee K. Recent insights into SARS-CoV-2 omicron variant. Rev Med Virol 2023;33:e2373. [PMID: 35662313 DOI: 10.1002/rmv.2373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
225 Shojaei S, Ashofteh P, Dwijendra NKA, Melesse AM, Shahvaran AR, Shojaei S, Homayoonnezhad I. Impacts on Global Temperature During the First Part of 2020 Due to the Reduction in Human Activities by COVID-19. Air, Soil and Water Research 2022;15:117862212211019. [DOI: 10.1177/11786221221101901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Liang H, Zhang W, Chen Z, Chen X. Visualizing a Field of Research for the Coronavirus Replication in Humans with Knowledge Mapping: Evidence from Web of Science. Interdiscip Sci Comput Life Sci 2022;14:471-484. [DOI: 10.1007/s12539-022-00504-4] [Reference Citation Analysis]
227 Zhang Z, Li D, Wang X, Wang Y, Lin J, Jiang S, Wu Z, He Y, Gao X, Zhu Z, Xiao Y, Qu Z, Li Y. Rapid detection of viruses: Based on silver nanoparticles modified with bromine ions and acetonitrile. Chemical Engineering Journal 2022;438:135589. [DOI: 10.1016/j.cej.2022.135589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
228 Baker CA, Gibson KE. Persistence of SARS-CoV-2 on Surfaces and Relevance to the Food Industry. Current Opinion in Food Science 2022. [DOI: 10.1016/j.cofs.2022.100875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
229 Chandra Y, Yagnik J. Experience of Perceived Stress and Impact of Health Locus of Control During COVID-19 Pandemic: Investigating Entrepreneurs and Corporate Employees. South Asian Journal of Human Resources Management 2022;9:79-99. [DOI: 10.1177/23220937221076245] [Reference Citation Analysis]
230 Sun X, Wandelt S, Zhang A. Air transportation as a puzzle piece of COVID-19 in Africa? Research in Transportation Business & Management 2022;43:100780. [DOI: 10.1016/j.rtbm.2022.100780] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
231 Leung KK, Zhang R, Hashim MJ, Fang M, Xu J, Sun D, Li X, Liu Y, Deng H, Zeng D, Lin Z, He P, Zhang Y, Zhu X, Liang D, Xing A, Lee SS, Memish ZA, Jiang G, Khan G. Effectiveness of containment strategies in preventing SARS-CoV-2 transmission. J Infect Public Health 2022;15:609-14. [PMID: 35537237 DOI: 10.1016/j.jiph.2022.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
232 Laskar R, Jilani MG, Nasrin T, Ali S. Microsatellite Signature of Reference Genome Sequence of SARS-CoV-2 and 32 Species of Coronaviridae Family. Int J Infect 2022;9. [DOI: 10.5812/iji-122019] [Reference Citation Analysis]
233 Kansal D, Gautam A, Patiyal N, Bodh S. Pattern of adverse effects following ChAdOx1 nCoV-19 COVISHIELD vaccine in tertiary healthcare institution in North India: A retrospective observational study. IJCAAP 2022;7:91-5. [DOI: 10.18231/j.ijcaap.2022.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Zhou B, Cheng L, Song S, Guo H, Shen S, Wang H, Ge X, Liu L, Ju B, Zhang Z. Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron. Virol J 2022;19. [DOI: 10.1186/s12985-022-01827-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Davenport BJ, Catala A, Weston SM, Johnson RM, Ardanuy J, Hammond HL, Dillen C, Frieman MB, Catalano CE, Morrison TE. Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease. NPJ Vaccines 2022;7:57. [PMID: 35618725 DOI: 10.1038/s41541-022-00481-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Matyushkina D, Shokina V, Tikhonova P, Manuvera V, Shirokov D, Kharlampieva D, Lazarev V, Varizhuk A, Vedekhina T, Pavlenko A, Penkin L, Arapidi G, Pavlov K, Pushkar D, Kolontarev K, Rumyantsev A, Rumyantsev S, Rychkova L, Govorun V. Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein. Viruses 2022;14:1141. [PMID: 35746613 DOI: 10.3390/v14061141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
237 Nunes DR, Braconi CT, Ludwig-begall LF, Arns CW, Durães-carvalho R. Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution. PLoS ONE 2022;17:e0268389. [DOI: 10.1371/journal.pone.0268389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
238 Comar CE, Otter CJ, Pfannenstiel J, Doerger E, Renner DM, Tan LH, Perlman S, Cohen NA, Fehr AR, Weiss SR. MERS-CoV endoribonuclease and accessory proteins jointly evade host innate immunity during infection of lung and nasal epithelial cells. Proc Natl Acad Sci U S A 2022;119:e2123208119. [PMID: 35594398 DOI: 10.1073/pnas.2123208119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
239 Li E, Wang S, He W, He J, Liu L, Zhang X, Yang S, Yan F, Gao Y, Liu B, Xia X. Clinical Characteristics of Immune Response in Asymptomatic Carriers and Symptomatic Patients With COVID-19. Front Microbiol 2022;13:896965. [DOI: 10.3389/fmicb.2022.896965] [Reference Citation Analysis]
240 Akkız H. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern. Front Med 2022;9:849217. [DOI: 10.3389/fmed.2022.849217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
241 Latinne A, Morand S. Climate Anomalies and Spillover of Bat-Borne Viral Diseases in the Asia–Pacific Region and the Arabian Peninsula. Viruses 2022;14:1100. [DOI: 10.3390/v14051100] [Reference Citation Analysis]
242 Forni D, Cagliani R, Pozzoli U, Mozzi A, Arrigoni F, De Gioia L, Clerici M, Sironi M. Dating the Emergence of Human Endemic Coronaviruses. Viruses 2022;14:1095. [DOI: 10.3390/v14051095] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Mukherjee V, Sauer LM, Mehta AK, Shea SY, Biddinger PD, Carr BG, Evans LE, Schwedhelm S, Lowe JJ. The Evolution of the National Special Pathogen System of Care. Health Secur 2022. [PMID: 35587214 DOI: 10.1089/hs.2022.0026] [Reference Citation Analysis]
244 Ning T, Liu S, Xu J, Yang Y, Zhang N, Xie S, Min L, Zhang S, Zhu S, Wang Y. Potential intestinal infection and faecal-oral transmission of human coronaviruses. Rev Med Virol 2022;:e2363. [PMID: 35584273 DOI: 10.1002/rmv.2363] [Reference Citation Analysis]
245 Domachowske J. A Primer on the Eight Coronaviruses Known to Infect Humans. Pediatr Ann 2022;51:e186-90. [PMID: 35575540 DOI: 10.3928/19382359-20220314-02] [Reference Citation Analysis]
246 Yu F, Pan T, Huang F, Ying R, Liu J, Fan H, Zhang J, Liu W, Lin Y, Yuan Y, Yang T, Li R, Zhang X, Lv X, Chen Q, Liang A, Zou F, Liu B, Hu F, Tang X, Li L, Deng K, He X, Zhang H, Zhang Y, Ma X. Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L. Front Microbiol 2022;13:884034. [PMID: 35572668 DOI: 10.3389/fmicb.2022.884034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Burgold-Voigt S, Müller E, Zopf D, Monecke S, Braun SD, Frankenfeld K, Kiehntopf M, Weis S, Schumacher T, Pletz MW, Ehricht R; CoNAN Study Group. Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2. Sci Rep 2022;12:8067. [PMID: 35577791 DOI: 10.1038/s41598-022-10823-7] [Reference Citation Analysis]
248 Zhang Z, Jiang S, Wang X, Dong T, Wang Y, Li D, Gao X, Qu Z, Li Y. A novel enhanced substrate for label-free detection of SARS-CoV-2 based on surface-enhanced Raman scattering. Sens Actuators B Chem 2022;359:131568. [PMID: 35185297 DOI: 10.1016/j.snb.2022.131568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
249 Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol Biol Lett 2022;27:38. [PMID: 35562685 DOI: 10.1186/s11658-022-00339-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
250 Lim CP, Kok BH, Lim HT, Chuah C, Abdul Rahman B, Abdul Majeed AB, Wykes M, Leow CH, Leow CY. Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design. Pathog Glob Health 2022;:1-18. [PMID: 35550001 DOI: 10.1080/20477724.2022.2072456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Alcendor DJ, Matthews-juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines 2022;10:755. [DOI: 10.3390/vaccines10050755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
252 Slis’ SS, Kovalev EV, Yanovich EG, Kononenko AA, Noskov AK. The Main Risks of an Еpidemic Emergency Associated with New Respiratory Viruses. Epidemiology and Vaccinal Prevention 2022;21:74-82. [DOI: 10.31631/2073-3046-2022-21-2-74-82] [Reference Citation Analysis]
253 Cabal ABS, Wu T. Recombinant Protein Technology in the Challenging Era of Coronaviruses. Processes 2022;10:946. [DOI: 10.3390/pr10050946] [Reference Citation Analysis]
254 Peng L, Fang Z, Renauer PA, Mcnamara A, Park JJ, Lin Q, Zhou X, Dong MB, Zhu B, Zhao H, Wilen CB, Chen S. Simultaneous and sequential multi-species coronavirus vaccination.. [DOI: 10.1101/2022.05.07.491038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Pérez-gómez HR, Morfín-otero R, González-díaz E, Esparza-ahumada S, León-garnica G, Rodríguez-noriega E. The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic. Pathogens 2022;11:556. [DOI: 10.3390/pathogens11050556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Mahmudiono T, Ramaiah P, Maleki H, Doewes RI, Shalaby MN, Alsaikhan F, Mohammadi MJ. Evaluation of the impact of different disinfectants on new coronavirus and human health. Rev Environ Health 2022. [PMID: 35508445 DOI: 10.1515/reveh-2022-0051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
257 Sarychev AK, Sukhanova A, Ivanov AV, Bykov IV, Bakholdin NV, Vasina DV, Gushchin VA, Tkachuk AP, Nifontova G, Samokhvalov PS, Karaulov A, Nabiev I. Label-Free Detection of the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein at Physiologically Relevant Concentrations Using Surface-Enhanced Raman Spectroscopy. Biosensors 2022;12:300. [DOI: 10.3390/bios12050300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
258 Ng TI, Correia I, Seagal J, Degoey DA, Schrimpf MR, Hardee DJ, Noey EL, Kati WM. Antiviral Drug Discovery for the Treatment of COVID-19 Infections. Viruses 2022;14:961. [DOI: 10.3390/v14050961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
259 Tse LV, Meganck RM, Araba KC, Yount BL, Shaffer KM, Hou YJ, Munt JE, Adams LE, Wykoff JA, Morowitz JM, Dong S, Magness ST, Marzluff WF, Gonzalez LM, Ehre C, Baric RS. Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection. Proc Natl Acad Sci U S A 2022;119:e2118126119. [PMID: 35476513 DOI: 10.1073/pnas.2118126119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
260 Ղազարյան Ա. SARS-COV-2 ՎԱՐԱԿ. ԱՌՈՂՋԱՊԱՀԱԿԱՆ ՆՈՐ ՄԱՐՏԱՀՐԱՎԵՐ (ԱԿՆԱՐԿ). MSEJ 2022. [DOI: 10.56936/18291775-2022.33-29] [Reference Citation Analysis]
261 Kuo P, Brawiswa Putra IG, Setiawan FA, Wen T, Chiu C, Sulistyah UD. The impact of the COVID-19 pandemic on O-D flow and airport networks in the origin country and in Northeast Asia. Journal of Air Transport Management 2022;100:102192. [DOI: 10.1016/j.jairtraman.2022.102192] [Reference Citation Analysis]
262 Rahman MM, Khatun F, Sami SI, Uzzaman A. The evolving roles and impacts of 5G enabled technologies in healthcare: The world epidemic COVID-19 issues. Array 2022. [DOI: 10.1016/j.array.2022.100178] [Reference Citation Analysis]
263 Rajpal VR, Sharma S, Sehgal D, Singh A, Kumar A, Vaishnavi S, Tiwari M, Bhalla H, Goel S, Raina SN. A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program. Future Virol 2022. [PMID: 35747328 DOI: 10.2217/fvl-2021-0277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Chin CV, Saeed M. Surgical Strikes on Host Defenses: Role of the Viral Protease Activity in Innate Immune Antagonism. Pathogens 2022;11:522. [DOI: 10.3390/pathogens11050522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
265 Varret M, Martin FX, Varret F, Lévy J. A tentative tracking of the SARS-Cov2 pandemic in France, based on a corrected SIR model including vaccination effects. EPJ Web Conf 2022;263:01002. [DOI: 10.1051/epjconf/202226301002] [Reference Citation Analysis]
266 Kambarami MS, Justen M, Tawanda M. Observed strong pervasive positive selection in the N-terminal domain, receptor-binding domain and furin-cleavage sites of SARS-CoV-2 Spike protein sampled from Zimbabwean COVID-19 patients.. [DOI: 10.1101/2022.04.27.22274357] [Reference Citation Analysis]
267 Kuchinski KS, Loos KD, Suchan DM, Russell JN, Sies AN, Kumakamba C, Muyembe F, Kingebeni PM, Lukusa IN, N’kawa F, Losoma JA, Makuwa M, Gillis A, Lebreton M, Ayukekbong JA, Monagin C, Joly DO, Saylors K, Wolfe ND, Rubin EM, Tamfum JJM, Prystajecky NA, Mciver DJ, Lange CE, Cameron AD. Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats.. [DOI: 10.1101/2022.04.25.489472] [Reference Citation Analysis]
268 Mohamed FF, Anhlan D, Schöfbänker M, Schreiber A, Classen N, Hensel A, Hempel G, Scholz W, Kühn J, Hrincius ER, Ludwig S. Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals 2022;15:530. [DOI: 10.3390/ph15050530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
269 Priyadarshi R, Purohit SD, Roy S, Ghosh T, Rhim J, Han SS. Antiviral Biodegradable Food Packaging and Edible Coating Materials in the COVID-19 Era: A Mini-Review. Coatings 2022;12:577. [DOI: 10.3390/coatings12050577] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
270 Sulimov A, Kutov D, Ilin I, Xiao Y, Jiang S, Sulimov V. Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus. Molecules 2022;27:2721. [DOI: 10.3390/molecules27092721] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
271 Fan W, Chen J, Zhang Y, Deng Q, Wei L, Zhao C, Lv D, Lin L, Zhang B, Wei T, Huang T, Wei P, Mo M. Phylogenetic and Spatiotemporal Analyses of the Complete Genome Sequences of Avian Coronavirus Infectious Bronchitis Virus in China During 1985-2020: Revealing Coexistence of Multiple Transmission Chains and the Origin of LX4-Type Virus. Front Microbiol 2022;13:693196. [PMID: 35444624 DOI: 10.3389/fmicb.2022.693196] [Reference Citation Analysis]
272 Yang Z, Wang Q, Zhao L, Long E. Decay characteristics of aerosolized viruses in the air and control strategy of thermal and humid environment for epidemic prevention. Indoor and Built Environment. [DOI: 10.1177/1420326x211052603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
273 Wang Y, Liu M, Shen Y, Ma Y, Li X, Zhang Y, Liu M, Yang XL, Chen J, Yan R, Luan D, Wang Y, Chen Y, Wang Q, Lin H, Li Y, Wu K, Zhu T, Zhao J, Lu H, Wen Y, Jiang S, Wu F, Zhou Q, Shi ZL, Huang J. Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses. Cell Discov 2022;8:36. [PMID: 35443747 DOI: 10.1038/s41421-022-00401-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
274 Geanes ES, LeMaster C, Fraley ER, Khanal S, McLennan R, Grundberg E, Selvarangan R, Bradley T. Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination. Sci Rep 2022;12:6496. [PMID: 35444221 DOI: 10.1038/s41598-022-10230-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
275 Zhao Y, Zhu Y, Liu X, Jin Z, Duan Y, Zhang Q, Wu C, Feng L, Du X, Zhao J, Shao M, Zhang B, Yang X, Wu L, Ji X, Guddat LW, Yang K, Rao Z, Yang H. Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2. Proc Natl Acad Sci U S A 2022;119:e2117142119. [PMID: 35380892 DOI: 10.1073/pnas.2117142119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
276 Shaymaa Hasan Abbas, Rasha Saadi Abbas, Lubab Tarek Nafea. Severity and Risk of Death Due to COVID 19. AJPS 2022;20:1-12. [DOI: 10.32947/ajps.v20i4.769] [Reference Citation Analysis]
277 Färber I, Krüger J, Rocha C, Armando F, von Köckritz-Blickwede M, Pöhlmann S, Braun A, Baumgärtner W, Runft S, Krüger N. Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract. Viruses 2022;14:828. [PMID: 35458558 DOI: 10.3390/v14040828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
278 Melzow F, Mertens S, Todorov H, Groneberg DA, Paris S, Gerber A. Aerosol exposure of staff during dental treatments: a model study. BMC Oral Health 2022;22. [DOI: 10.1186/s12903-022-02155-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
279 Alkharsah KR, Aljaroodi SA, Rahman JU, Alnafie AN, Al Dossary R, Aljindan RY, Alnimr AM, Hussen J. Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicity. PLoS One 2022;17:e0266603. [PMID: 35413090 DOI: 10.1371/journal.pone.0266603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
280 Ngai HW, Kim DH, Hammad M, Gutova M, Aboody K, Cox CD. Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17265] [Reference Citation Analysis]
281 Beeraka NM, Sukocheva OA, Lukina E, Liu J, Fan R. Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines. Rev Med Virol 2022;:e2346. [PMID: 35416390 DOI: 10.1002/rmv.2346] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
282 Feng C, Liu Y, Lyu G, Shang S, Xia H, Zhang J, Irwin DM, Wang Z, Zhang S, Harrison P. Adaptive Evolution of the Fox Coronavirus Based on Genome-Wide Sequence Analysis. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/9627961] [Reference Citation Analysis]
283 Kumar S, Chauhan R, Kumar M. Sensitivity Enhancement of Dual Gate FET Based Biosensor Using Modulated Dielectric for Covid Detection. Silicon. [DOI: 10.1007/s12633-022-01865-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
284 Kunduru KR, Kutner N, Nassar‐marjiya E, Shaheen‐mualim M, Rizik L, Farah S. Disinfectants role in the prevention of spreading the COVID ‐19 and other infectious diseases: The need for functional polymers! Polymers for Advanced Techs. [DOI: 10.1002/pat.5689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Kopańska M, Barnaś E, Błajda J, Kuduk B, Łagowska A, Banaś-ząbczyk A. Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body. IJMS 2022;23:4178. [DOI: 10.3390/ijms23084178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
286 Candido KL, Eich CR, de Fariña LO, Kadowaki MK, da Conceição Silva JL, Maller A, Simão RCG. Spike protein of SARS-CoV-2 variants: a brief review and practical implications. Braz J Microbiol 2022. [PMID: 35397075 DOI: 10.1007/s42770-022-00743-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
287 Islam MA, Haque MA, Rahman MA, Hossen F, Reza M, Barua A, Marzan AA, Das T, Kumar Baral S, He C, Ahmed F, Bhattacharya P, Jakariya M. A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection. Front Immunol 2022;13:837290. [PMID: 35371007 DOI: 10.3389/fimmu.2022.837290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
288 Chourasia R, Padhi S, Phukon LC, Abedin MM, Sirohi R, Singh SP, Rai AK. Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection. Bioengineered 2022;13:9435-54. [PMID: 35387556 DOI: 10.1080/21655979.2022.2060453] [Reference Citation Analysis]
289 Bhanot A, Qureshi NI. Healthcare Management Intricacy, Governance, and Strategic Plan During the COVID-19 Pandemic (With Special Reference to India). Advances in Medical Technologies and Clinical Practice 2022. [DOI: 10.4018/978-1-7998-9831-3.ch003] [Reference Citation Analysis]
290 Laydon DJ, Cauchemez S, Hinsley WR, Bhatt S, Ferguson NM. Prophylactic and reactive vaccination strategies for healthcare workers against MERS-CoV.. [DOI: 10.1101/2022.04.06.22273497] [Reference Citation Analysis]
291 Au GG, Marsh GA, McAuley AJ, Lowther S, Trinidad L, Edwards S, Todd S, Barr J, Bruce MP, Poole TB, Brown S, Layton R, Riddell S, Rowe B, Soldani E, Suen WW, Bergfeld J, Bingham J, Payne J, Durr PA, Drew TW, Vasan SS. Characterisation and natural progression of SARS-CoV-2 infection in ferrets. Sci Rep 2022;12:5680. [PMID: 35383204 DOI: 10.1038/s41598-022-08431-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
292 Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases. Acta Pharm Sin B 2022;12:1652-61. [PMID: 34367893 DOI: 10.1016/j.apsb.2021.07.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
293 Di Gennaro F, Petrosillo N. New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites. Acta Otorhinolaryngol Ital 2022;42:S5-S13. [PMID: 35763270 DOI: 10.14639/0392-100X-suppl.1-42-2022-01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
294 Grellet E, L’hôte I, Goulet A, Imbert I. Replication of the coronavirus genome: a paradox among positive-strand RNA viruses. Journal of Biological Chemistry 2022. [DOI: 10.1016/j.jbc.2022.101923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Schilling-loeffler K, Falkenhagen A, Johne R. Coronaviruses are stable on glass, but are eliminated by manual dishwashing procedures. Food Microbiology 2022. [DOI: 10.1016/j.fm.2022.104036] [Reference Citation Analysis]
296 Ayubov MS, Buriev ZT, Mirzakhmedov MK, Yusupov AN, Usmanov DE, Shermatov SE, Ubaydullaeva KA, Abdurakhmonov IY. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan. PLoS One 2022;17:e0266417. [PMID: 35358277 DOI: 10.1371/journal.pone.0266417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
297 Hadisi N, Abedi H, Shokoohi M, Tasdemir S, Mamikhani SH, Meshgi SH, Zolfagharzadeh A, Roshangar L. COVID-19 and Endocrine System: A Cross-Sectional Study on 60 Patients with Endocrine Abnormality. Cell J 2022;24:182-7. [PMID: 35674019 DOI: 10.22074/cellj.2022.8079] [Reference Citation Analysis]
298 Sha X, Li Y, Huang J, Zhou Q, Song X, Zhang B. Detection and molecular characteristics of canine coronavirus in Chengdu city, Southwest China from 2020 to 2021. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105548] [Reference Citation Analysis]
299 Moharana M, Das A, Sahu SN, Pattanayak SK, Khan F. Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study. Journal of the Indian Chemical Society 2022;99:100417. [DOI: 10.1016/j.jics.2022.100417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
300 He WT, Hou X, Zhao J, Sun J, He H, Si W, Wang J, Jiang Z, Yan Z, Xing G, Lu M, Suchard MA, Ji X, Gong W, He B, Li J, Lemey P, Guo D, Tu C, Holmes EC, Shi M, Su S. Virome characterization of game animals in China reveals a spectrum of emerging pathogens. Cell 2022;185:1117-1129.e8. [PMID: 35298912 DOI: 10.1016/j.cell.2022.02.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
301 Ahmed A, Alsenaidy AM, Mobaireek KF, Alsaadi MM. Viral etiology of acute respiratory infections during 2014–16 in Riyadh, Saudi Arabia. Future Virology. [DOI: 10.2217/fvl-2020-0071] [Reference Citation Analysis]
302 Kandemir Demirci G, Bilgi MM, Erdoğan E, Kaşıkçı Bilgi İ, Çalışkan MK. Psychological Effects of COVID-19 Pandemic in Dental Healthcare Workers. meandros 2022;23:125-135. [DOI: 10.4274/meandros.galenos.2021.58751] [Reference Citation Analysis]
303 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 33.0] [Reference Citation Analysis]
304 Bovo S, Schiavo G, Fontanesi L. One Health and Cattle Genetic Resources: Mining More than 500 Cattle Genomes to Identify Variants in Candidate Genes Potentially Affecting Coronavirus Infections. Animals 2022;12:838. [DOI: 10.3390/ani12070838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Khan FI, Lobb KA, Lai D. The Molecular Basis of the Effect of Temperature on the Structure and Function of SARS-CoV-2 Spike Protein. Front Mol Biosci 2022;9:794960. [DOI: 10.3389/fmolb.2022.794960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
306 Ambrose PA, Goodman WA. Impact of COVID-19 on Patients with Inflammatory Bowel Disease. J Explor Res Pharmacol 2022;7:37-44. [DOI: 10.14218/jerp.2021.00014] [Reference Citation Analysis]
307 Aminpour M, Cannariato M, Preto J, Safaeeardebili ME, Moracchiato A, Doria D, Donato F, Zizzi EA, Deriu MA, Scheim DE, Santin AD, Tuszynski JA. In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds. Computation 2022;10:51. [DOI: 10.3390/computation10040051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Lu S, Tong X, Han Y, Zhang K, Zhang Y, Chen Q, Duan J, Lei X, Huang M, Qiu Y, Zhang DY, Zhou X, Zhang Y, Yin H. Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a. Nat Biomed Eng 2022;6:286-97. [PMID: 35314803 DOI: 10.1038/s41551-022-00861-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
309 Mingoti MED, Bertollo AG, Simões JLB, Francisco GR, Bagatini MD, Ignácio ZM. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route. J Mol Neurosci 2022. [PMID: 35322375 DOI: 10.1007/s12031-022-02004-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
310 Bratu IA, Dinca LC, Enescu CM, Stanciu M. The Role of Social Media in Public Forest Management Policies during COVID-19: Implications for Stakeholder Engagement. Sustainability 2022;14:3778. [DOI: 10.3390/su14073778] [Reference Citation Analysis]
311 Priyadarshani KN, Singh S, Mohammed MKA. Gate-all-around junctionless FET based label-free dielectric/charge modulation detection of SARS-CoV-2 virus. RSC Adv 2022;12:9202-9. [PMID: 35424897 DOI: 10.1039/d1ra08587e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
312 Baron MV, Santos MPD, Werle TM, Scherer GDLG, Santos MMD, Dominguez LML, Brandenburg C, Feltez G, Sampaio AR, de Mello Pinto MV, Carvalho S, Meyer PF, Picariello F, Pacheco EF, Reinheimer IC, Sancho AG, da Costa BEP. Does COVID-19 infection increase the risk of pressure injury in critically ill patients?: A narrative review. Medicine (Baltimore) 2022;101:e29058. [PMID: 35356924 DOI: 10.1097/MD.0000000000029058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Okoh OS, Nii-Trebi NI, Jakkari A, Olaniran TT, Senbadejo TY, Kafintu-Kwashie AA, Dairo EO, Ganiyu TO, Akaninyene IE, Ezediuno LO, Adeosun IJ, Ockiya MA, Jimah EM, Spiro DJ, Oladipo EK, Trovão NS. Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa. iScience 2022;25:103880. [PMID: 35156006 DOI: 10.1016/j.isci.2022.103880] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Wang ZN, Yang XS, Sun J, Zhao JC, Zhong NS, Tang XX. Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses. iScience 2022;25:103967. [PMID: 35224468 DOI: 10.1016/j.isci.2022.103967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Godkov MA, Shustov VV, Korshunov VA, Stepanov FS, Bazhenov AI. Formation of Herd Immunity to SARS-CoV-2 in the Population of Moscow. Epidemiology and Vaccinal Prevention 2022;21:81-91. [DOI: 10.31631/2073-3046-2022-21-1-81-91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
316 Turecek PL, Hibbett D, Kreil TR. Plasma procurement and plasma product safety in light of the COVID-19 pandemic from the perspective of the plasma industry. Vox Sang 2022. [PMID: 35298841 DOI: 10.1111/vox.13267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Kirichenko AD, Poroshina AA, Sherbakov DY, Sadovsky MG, Krutovsky KV. Comparative analysis of alignment-free genome clustering and whole genome alignment-based phylogenomic relationship of coronaviruses. PLoS One 2022;17:e0264640. [PMID: 35259178 DOI: 10.1371/journal.pone.0264640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
318 Wangkheirakpam VD, Bhowmick B, Pukhrambam PD. Detection of SARS-CoV-2 using dielectric modulated TFET-based biosensor. J Mater Sci: Mater Electron 2022;33:10323-34. [DOI: 10.1007/s10854-022-08020-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Nguyen TL, Lee Y, Kim H. Immunogenic Epitope-Based Vaccine Prediction from Surface Glycoprotein of MERS-CoV by Deploying Immunoinformatics Approach. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10382-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Symvoulakis EK, Karageorgiou I, Linardakis M, Papagiannis D, Hatzoglou C, Symeonidis A, Rachiotis G. Knowledge, Attitudes, and Practices of Primary Care Physicians towards COVID-19 in Greece: A Cross-Sectional Study. Healthcare 2022;10:545. [DOI: 10.3390/healthcare10030545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Mallick Gupta A, Mandal S, Mandal S, Chakrabarti J. Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2. J Biomol Struct Dyn 2022;:1-11. [PMID: 35293850 DOI: 10.1080/07391102.2022.2051746] [Reference Citation Analysis]
322 Mishra L, Bandyopadhyay T. Unbinding of hACE2 and inhibitors from the receptor binding domain of SARS-CoV-2 spike protein. J Biomol Struct Dyn 2022;:1-20. [PMID: 35293839 DOI: 10.1080/07391102.2022.2046641] [Reference Citation Analysis]
323 Gelmez Taş B, Selvi HR, Öztürk GZ, Arıca SG, Eğici MT. Evaluation of Knowledge, Practices, and Attitudes Towards Coronavirus in Individuals Aged 20-64 Years. hamidiyemedj 2022;3:59-66. [DOI: 10.4274/hamidiyemedj.galenos.2021.83703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Kabay G, DeCastro J, Altay A, Smith K, Lu HW, Capossela AM, Moarefian M, Aran K, Dincer C. Emerging Biosensing Technologies for the Diagnostics of Viral Infectious Diseases. Adv Mater 2022;:e2201085. [PMID: 35288985 DOI: 10.1002/adma.202201085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Souza PFN, Mesquita FP, Amaral JL, Landim PGC, Lima KRP, Costa MB, Farias IR, Belém MO, Pinto YO, Moreira HHT, Magalhaes ICL, Castelo-Branco DSCM, Montenegro RC, de Andrade CR. The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape. Int J Biol Macromol 2022:S0141-8130(22)00528-1. [PMID: 35300999 DOI: 10.1016/j.ijbiomac.2022.03.058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
326 Bayati M, Hsieh H, Hsu S, Li C, Rogers E, Belenchia A, Zemmer SA, Blanc T, Lepage C, Klutts J, Reynolds M, Semkiw E, Johnson H, Foley T, Wieberg CG, Wenzel J, Lyddon T, Lepique M, Rushford C, Salcedo B, Young K, Graham M, Suarez R, Ford A, Lei Z, Sumner L, Mooney BP, Wei X, Greenlief CM, Johnson MC, Lin C. Identification and Quantification of Bioactive Compounds Suppressing SARS-CoV-2 Signals in Wastewater-based Epidemiology Surveillance.. [DOI: 10.1101/2022.03.09.22272155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Praharaj MR, Garg P, Kesarwani V, Topno NA, Khan RIN, Sharma S, Panigrahi M, Mishra BP, Mishra B, Kumar GS, Gandham RK, Singh RK, Majumdar S, Mohapatra T. SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals. Front Med 2022;8:775572. [DOI: 10.3389/fmed.2021.775572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
328 Yépez Y, Marcano-Ruiz M, Bezerra RS, Fam B, Ximenez JP, Silva WA Jr, Bortolini MC. Evolutionary history of the SARS-CoV-2 Gamma variant of concern (P.1): a perfect storm. Genet Mol Biol 2022;45:e20210309. [PMID: 35266951 DOI: 10.1590/1678-4685-GMB-2021-0309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
329 Lwande OW, Thalin T, de Jong J, Sjödin A, Näslund J, Evander M, Ecke F. Alphacoronavirus in a Daubenton’s Myotis Bat (Myotis daubentonii) in Sweden. Viruses 2022;14:556. [DOI: 10.3390/v14030556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
330 Basch CE, Basch CH. Epidemiology, Secondary School Curricula, and Preparing the Next Generation for Global Citizenship. JMIR Public Health Surveill 2022;8:e36006. [PMID: 35254281 DOI: 10.2196/36006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 González-Maldonado P, Alvarenga N, Burgos-Edwards A, Flores-Giubi ME, Barúa JE, Romero-Rodríguez MC, Soto-Rifo R, Valiente-Echeverría F, Langjahr P, Cantero-González G, Sotelo PH. Screening of Natural Products Inhibitors of SARS-CoV-2 Entry. Molecules 2022;27:1743. [PMID: 35268843 DOI: 10.3390/molecules27051743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
332 Zhou P, Song G, He WT, Beutler N, Tse LV, Martinez DR, Schäfer A, Anzanello F, Yong P, Peng L, Dueker K, Musharrafieh R, Callaghan S, Capozzola T, Yuan M, Liu H, Limbo O, Parren M, Garcia E, Rawlings SA, Smith DM, Nemazee D, Jardine JG, Wilson IA, Safonova Y, Rogers TF, Baric RS, Gralinski LE, Burton DR, Andrabi R. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease. bioRxiv 2022:2022. [PMID: 35291291 DOI: 10.1101/2022.03.04.479488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
333 Kirmani SAK, Ali P, Ahmad J, Tang Z. Topological Coindices and Quantitative Structure-Property Analysis of Antiviral Drugs Investigated in the Treatment of COVID-19. Journal of Chemistry 2022;2022:1-15. [DOI: 10.1155/2022/3036655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
334 Lall D, Rathore S, Agrawal B, Sharma N. Black Pepper an Ideal Choice against Corona Virus: A Systemic study against Pandemic Covid-19. RJPP 2022. [DOI: 10.52711/0975-4385.2022.00012] [Reference Citation Analysis]
335 Smirnova I, Petrova A, Lobov A, Minnibaeva E, Phoung TTT, Van LT, Khine MM, Esaulkova I, Slita A, Zarubaev V, Kazakova O. Azepanodipterocarpol is potential candidate for inhibits influenza H1N1 type among other lupane, oleanane, and dammarane A-ring amino-triterpenoids. J Antibiot (Tokyo) 2022. [PMID: 35246615 DOI: 10.1038/s41429-022-00514-w] [Reference Citation Analysis]
336 Chi H, Wang Y, Li E, Wang X, Wang H, Jin H, Han Q, Wang Z, Wang X, Zhu A, Sun J, Zhuang Z, Zhang L, Ye J, Wang H, Feng N, Hu M, Gao Y, Zhao J, Zhao Y, Yang S, Xia X. Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas. Front Immunol 2022;13:823949. [PMID: 35173733 DOI: 10.3389/fimmu.2022.823949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Rayati Damavandi A, Dowran R, Al Sharif S, Kashanchi F, Jafari R. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy. Med Microbiol Immunol 2022. [PMID: 35235048 DOI: 10.1007/s00430-022-00729-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
338 Ilyicheva TN, Netesov SV, Gureyev VN. COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part I. COVID-19 and Influenza. Mol Genet Microbiol Virol 2022;37:1-9. [DOI: 10.3103/s0891416822010025] [Reference Citation Analysis]
339 Mattoo SU, Myoung J. T cell responses to SARS-CoV-2 in humans and animals. J Microbiol 2022;60:276-89. [PMID: 35157219 DOI: 10.1007/s12275-022-1624-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
340 Morales L, Oliveros JC, Enjuanes L, Sola I. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology. mBio 2022;:e0313521. [PMID: 35229638 DOI: 10.1128/mbio.03135-21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
341 Pasquero S, Gugliesi F, Griffante G, Dell’oste V, Biolatti M, Albano C, Bajetto G, Delbue S, Signorini L, Dolci M, Landolfo S, De Andrea M. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2. Antiviral Research 2022. [DOI: 10.1016/j.antiviral.2022.105278] [Reference Citation Analysis]
342 Qin Y, Feng T, Shi H, Zhang J, Zhang L, Feng S, Chen J, He Y, Zhang X, Chen Z, Liu J, Liu D, Shi D, Feng L. Identification and epitope mapping of swine acute diarrhea syndrome coronavirus accessory protein NS7a via monoclonal antibodies. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198742] [Reference Citation Analysis]
343 Zhou C, Qin X, Yan L, Jiang Y, Yu X. Global trends in COVID-19. Infectious Medicine 2022;1:31-9. [DOI: 10.1016/j.imj.2021.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Hemmati SA, Tabein S. Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease. Computers in Biology and Medicine 2022;142:105228. [DOI: 10.1016/j.compbiomed.2022.105228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Kakovan M, Shirkouhi SG, Zarei M, Andalib S. Stroke Associated with COVID-19 Vaccines. Journal of Stroke and Cerebrovascular Diseases 2022. [DOI: 10.1016/j.jstrokecerebrovasdis.2022.106440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
346 Lu W, Zhao Z, Huang Y, Wang B. Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic. International Journal of Biological Macromolecules 2022;200:487-97. [DOI: 10.1016/j.ijbiomac.2022.01.108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Uppalapati L, Roitburd-berman A, Weiss-ottolenghi Y, Graham BS, Dimitrov DS, Ying T, Failayev H, Tsfadia Y, Gershoni JM. Functional Reconstitution of the MERS CoV Receptor Binding Motif. Molecular Immunology 2022. [DOI: 10.1016/j.molimm.2022.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
348 Tsai TI, Khalili JS, Gilchrist M, Waight AB, Cohen D, Zhuo S, Zhang Y, Ding M, Zhu H, Nga-Sze Mak A, Zhu Y, Goulet DR. ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern. Antiviral Res 2022;:105271. [PMID: 35240221 DOI: 10.1016/j.antiviral.2022.105271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
349 Wang F, Chen C, Wang Z, Han X, Shi P, Zhou K, Liu X, Xiao Y, Cai Y, Huang J, Zhang L, Yang H. The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals. Viruses 2022;14:486. [DOI: 10.3390/v14030486] [Reference Citation Analysis]
350 Scheim DE. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int J Mol Sci 2022;23:2558. [PMID: 35269703 DOI: 10.3390/ijms23052558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
351 Novikov M, Hasanpourghadi M, Ambrose R, Chekaoui A, Newman D, Giles-davis W, Xiang Z, Zhou XY, Ertl HC. Pre-clinical testing of two serologically distinct chimpanzee-origin adenovirus vectors expressing spike of SARS-CoV-2.. [DOI: 10.1101/2022.02.23.481620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Adesokan A, Obeid MA, Lawal AF. SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments. Ther Deliv 2022. [PMID: 35195017 DOI: 10.4155/tde-2021-0075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
353 D. Pence B, J. Cory T. Targeting Mononuclear Phagocytes to Treat COVID-19. Biotechnology to Combat COVID-19 2022. [DOI: 10.5772/intechopen.98967] [Reference Citation Analysis]
354 Yue K, Yao B, Shi Y, Yang Y, Qian Z, Ci Y, Shi L. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity. Biochem Biophys Res Commun 2022;601:129-36. [PMID: 35245742 DOI: 10.1016/j.bbrc.2022.02.068] [Reference Citation Analysis]
355 Alanazi N, Bahjri K. Knowledge, Attitude, and Psychological Impacts of COVID-19 in Saudi Arabia. Front Public Health 2022;10:801777. [DOI: 10.3389/fpubh.2022.801777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Waseem R, Ullah I, Irfan M, Dominari A, Elmahi OKO, Tahir MJ. MERS and COVID ‐19: A double burden for the healthcare system of Saudi Arabia. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
357 Li SG, Yang KS, Blankenship LR, Cho CD, Xu S, Wang H, Liu WR. An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library. Front Chem 2022;10:816576. [DOI: 10.3389/fchem.2022.816576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
358 AlMalki FA, Albukhaty S, Alyamani AA, Khalaf MN, Thomas S. The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment. Environ Sci Pollut Res Int 2022. [PMID: 35175517 DOI: 10.1007/s11356-022-18868-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
359 Möller S, Theiß J, Deinert TIL, Golat K, Heinze J, Niemeyer D, Wyrwa R, Schnabelrauch M, Bogner E. High-Sulfated Glycosaminoglycans Prevent Coronavirus Replication. Viruses 2022;14:413. [DOI: 10.3390/v14020413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
360 Durojaye OA, Sedzro DM, Idris MO, Yekeen AA, Fadahunsi AA, Alakanse OS. Identification of a Potential mRNA‐based Vaccine Candidate against the SARS‐CoV‐2 Spike Glycoprotein: A Reverse Vaccinology Approach. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202103903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
361 Mollarasouli F, Zare-shehneh N, Ghaedi M. A review on corona virus disease 2019 (COVID-19): current progress, clinical features and bioanalytical diagnostic methods. Microchim Acta 2022;189. [DOI: 10.1007/s00604-022-05167-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
362 Hussein M, Andrade dos Ramos Z, Berkhout B, Herrera-carrillo E. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack. Viruses 2022;14:385. [DOI: 10.3390/v14020385] [Reference Citation Analysis]
363 Alali AH, Smaisem MS, Alsheikh AM, Alshareef AA, Smaisem FS, Alnahar BW, Hassouneh AK, Al-Tawfiq JA, Memish ZA. Myocardial injuries among patients with COVID-19: a systematic review. Infez Med 2021;29:345-54. [PMID: 35146339 DOI: 10.53854/liim-2903-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
364 Vere G, Alam MR, Farrar S, Kealy R, Kessler BM, O’brien DP, Pinto-fernández A. Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19. Biomolecules 2022;12:300. [DOI: 10.3390/biom12020300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
365 Ayubov MS, Buriev ZT, Mirzakhmedov MK, Yusupov AN, Usmanov DE, Shermatov SE, Ubaydullaeva KA, Abdurakhmonov IY. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan.. [DOI: 10.1101/2022.02.10.479714] [Reference Citation Analysis]
366 Nagwa Ali S, Mohamed Ahmed R, Eslam Mansour S, Sara Ahmed R. Genetic variants of COVID-19 and vaccination. Is there a Correlation? Open J Proteom Genom 2022;7:001-005. [DOI: 10.17352/ojpg.000011] [Reference Citation Analysis]
367 Kumar S, Hasija Y. Immunoinformatics Tools: A boon in vaccine Development Against Covid-19. 2022 IEEE Delhi Section Conference (DELCON) 2022. [DOI: 10.1109/delcon54057.2022.9753152] [Reference Citation Analysis]
368 da Silva Torres MK, Bichara CDA, de Almeida MDNDS, Vallinoto MC, Queiroz MAF, Vallinoto IMVC, dos Santos EJM, de Carvalho CAM, Vallinoto ACR. The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic. Front Microbiol 2022;13:789882. [DOI: 10.3389/fmicb.2022.789882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
369 Khan FI, Hassan F, Lai D. In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor. Front Immunol 2021;12:794780. [PMID: 35095870 DOI: 10.3389/fimmu.2021.794780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
370 Gradisteanu Pircalabioru G, Iliescu FS, Mihaescu G, Cucu AI, Ionescu ON, Popescu M, Simion M, Burlibasa L, Tica M, Chifiriuc MC, Iliescu C. Advances in the Rapid Diagnostic of Viral Respiratory Tract Infections. Front Cell Infect Microbiol 2022;12:807253. [DOI: 10.3389/fcimb.2022.807253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
371 Mansy SS, AbouSamra MM. Electron microscopy overview of SARS-COV2 and its clinical impact. Ultrastruct Pathol 2022;:1-17. [PMID: 35139747 DOI: 10.1080/01913123.2022.2035475] [Reference Citation Analysis]
372 Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D, He WT, Zhu X, Callaghan S, Yong P, Anzanello F, Peng L, Ricketts J, Parren M, Garcia E, Rawlings SA, Smith DM, Nemazee D, Teijaro JR, Rogers TF, Wilson IA, Burton DR, Andrabi R. A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Sci Transl Med 2022;:eabi9215. [PMID: 35133175 DOI: 10.1126/scitranslmed.abi9215] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 36.0] [Reference Citation Analysis]
373 Alnima T, Mulder MMG, van Bussel BCT, Ten Cate H. COVID-19 Coagulopathy: From Pathogenesis to Treatment. Acta Haematol 2022;145:282-96. [PMID: 35499460 DOI: 10.1159/000522498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
374 Dey D, Singh S, Khan S, Martin M, Schnicker NJ, Gakhar L, Pierce BG, Hasan SS. An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking. Commun Biol 2022;5:115. [PMID: 35136165 DOI: 10.1038/s42003-022-03063-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
375 Everest H, Stevenson-leggett P, Bailey D, Bickerton E, Keep S. Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review. Viruses 2022;14:351. [DOI: 10.3390/v14020351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
376 Alzain AA, Elbadwi FA, Alsamani FO. Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies. Inform Med Unlocked 2022;29:100870. [PMID: 35128036 DOI: 10.1016/j.imu.2022.100870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
377 Pan Z, Feng Y, Wang Z, Lei Z, Han Q, Zhang J. MERS-CoV nsp1 impairs the cellular metabolic processes by selectively downregulating mRNAs in a novel granules. Virulence 2022;13:355-69. [DOI: 10.1080/21505594.2022.2032928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Attaullah, Ashraf S, Rehman N, Alsalman H, Gumaei AH, Abramović B. A Decision-Making Framework Using q-Rung Orthopair Probabilistic Hesitant Fuzzy Rough Aggregation Information for the Drug Selection to Treat COVID-19. Complexity 2022;2022:1-37. [DOI: 10.1155/2022/5556309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
379 Chiu W, Verschueren L, Van den Eynde C, Buyck C, De Meyer S, Jochmans D, Bojkova D, Ciesek S, Cinatl J, De Jonghe S, Leyssen P, Neyts J, Van Loock M, Van Damme E. Development and optimisation of a high-throughput screening assay for in vitro anti–SARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures.. [DOI: 10.1101/2022.02.02.478671] [Reference Citation Analysis]
380 Salleh MZ, Deris ZZ. In Silico Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility. Life 2022;12:231. [DOI: 10.3390/life12020231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
381 Türker ÜA, Çatak B. Are Women Aware of the Vaccine Against Human Papillomavirus? A hospital-focused cross-sectional Study. SDÜ Tıp Fakültesi Dergisi 2022. [DOI: 10.17343/sdutfd.937284] [Reference Citation Analysis]
382 Hemida MG, Al-Sabi M, Alhammadi M, Almathen F, Alnaeem A. Analyzing the roles of some species of arthropods in the transmission of the Middle East respiratory syndrome coronavirus. Vet Med Sci 2022. [PMID: 35104060 DOI: 10.1002/vms3.717] [Reference Citation Analysis]
383 Li CX, Noreen S, Zhang LX, Saeed M, Wu PF, Ijaz M, Dai DF, Maqbool I, Madni A, Akram F, Naveed M, Li JH. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies. Biomed Pharmacother 2022;146:112550. [PMID: 34959116 DOI: 10.1016/j.biopha.2021.112550] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
384 Shinoda S; Collaborative Research Center for Infectious Diseases in India, Okayama University Tsushima-naka, Okayama, Okayama 700-8530, Japan. COVID-19 and Spanish Flu, the Representative Pandemics of the 21st and 20th Centuries. JDR 2022;17:65-72. [DOI: 10.20965/jdr.2022.p0065] [Reference Citation Analysis]
385 Toro A, Ruiz MS, Lage-vickers S, Sanchis P, Sabater A, Pascual G, Seniuk R, Cascardo F, Ledesma-bazan S, Vilicich F, Vazquez E, Gueron G. A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene? Antioxidants 2022;11:276. [DOI: 10.3390/antiox11020276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
386 Li K, Wohlford-Lenane C, Bartlett JA, McCray PB Jr. Inter-individual Variation in Receptor Expression Influences MERS-CoV Infection and Immune Responses in Airway Epithelia. Front Public Health 2021;9:756049. [PMID: 35059374 DOI: 10.3389/fpubh.2021.756049] [Reference Citation Analysis]
387 Du L, Yang Y, Zhang X, Li F. Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 2022;14:1054-74. [PMID: 35018939 DOI: 10.1039/d1nr03831a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
388 Shaqra AM, Zvornicanin S, Huang QY, Lockbaum GJ, Knapp M, Tandeske L, Barkan DT, Flynn J, Bolon DN, Moquin S, Dovala D, Kurt Yilmaz N, Schiffer CA. Defining the Substrate Envelope of SARS-CoV-2 Main Protease to Predict and Avoid Drug Resistance.. [DOI: 10.1101/2022.01.25.477757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
389 Zou L, Moch C, Graille M, Chapat C. The SARS-CoV-2 protein NSP2 impairs the microRNA-induced silencing capacity of human cells.. [DOI: 10.1101/2022.01.25.477753] [Reference Citation Analysis]
390 Flynn JM, Samant N, Schneider-nachum G, Barkan DT, Yilmaz NK, Schiffer CA, Moquin SA, Dovala D, Bolon DN. Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms.. [DOI: 10.1101/2022.01.26.477860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
391 Xiong Q, Cao L, Ma C, Liu C, Si J, Liu P, Gu M, Wang C, Shi L, Tong F, Huang M, Li J, Zhao C, Shen C, Chen Y, Zhao H, Lan K, Wang X, Yan H. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors.. [DOI: 10.1101/2022.01.24.477490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
392 Pan R, Kindler E, Cao L, Zhou Y, Zhang Z, Liu Q, Ebert N, Züst R, Sun Y, Gorbalenya AE, Perlman S, Thiel V, Chen Y, Guo D. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition. mBio 2022;:e0366221. [PMID: 35073761 DOI: 10.1128/mbio.03662-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
393 Jang TH, Park WJ, Lee H, Woo HM, Lee SY, Kim KC, Kim SS, Hong E, Song J, Lee JY. The structure of a novel antibody against the spike protein inhibits Middle East respiratory syndrome coronavirus infections. Sci Rep 2022;12:1260. [PMID: 35075213 DOI: 10.1038/s41598-022-05318-4] [Reference Citation Analysis]
394 Bò L, Miotto M, Di Rienzo L, Milanetti E, Ruocco G. Exploring the Association Between Sialic Acid and SARS-CoV-2 Spike Protein Through a Molecular Dynamics-Based Approach. Front Med Technol 2020;2:614652. [PMID: 35047894 DOI: 10.3389/fmedt.2020.614652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
395 Shaheen MNF. The concept of one health applied to the problem of zoonotic diseases. Rev Med Virol 2022;:e2326. [PMID: 35060214 DOI: 10.1002/rmv.2326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Schaeffer R, Temeeyasen G, Hause BM. Alphacoronaviruses Are Common in Bats in the Upper Midwestern United States. Viruses 2022;14:184. [DOI: 10.3390/v14020184] [Reference Citation Analysis]
397 Malik H, Anees T, Mui-zzud-din. BDCNet: multi-classification convolutional neural network model for classification of COVID-19, pneumonia, and lung cancer from chest radiographs. Multimedia Systems. [DOI: 10.1007/s00530-021-00878-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
398 Yang X, Zhu Y, Zhao X, Liu J, Xun J, Yuan S, Chen J, Pan H, Yang J, Wang J, Liang Z, Shen X, Liang Y, Lin Q, Liang H, Li M, Lu H, Zhu H. ASGR1 is a candidate receptor for SARS-CoV-2 that promotes infection of liver cells.. [DOI: 10.1101/2022.01.15.476426] [Reference Citation Analysis]
399 Lohrasbi-Nejad A. Detection of homologous recombination events in SARS-CoV-2. Biotechnol Lett 2022. [PMID: 35037234 DOI: 10.1007/s10529-021-03218-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
400 Ye L, Yao G, Lin S, Fang Y, Chen X, Wang L, He S, Xiaoqing G. The Investigation of Pulmonary Function Changes of COVID-19 Patients in Three Months. Journal of Healthcare Engineering 2022;2022:1-6. [DOI: 10.1155/2022/9028835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Khalil BA, Shakartalla SB, Goel S, Madkhana B, Halwani R, Maghazachi AA, Alsafar H, Al-omari B, Al Bataineh MT. Immune Profiling of COVID-19 in Correlation with SARS and MERS. Viruses 2022;14:164. [DOI: 10.3390/v14010164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
402 Wang P, Ding P, Wei Q, Liu H, Liu Y, Li Q, Xing Y, Li G, Zhou E, Zhang G. Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies. Int J Biol Macromol 2022;195:609-19. [PMID: 34871658 DOI: 10.1016/j.ijbiomac.2021.11.192] [Reference Citation Analysis]
403 Lau SKP, Li KSM, Li X, Tsang K, Sridhar S, Woo PCY. Fatal Pneumonia Associated With a Novel Genotype of Human Coronavirus OC43. Front Microbiol 2022;12:795449. [DOI: 10.3389/fmicb.2021.795449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
404 Zhou Y, Zheng R, Liu S, Disoma C, Du A, Li S, Chen Z, Dong Z, Zhang Y, Li S, Liu P, Razzaq A, Chen X, Liao Y, Tao S, Liu Y, Xu L, Zhang Q, Peng J, Deng X, Li S, Jiang T, Xia Z. Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation. J Biol Chem 2022;298:101584. [PMID: 35032548 DOI: 10.1016/j.jbc.2022.101584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
405 Sun X, Wandelt S, Zhang A. Travel Bubbles in Air Transportation: Myth or Reality? Aerospace 2022;9:38. [DOI: 10.3390/aerospace9010038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 Abramczyk U, Nowaczyński M, Słomczyński A, Wojnicz P, Zatyka P, Kuzan A. Consequences of COVID-19 for the Pancreas. Int J Mol Sci 2022;23:864. [PMID: 35055050 DOI: 10.3390/ijms23020864] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
407 Fevrier B. Severe Acute Respiratory Syndromes and Coronaviruses (SARS-CoV, MERS-CoV, and SARS-CoV-2). Current Perspectives on Viral Disease Outbreaks - Epidemiology, Detection and Control 2022. [DOI: 10.5772/intechopen.97564] [Reference Citation Analysis]
408 Jiang Y, Rubin L, Peng T, Liu L, Xing X, Lazarovici P, Zheng W. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy. Int J Biol Sci 2022;18:459-72. [PMID: 35002503 DOI: 10.7150/ijbs.59272] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 24.0] [Reference Citation Analysis]
409 Napolitano V, Dabrowska A, Schorpp K, Mourão A, Barreto-Duran E, Benedyk M, Botwina P, Brandner S, Bostock M, Chykunova Y, Czarna A, Dubin G, Fröhlich T, Hölscher M, Jedrysik M, Matsuda A, Owczarek K, Pachota M, Plettenburg O, Potempa J, Rothenaigner I, Schlauderer F, Slysz K, Szczepanski A, Greve-Isdahl Mohn K, Blomberg B, Sattler M, Hadian K, Popowicz GM, Pyrc K. Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chem Biol 2022:S2451-9456(21)00513-4. [PMID: 35021060 DOI: 10.1016/j.chembiol.2021.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
410 Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, Costa Antunes AE. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol 2022;120:174-92. [PMID: 35002079 DOI: 10.1016/j.tifs.2021.12.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
411 Li Y, Zhang S, Guo L, Liu J, Wu Y, Wu X. NetNMSP: Nonoverlapping maximal sequential pattern mining. Appl Intell. [DOI: 10.1007/s10489-021-02912-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
412 Kim YI, Yu KM, Koh JY, Kim EH, Kim SM, Kim EJ, Casel MAB, Rollon R, Jang SG, Song MS, Park SJ, Jeong HW, Kim EG, Lee OJ, Kim YD, Choi Y, Lee SA, Choi YJ, Park SH, Jung JU, Choi YK. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets. Nat Commun 2022;13:21. [PMID: 35013229 DOI: 10.1038/s41467-021-27717-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
413 Mishra A, Rathore AS. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2. Mol Divers 2022. [PMID: 35000060 DOI: 10.1007/s11030-021-10358-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Wang Z, Guo K, Gao P, Pu Q, Li C, Hur J, Wu M. Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications. Precis Clin Med 2021;4:215-30. [PMID: 34993416 DOI: 10.1093/pcmedi/pbab022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
415 Peiris M, Perlman S. Unresolved questions in the zoonotic transmission of MERS. Curr Opin Virol 2022;52:258-64. [PMID: 34999369 DOI: 10.1016/j.coviro.2021.12.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
416 Feng T, Nie C, Peng P, Lu H, Wang T, Li P, Huang W. Nanoagent-based theranostic strategies against human coronaviruses. Nano Res 2022;:1-15. [PMID: 35003529 DOI: 10.1007/s12274-021-3949-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
417 El-Said WA, Al-Bogami AS, Alshitari W. Synthesis of gold nanoparticles@reduced porous graphene-modified ITO electrode for spectroelectrochemical detection of SARS-CoV-2 spike protein. Spectrochim Acta A Mol Biomol Spectrosc 2022;264:120237. [PMID: 34352502 DOI: 10.1016/j.saa.2021.120237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
418 Ponprabha R, Thiagarajan S, Balamurugesan K, Davis P. A Clinical Retrospective Study on the Transmission of COVID-19 From Mothers to Their Newborn and Its Outcome. Cureus 2022. [DOI: 10.7759/cureus.20963] [Reference Citation Analysis]
419 Roy A, Das R, Roy D, Saha S, Ghosh NN, Bhattacharyya S, Roy MN. Encapsulated hydroxychloroquine and chloroquine into cyclic oligosaccharides are the potential therapeutics for COVID-19: insights from first-principles calculations. J Mol Struct 2022;1247:131371. [PMID: 34462609 DOI: 10.1016/j.molstruc.2021.131371] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
420 Zhang J. Analysis of the COVID-19 virus: Conformation, treatments, and vaccine production. 7TH INTERNATIONAL CONFERENCE ON MATHEMATICS: PURE, APPLIED AND COMPUTATION: Mathematics of Quantum Computing 2022. [DOI: 10.1063/5.0125290] [Reference Citation Analysis]
421 Manoharan S, Thangavelu L, Kumar MS, Gupta G, Dua K, Chellappan DK. Microbiome in SARS-CoV-2 (Covid-19). Microbiome in Inflammatory Lung Diseases 2022. [DOI: 10.1007/978-981-16-8957-4_15] [Reference Citation Analysis]
422 Enjuanes L, Sola I, Zúñiga S, Honrubia JM, Bello-pérez M, Sanz-bravo A, González-miranda E, Hurtado-tamayo J, Requena-platek R, Wang L, Muñoz-santos D, Sánchez CM, Esteban A, Ripoll-gómez J. Nature of viruses and pandemics: Coronaviruses. Current Research in Immunology 2022;3:151-158. [DOI: 10.1016/j.crimmu.2022.08.003] [Reference Citation Analysis]
423 Chakraborty A, Mitra S, Das D, Battacharyya D, De D, Mondal SP, Pal AJ. Active Learning-Based Estimation of COVID-19 Pandemic: A Synergetic Case Study in Selective Regions Population. Healthcare Informatics for Fighting COVID-19 and Future Epidemics 2022. [DOI: 10.1007/978-3-030-72752-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
424 Mahroum N, Alghory A, Kiyak Z, Alwani A, Seida R, Alrais M, Shoenfeld Y. Ferritin - from iron, through inflammation and autoimmunity, to COVID-19. J Autoimmun 2022;126:102778. [PMID: 34883281 DOI: 10.1016/j.jaut.2021.102778] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 30.0] [Reference Citation Analysis]
425 Gomes BM, Rebelo CB, Alves de Sousa L. Public health, surveillance systems and preventive medicine in an interconnected world. One Health 2022. [DOI: 10.1016/b978-0-12-822794-7.00006-x] [Reference Citation Analysis]
426 Arslan NG, Ulubay G, Skoczyński S. Pregnancy and Postpartum Period Community-Acquired Pneumonia. ENT Diseases: Diagnosis and Treatment during Pregnancy and Lactation 2022. [DOI: 10.1007/978-3-031-05303-0_62] [Reference Citation Analysis]
427 Aan FJ, Glibetic N, Montoya-uribe V, Matter ML. COVID-19 and the Microbiome: The Gut-Lung Connection. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00048-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
428 Norouzi M, Miles MA, Norouzi S. Genetics and Biological Characteristics of SARS-CoV-2. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_4] [Reference Citation Analysis]
429 Mao Q, Chu S, Shapiro S, Young L, Russo M, De Paepe ME. Placental SARS-CoV-2 distribution correlates with level of tissue oxygenation in COVID-19-associated necrotizing histiocytic intervillositis/perivillous fibrin deposition. Placenta 2022;117:187-93. [DOI: 10.1016/j.placenta.2021.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
430 Sazmand A, Nourian A. Camel-Related Zoonoses: A Light on “Ship of the Desert”. Zoonoses: Infections Affecting Humans and Animals 2022. [DOI: 10.1007/978-3-030-85877-3_48-1] [Reference Citation Analysis]
431 Schoeman D, Gordon B, Fielding BC. Coronaviruses. Encyclopedia of Infection and Immunity 2022. [DOI: 10.1016/b978-0-12-818731-9.00052-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
432 Ilyicheva T, Netesov S, Gureyev V. COVID-19, influenza, and other acute respiratory viral infections: etiology, immunopathogenesis, diagnosis, and treatment. Part I. COVID-19 and influenza. Mol genet mikrobiol virusol 2022;40:3. [DOI: 10.17116/molgen2022400113] [Reference Citation Analysis]
433 Meenakshi A, Armstrong AN, Senbagamalar J. Mathematical model of analysation of COVID-19 using graphs. 2ND INTERNATIONAL CONFERENCE ON MATHEMATICAL TECHNIQUES AND APPLICATIONS: ICMTA2021 2022. [DOI: 10.1063/5.0109199] [Reference Citation Analysis]
434 Stein RA. Super-Spreading in Infectious Diseases: A Global Challenge for All Disciplines. Integrated Science 2022. [DOI: 10.1007/978-3-030-96814-4_16] [Reference Citation Analysis]
435 Ndziessi G, Ngatse JA, Niama FR, Poaty H, Issamou MP, Mbele FG, Linguissi LSG, Ntoumi F. Diagnostic Performance of Five Rapid Serological Tests for SARS-CoV-2. OJEpi 2022;12:470-480. [DOI: 10.4236/ojepi.2022.124037] [Reference Citation Analysis]
436 Sriwilaijaroen N, Suzuki Y. Roles of Sialyl Glycans in HCoV-OC43, HCoV-HKU1, MERS-CoV and SARS-CoV-2 Infections. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2635-1_17] [Reference Citation Analysis]
437 Zhang Z, Ma P, Ahmed R, Wang J, Akin D, Soto F, Liu BF, Li P, Demirci U. Advanced Point-of-Care Testing Technologies for Human Acute Respiratory Virus Detection. Adv Mater 2022;34:e2103646. [PMID: 34623709 DOI: 10.1002/adma.202103646] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 24.0] [Reference Citation Analysis]
438 Babić I, Brida M. COVID-19 and Adult Congenital Heart Disease. Guide for Advanced Nursing Care of the Adult with Congenital Heart Disease 2022. [DOI: 10.1007/978-3-031-07598-8_21] [Reference Citation Analysis]
439 Srivastava AK, Verma S, Mili M, Maji S, Anis A, Hashmi SAR, Pal K. A Detailed Scientometric Review of Coronavirus Research. Materials Horizons: From Nature to Nanomaterials 2022. [DOI: 10.1007/978-981-16-4372-9_10] [Reference Citation Analysis]
440 Xiong Q, Cao L, Ma C, Tortorici MA, Liu C, Si J, Liu P, Gu M, Walls AC, Wang C, Shi L, Tong F, Huang M, Li J, Zhao C, Shen C, Chen Y, Zhao H, Lan K, Corti D, Veesler D, Wang X, Yan H. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors. Nature 2022;612:748-57. [PMID: 36477529 DOI: 10.1038/s41586-022-05513-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
441 Vaithilingam CA, Natesan S, Rajalaxmi RR, Tamilarasi K, Praveena NG, Abdul Karim SA. Evolution of Outbreaks, Lessons Learnt and Challenges Towards “New Normalcy”—Post COVID-19 World. Studies in Systems, Decision and Control 2022. [DOI: 10.1007/978-3-030-79610-5_1] [Reference Citation Analysis]
442 Ikeda H, Mino Y, Takahashi Y, Iguchi Y, Iguchi D, Fujita K, Ocho K. Pulmonary aspergillosis occurred during the acute phase of COVID-19 in a patient on hemodialysis. Nihon Toseki Igakkai Zasshi 2022;55:467-473. [DOI: 10.4009/jsdt.55.467] [Reference Citation Analysis]
443 Alenazi TH, Arabi YM. Severe Middle East Respiratory Syndrome (MERS) Pneumonia. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-12-801238-3.11488-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Echchakery M, El Mouahid S, El Baz S, Mountassir M, Hakkoum AT, Klevor R, Keita AM, El Hizazi S, Ahmed D, Zouhairi N, Aimrane A, Benksim A, Chatoui R, Zemrani Y, Lamrani Hanchi A, Alouani M. Symptomatology and Clinical Features of Human COVID-19. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19 2022. [DOI: 10.4018/978-1-7998-8225-1.ch003] [Reference Citation Analysis]
445 Karami C, Dargahi A, Vosoughi M, Normohammadi A, Jeddi F, Asghariazar V, Mokhtari A, Sedigh A, Zandian H, Alighadri M. SARS-CoV-2 in municipal wastewater treatment plant, collection network, and hospital wastewater. Environ Sci Pollut Res Int 2022;29:85577-85. [PMID: 34264498 DOI: 10.1007/s11356-021-15374-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
446 Overgaauw P, van Knapen F. Dogs and Transmission of Infection to Man, “Respected Member of the Family?”. Zoonoses: Infections Affecting Humans and Animals 2022. [DOI: 10.1007/978-3-030-85877-3_22-1] [Reference Citation Analysis]
447 Lalchhandama K. A history of coronaviruses. Wiki J Med 2022;9:5. [DOI: 10.15347/wjm/2022.005] [Reference Citation Analysis]
448 Shyr ZA, Cheng Y, Zheng W. Drug Combinations. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00058-x] [Reference Citation Analysis]
449 Liu W, Liu P, J Liu W, Wang Q, Tong Y, F. Gao G; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China, CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. . China CDC Weekly 2022;4:823-7. [DOI: 10.46234/ccdcw2022.171] [Reference Citation Analysis]
450 Patel VK, Shirbhate E, Rajak H. Coronavirus reinfections: An outlook on evidences and effects. Lessons from COVID-19 2022. [DOI: 10.1016/b978-0-323-99878-9.00013-3] [Reference Citation Analysis]
451 Rathod S. Origin, evolution, and pathogenesis of coronaviruses. Nanotechnological Applications in Virology 2022. [DOI: 10.1016/b978-0-323-99596-2.00005-4] [Reference Citation Analysis]
452 Singh J, Singhal D. Potential antiviral therapies for coronavirus disease 2019 (COVID-19). Data Science for COVID-19 2022. [DOI: 10.1016/b978-0-323-90769-9.00036-0] [Reference Citation Analysis]
453 Dayal A, Thakkar H, Prajapati V, Suri S. Haematological parameters in COVID-19 disease: A tertiary care centre experience. Curr Med Res Pract 2022;12:61. [DOI: 10.4103/cmrp.cmrp_125_21] [Reference Citation Analysis]
454 Dunbar SA, Tang Y. Diagnostic Tests and Procedures During the COVID-19 Pandemic. Springer Actuarial 2022. [DOI: 10.1007/978-3-030-78334-1_10] [Reference Citation Analysis]
455 Pawar MV, Anuradha J, Pawar AM, Sanap S, Sachdeo RK, Ravande K, Malhotra J, Bhapkar HR, Pawar P. COVID-19 Epidemic Impact on Various Society Sectors. Healthcare Informatics for Fighting COVID-19 and Future Epidemics 2022. [DOI: 10.1007/978-3-030-72752-9_11] [Reference Citation Analysis]
456 Shimose LA, Masuda E, Caban AB, Bueno Rios MX, Munoz-price LS. Air Contamination in the Hospital Environment. Infection Prevention 2022. [DOI: 10.1007/978-3-030-98427-4_17] [Reference Citation Analysis]
457 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2022;67:1975-86. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Akhlaq M, Babar Z, Ajaz M, Khan MA, Kilinc E, Adeel M, Badar M, Nawaz A, Jalil A. Covid-19 Pandemic and Coronaviruses from Discovery to Treatment: A Tale of Two Decades of 21st Century. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention 2022. [DOI: 10.1007/978-3-030-72834-2_30] [Reference Citation Analysis]
459 Peng Y, Nascimento ARD, Nascimento IFD, Souza JGDM, Nagata T, Albuquerque PHM, Kimura H, Nagata MH. Understanding COVID-19 in Brazil: Socioeconomic Impacts, Statistical Analysis and Future Challenges. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention 2022. [DOI: 10.1007/978-3-030-72834-2_20] [Reference Citation Analysis]
460 Patel KD, Patel AK, Kurian AG, Singh RK, Kim H. Tuning the properties of inorganic nanomaterials for theranostic applications in infectious diseases: Carbon nanotubes, quantum dots, graphene, and mesoporous carbon nanoparticles. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases 2022. [DOI: 10.1016/b978-0-323-91201-3.00011-6] [Reference Citation Analysis]
461 Zameer S, Khan I, Mansoor S, Shamas S, Gani MU. Nanocarriers as potential and effective delivery tool for COVID-19 drugs. Coronavirus Drug Discovery 2022. [DOI: 10.1016/b978-0-323-95574-4.00009-3] [Reference Citation Analysis]
462 El Baz S, El Hidan MA, Zouhairi N, Aimrane A, Chatoui R, Echchakery M. COVID-19. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19 2022. [DOI: 10.4018/978-1-7998-8225-1.ch001] [Reference Citation Analysis]
463 El Hidan MA, El Baz S, Merzouki M, Kahime K, Ait Baamrane MA, Rhazi M, Draoui A, Agnaou M, Ait Hamza M, El Finti A, Zahidi A, El Mousadik A. Historical Insight, Classification, and Common Features of Coronavirus Family. Advances in Human Services and Public Health 2022. [DOI: 10.4018/978-1-7998-8202-2.ch001] [Reference Citation Analysis]
464 Korath ADJ, Janda J, Untersmayr E, Sokolowska M, Feleszko W, Agache I, Adel Seida A, Hartmann K, Jensen-Jarolim E, Pali-Schöll I. One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2. Allergy 2022;77:55-71. [PMID: 34180546 DOI: 10.1111/all.14991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
465 Bharati S, Podder P, Mondal MRH, Podder P, Kose U. A review on epidemiology, genomic characteristics, spread, and treatments of COVID-19. Data Science for COVID-19 2022. [DOI: 10.1016/b978-0-323-90769-9.00011-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
466 Peng O, Wei X, Ashraf U, Hu F, Xia Y, Xu Q, Hu G, Xue C, Cao Y, Zhang H. Genome-wide transcriptome analysis of porcine epidemic diarrhea virus virulent or avirulent strain-infected porcine small intestinal epithelial cells. Virologica Sinica 2022. [DOI: 10.1016/j.virs.2022.01.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
467 Tatara AM. Modeling viral infection with tissue engineering: COVID-19 and the next outbreaks. Tissue Engineering 2022. [DOI: 10.1016/b978-0-12-824064-9.00015-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Wang H, Wang C. Peptide-Based Dual HIV and Coronavirus Entry Inhibitors. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-981-16-8702-0_6] [Reference Citation Analysis]
469 Li ZX, Feng S, Zhang H, Zhuang XY, Shang C, Sun SY, Han JC, Xie YB, Zhang JY, Wang W, Li CH, Zhao GY, Hao PF, Ma JX, Gao Y, Zeng JQ, Tian MY, Ha Z, Lu HJ, Jin NY. Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice. Arch Virol 2022;167:2519-28. [PMID: 36083350 DOI: 10.1007/s00705-022-05562-z] [Reference Citation Analysis]
470 Nguyen HQ, Bui HK, Phan VM, Seo TS. An internet of things-based point-of-care device for direct reverse-transcription-loop mediated isothermal amplification to identify SARS-CoV-2. Biosens Bioelectron 2022;195:113655. [PMID: 34571479 DOI: 10.1016/j.bios.2021.113655] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
471 Rees AR. Immunological challenges of the “new” infections: corona viruses. A New History of Vaccines for Infectious Diseases 2022. [DOI: 10.1016/b978-0-12-812754-4.00017-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
472 Bhat RA, Maqbool S, Rathi A, Ali SM, Hussenbocus YAAM, Wentao X, Qu Y, Zhang Y, Sun Y, Fu HX, Wang LY, Dwivedi A, Bhat JA, Iqbal RS, Islam MM, Tibrewal A, Gao C. The Effects of the SARS-CoV-2 Virus on the Cardiovascular System and Coagulation State Leading to Cardiovascular Diseases: A Narrative Review. Inquiry 2022;59:469580221093442. [PMID: 35613600 DOI: 10.1177/00469580221093442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
473 Crossman LC. Deep Recurrent Neural Networks for the Generation of Synthetic Coronavirus Spike Protein Sequences. Computational Intelligence Methods for Bioinformatics and Biostatistics 2022. [DOI: 10.1007/978-3-031-20837-9_17] [Reference Citation Analysis]
474 Kocamemi BA, Kurt H, Erken E, Saatçi AM. Wastewater-Based Epidemiology (WBE) Studies for Monitoring of Covid-19 Spread. Water and Wastewater Management 2022. [DOI: 10.1007/978-3-030-95288-4_14] [Reference Citation Analysis]
475 Mukherjee A, Das B. Mesenchymal stem cells: Novel avenues in combating COVID-19. Stem Cells and COVID-19 2022. [DOI: 10.1016/b978-0-323-89972-7.00009-x] [Reference Citation Analysis]
476 Sengupta S, Addya S, Biswas D, Banerjee P, Sarma JD. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in murine β-coronavirus-induced neuroinflammation. Virology 2022;566:122-35. [PMID: 34906793 DOI: 10.1016/j.virol.2021.11.012] [Reference Citation Analysis]
477 Kayal G, Balfaqih H, Durani F, Akeel H, Abukwaik A, Azudin N. Evaluating the Impact of Verified Government Accounts on the Knowledge, Attitudes, and Intentions of Saudi Residents During the COVID-19 Pandemic: . International Journal of Electronic Government Research 2022;18:1-23. [DOI: 10.4018/ijegr.288073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
478 Verma M, Verma Y, Mann H, Briese T, Chowdhary R. Lesson learned from coronaviruses (SARS-CoV, MERS-CoV, and SARS-CoV-2) and socioeconomic impact of (SARS-CoV-2) pandemic. Advanced Biosensors for Virus Detection 2022. [DOI: 10.1016/b978-0-12-824494-4.00019-9] [Reference Citation Analysis]
479 Akhlaq M, Jalil A, Hussain A, Siddiqua A, Imran M. Does Pandemics Effects Human Future? Decisive Role of COVID-19 in Human Evolution. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention 2022. [DOI: 10.1007/978-3-030-72834-2_31] [Reference Citation Analysis]
480 Alefishat E, Jelinek HF, Mousa M, Tay GK, Alsafar HS. Immune response to SARS-CoV-2 Variants: A focus on severity, susceptibility, and preexisting immunity. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
481 Aravind S, Mathew KA, Madathil BK, Mini S, John A. Current strategies and future perspectives in COVID-19 therapy. Stem Cells and COVID-19 2022. [DOI: 10.1016/b978-0-323-89972-7.00011-8] [Reference Citation Analysis]
482 Keyoumu T, Ma W, Guo K; School of Mathematics and Physics, University of Science and Technology Beijing, Beijing 100083, China. . MATH 2022;7:3083-96. [DOI: 10.3934/math.2022171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
483 Li J, Wang J, Xiong C, Wang Y, Pei Y. Epidemic Data Visualization Analysis of the Covid-19 Development in China. Lecture Notes in Electrical Engineering 2022. [DOI: 10.1007/978-981-16-4258-6_6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
484 Kappi M, Chaman SM, Biradar BS, Bagalkoti VT. Coronavirus. Data Science for COVID-19 2022. [DOI: 10.1016/b978-0-323-90769-9.00019-0] [Reference Citation Analysis]
485 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Macciò L, Meneguzzi C, Mioni D, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Caio G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA). Addict Biol 2022;27:e13090. [PMID: 34532923 DOI: 10.1111/adb.13090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
486 Phukan J, Banerjee A, Banerjee J, Mazumdar M. Impact of various hematological and biochemical parameters in severe and nonsevere COVID-19 patients: A retrospective single-center study. Mustansiriya Med J 2022;21:178. [DOI: 10.4103/mj.mj_52_22] [Reference Citation Analysis]
487 Zahan M, Habibi H, Pencil A, Abdul-ghafar J, Ahmadi S, Juyena N, Rahman M, Parvej M. Diagnosis of COVID-19 in symptomatic patients: An updated review. Vacunas (English Edition) 2022;23:55-61. [DOI: 10.1016/j.vacune.2022.04.002] [Reference Citation Analysis]
488 Akbulut E. Investigation of changes in protein stability and substrate affinity of 3CL-protease of SARS-CoV-2 caused by mutations. Genet Mol Biol 2022;45:e20210404. [DOI: 10.1590/1678-4685-gmb-2021-0404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
489 Pidpala OV, Lukash LL. Fragments of different origins mobile genetic elements in the genome of coronavirus SARS-CoV-2. Visn ukr tov genet sel 2021;19:4-10. [DOI: 10.7124/visnyk.utgis.19.1-2.1434] [Reference Citation Analysis]
490 Kaya E, İzol E, Gürçay M, Şimşek H. Propolisin Coronavirüslere Karşı Potansiyel Etkileri. Türk Doğa ve Fen Dergisi 2021;10:303-311. [DOI: 10.46810/tdfd.855012] [Reference Citation Analysis]
491 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
492 Labban N, Alfouzan AF, Al-shibani N, Al-otaibi HN, Al Taweel SM, Al Ghanem SH, Schrader SM. COVID-19 Pandemic Driven Knowledge, Attitude, Clinical Practice, Distress Reactions, and Post-Traumatic Growth of Dental Care Providers in Riyadh City, Saudi Arabia: A Cross-Sectional Study. TODENTJ 2021;15:748-59. [DOI: 10.2174/1874210602115010748] [Reference Citation Analysis]
493 Hossain MM, Zahidul Islam KM, Masud AA, Biswas S, Hossain MA. Behavioral intention and continued adoption of Facebook: An exploratory study of graduate students in Bangladesh during the Covid-19 pandemic. Management 2021;25:153-86. [DOI: 10.2478/manment-2019-0078] [Reference Citation Analysis]
494 Faisal S, Badshah SL, Kubra B, Sharaf M, Emwas AH, Jaremko M, Abdalla M. Computational Study of SARS-CoV-2 RNA Dependent RNA Polymerase Allosteric Site Inhibition. Molecules 2021;27:223. [PMID: 35011458 DOI: 10.3390/molecules27010223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
495 Gupta S, Rouse BT, Sarangi PP. Did Climate Change Influence the Emergence, Transmission, and Expression of the COVID-19 Pandemic? Front Med (Lausanne) 2021;8:769208. [PMID: 34957147 DOI: 10.3389/fmed.2021.769208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
496 Kratzel A, Kelly JN, V'kovski P, Portmann J, Brüggemann Y, Todt D, Ebert N, Shrestha N, Plattet P, Staab-Weijnitz CA, von Brunn A, Steinmann E, Dijkman R, Zimmer G, Pfaender S, Thiel V. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets. PLoS Biol 2021;19:e3001490. [PMID: 34962926 DOI: 10.1371/journal.pbio.3001490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
497 Madani TA, Abuelzein EME, Hussien HS, Bashri MA, Hassan AM, Azhar EI. Monitoring of the Middle East Respiratory Syndrome Coronavirus Activity in a Secluded Herd of Camels Kept Under Field Conditions. Vector Borne Zoonotic Dis 2021;21:994-1002. [PMID: 34958265 DOI: 10.1089/vbz.2021.0020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
498 Nyaguthii DM, Otieno GP, Kombe IK, Koech D, Mutunga M, Medley GF, Nokes DJ, Munywoki PK. Infection patterns of endemic human coronaviruses in rural households in coastal Kenya. Wellcome Open Res 2021;6:27. [PMID: 34957334 DOI: 10.12688/wellcomeopenres.16508.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
499 Zhang T, Tong X, Zhang S, Wang D, Wang L, Wang Q, Fan H. The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence. Front Pharmacol 2021;12:731453. [PMID: 34955820 DOI: 10.3389/fphar.2021.731453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
500 Hussain M, Collier P, Moudgil R. Cardiovascular Complications in Major 21st Century Viral Epidemics and Pandemics: an Insight into COVID-19. Curr Cardiol Rev 2021;17:e051121192897. [PMID: 33874873 DOI: 10.2174/1573403X17666210419113037] [Reference Citation Analysis]
501 Basch CE, Basch CH. Epidemiology, Secondary School Curricula, and Preparing the Next Generation for Global Citizenship (Preprint).. [DOI: 10.2196/preprints.36006] [Reference Citation Analysis]
502 Zanganeh S, Goodarzi N, Doroudian M, Movahed E. Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review. Rev Med Virol 2021;:e2321. [PMID: 34958163 DOI: 10.1002/rmv.2321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
503 Xia J, Tang W, Wang J, Lai D, Xu Q, Huang R, Hu Y, Gong X, Fan J, Shu Q, Xu J. SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-ĸB Activation. Front Immunol 2021;12:791753. [PMID: 34950152 DOI: 10.3389/fimmu.2021.791753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
504 Zhou H, Yang J, Zhou C, Chen B, Fang H, Chen S, Zhang X, Wang L, Zhang L. A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV. Front Med (Lausanne) 2021;8:628370. [PMID: 34950674 DOI: 10.3389/fmed.2021.628370] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
505 Pérez-Cataluña A, Chiner-Oms Á, Cuevas-Ferrando E, Díaz-Reolid A, Falcó I, Randazzo W, Girón-Guzmán I, Allende A, Bracho MA, Comas I, Sánchez G. Spatial and temporal distribution of SARS-CoV-2 diversity circulating in wastewater. Water Res 2021;211:118007. [PMID: 35033744 DOI: 10.1016/j.watres.2021.118007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
506 Huynh H, Levitz R, Huang R, Kahn JS. mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses. Sci Rep 2021;11:24442. [PMID: 34952911 DOI: 10.1038/s41598-021-03814-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
507 Van Brussel K, Holmes EC. Zoonotic disease and virome diversity in bats. Curr Opin Virol 2021;52:192-202. [PMID: 34954661 DOI: 10.1016/j.coviro.2021.12.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
508 Rui J, Wang Q, Lv J, Zhao B, Hu Q, Du H, Gong W, Zhao Z, Xu J, Zhu Y, Liu X, Wang Y, Yang M, Luo L, Chen Q, Zhao B, Su Y, Cui JA, Chen T. The transmission dynamics of Middle East Respiratory Syndrome coronavirus. Travel Med Infect Dis 2021;45:102243. [PMID: 34954112 DOI: 10.1016/j.tmaid.2021.102243] [Reference Citation Analysis]
509 Du Y, Zhao W, Du L, Liu J. Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study. Psychoradiology 2021;1:199-211. [DOI: 10.1093/psyrad/kkab019] [Reference Citation Analysis]
510 Riccio AA, Sullivan ED, Copeland WC. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors. J Biol Chem 2021;:101518. [PMID: 34942146 DOI: 10.1016/j.jbc.2021.101518] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
511 Tan CS, Noni V, Sathiya Seelan JS, Denel A, Anwarali Khan FA. Ecological surveillance of bat coronaviruses in Sarawak, Malaysian Borneo. BMC Res Notes 2021;14:461. [PMID: 34930456 DOI: 10.1186/s13104-021-05880-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
512 Dixit A, Samajdar DP, Bagga N. Label-Free Biosensing using Dielectric Modulated GaAs1-x Sbx FinFET under Dry/Wet Environment. 2021 IEEE 18th India Council International Conference (INDICON) 2021. [DOI: 10.1109/indicon52576.2021.9691731] [Reference Citation Analysis]
513 Al-Tawfiq JA, Azhar EI, Memish ZA, Zumla A. Middle East Respiratory Syndrome Coronavirus. Semin Respir Crit Care Med 2021;42:828-38. [PMID: 34918324 DOI: 10.1055/s-0041-1733804] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
514 Tian D, Sun Y, Zhou J, Ye Q. The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape. Front Immunol 2021;12:751778. [PMID: 34917076 DOI: 10.3389/fimmu.2021.751778] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 25.5] [Reference Citation Analysis]
515 Doyle N, Simpson J, Hawes PC, Maier HJ. Coronavirus RNA Synthesis Takes Place within Membrane-Bound Sites. Viruses 2021;13:2540. [PMID: 34960809 DOI: 10.3390/v13122540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
516 Faheem SM, D’mello J, Kaleem SM, Prasad BVLS, Siddiqui K. Rapid Serological Testing for Managing the COVID-19 Pandemic: A Review. TOBIOMJ 2021;11:99-107. [DOI: 10.2174/1875318302111010099] [Reference Citation Analysis]
517 Imran M, Iqbal S, Hussain A, Uddin J, Shahzad M, Khaliq T, Razzaq Ahmed A, Mushtaq L, Kashif M, Mahmood K. In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease. Arab J Chem 2022;15:103473. [PMID: 34909065 DOI: 10.1016/j.arabjc.2021.103473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
518 Yamamoto M, Gohda J, Kobayashi A, Tomita K, Hirayama Y, Koshikawa N, Seiki M, Semba K, Akiyama T, Kawaguchi Y, Inoue J. Metalloproteinase-dependent and TMPRSS2-independnt cell surface entry pathway of SARS-CoV-2 requires the furin-cleavage site and the S2 domain of spike protein.. [DOI: 10.1101/2021.12.14.472513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
519 Nascimento GC, Santos GM, Moura SRB, de Carvalho ARB, da Silva Andrade L, Moura LKB, Mendes F, Moreira MASP, Moura MEB. Bibliometric Analysis Of Research on Coronavirus Infection and Patient Safety in Health Care. TONURSJ 2021;15:373-9. [DOI: 10.2174/1874434602115010373] [Reference Citation Analysis]
520 Azad T, Janse van Rensburg HJ, Morgan J, Rezaei R, Crupi MJF, Chen R, Ghahremani M, Jamalkhah M, Forbes N, Ilkow C, Bell JC. Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic. ACS Nanosci Au 2021;1:15-37. [DOI: 10.1021/acsnanoscienceau.1c00009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
521 Neagu M, Constantin C, Surcel M. Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines. IJERPH 2021;18:13173. [DOI: 10.3390/ijerph182413173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
522 Carmen JM, Shrivastava S, Lu Z, Anderson A, Morrison EB, Sankhala RS, Chen WH, Chang WC, Bolton JS, Matyas GR, Michael NL, Joyce MG, Modjarrad K, Currier JR, Bergmann-Leitner E, Malloy AMW, Rao M. SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses. NPJ Vaccines 2021;6:151. [PMID: 34903722 DOI: 10.1038/s41541-021-00414-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
523 Zhuang Z, Liu D, Sun J, Li F, Zhao J. Immune responses to human respiratory coronaviruses infection in mouse models. Curr Opin Virol 2021;52:102-11. [PMID: 34906757 DOI: 10.1016/j.coviro.2021.11.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
524 Nelli RK, Phadke KS, Castillo G, Yen L, Saunders A, Rauh R, Nelson W, Bellaire BH, Giménez-Lirola LG. Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells. Cell Death Discov 2021;7:383. [PMID: 34893585 DOI: 10.1038/s41420-021-00781-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
525 Ding X, Li Z, Avery L, Ballesteros E, Makol R, Liu C. pH‐EVD: A pH‐Paper‐Based Extraction and Visual Detection System for Instrument‐Free SARS‐CoV‐2 Diagnostics. Advanced NanoBiomed Research 2022;2:2100101. [DOI: 10.1002/anbr.202100101] [Reference Citation Analysis]
526 Rao GSNK, Gowthami B, Naveen NR, Samudrala PK. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19. Curr Res Pharmacol Drug Discov 2021;2:100063. [PMID: 34870158 DOI: 10.1016/j.crphar.2021.100063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
527 Wallin R, van Iersel L, Kelk S, Stougie L. Applicability of several rooted phylogenetic network algorithms for representing the evolutionary history of SARS-CoV-2. BMC Ecol Evol 2021;21:220. [PMID: 34876022 DOI: 10.1186/s12862-021-01946-y] [Reference Citation Analysis]
528 Hooftman A, O'Neill LAJ. Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19? Curr Res Pharmacol Drug Discov 2021;2:100048. [PMID: 34870152 DOI: 10.1016/j.crphar.2021.100048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
529 Brantl V, Schworm B, Weber G, Schiefelbein J, Kreutzer TC, Michalakis S, Siedlecki J, Priglinger SG. Long-term ocular damage after recovery from COVID-19: lack of evidence at three months. BMC Ophthalmol 2021;21:421. [PMID: 34872499 DOI: 10.1186/s12886-021-02179-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
530 Štekláč M, Zajaček D, Bučinský L. 3CL(pro) and PL(pro) affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found? J Mol Struct 2021;1245:130968. [PMID: 34219808 DOI: 10.1016/j.molstruc.2021.130968] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
531 Zarubin EA, Kogan EA. [Pathogenesis and morphological changes in the lung in COVID-19]. Arkh Patol 2021;83:54-9. [PMID: 34859987 DOI: 10.17116/patol20218306154] [Reference Citation Analysis]
532 Craig N, Fletcher SL, Daniels A, Newman C, O’shea M, Warr A, Tait-burkard C. Direct lysis RT-qPCR of SARS-CoV-2 in cell culture supernatant allows for fast and accurate quantification of virus, opening a vast array of applications.. [DOI: 10.1101/2021.11.30.470550] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
533 Chapman RL, Andurkar SV. A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19. Med Chem Res 2021;:1-12. [PMID: 34873386 DOI: 10.1007/s00044-021-02826-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
534 Lana JFSD, Lana AVSD, Rodrigues QS, Santos GS, Navani R, Navani A, da Fonseca LF, Azzini GOM, Setti T, Mosaner T, Simplicio CL, Setti TM. Nebulization of glutathione and N-Acetylcysteine as an adjuvant therapy for COVID-19 onset. Adv Redox Res 2021;3:100015. [PMID: 35425932 DOI: 10.1016/j.arres.2021.100015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
535 Tumsekcali E, Ayyildiz E, Taskin A. Interval valued intuitionistic fuzzy AHP-WASPAS based public transportation service quality evaluation by a new extension of SERVQUAL Model: P-SERVQUAL 4.0. Expert Systems with Applications 2021;186:115757. [DOI: 10.1016/j.eswa.2021.115757] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
536 Payus AO, Jeffree MS, Ohn MH, Tan HJ, Ibrahim A, Chia YK, Raymond AA. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci 2021. [PMID: 34853897 DOI: 10.1007/s10072-021-05785-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
537 Hui DS, Zumla A. Historical perspective: other human coronavirus infectious diseases, SARS and MERS. COVID-19 2021. [DOI: 10.1183/2312508x.10025620] [Reference Citation Analysis]
538 Sinha S, Castillo V, Espinoza CR, Tindle C, Fonseca AG, Dan JM, Katkar GD, Das S, Sahoo D, Ghosh P. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.. [DOI: 10.1101/2021.11.28.470269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
539 Barry M, Temsah MH, Alhuzaimi A, Alamro N, Al-Eyadhy A, Aljamaan F, Saddik B, Alhaboob A, Alsohime F, Alhasan K, Alrabiaah A, Alaraj A, Halwani R, Jamal A, Alsubaie S, Al-Shahrani FS, Memish ZA, Al-Tawfiq JA. COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation. PLoS One 2021;16:e0244415. [PMID: 34843462 DOI: 10.1371/journal.pone.0244415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
540 Tai L, Zhu G, Yang M, Cao L, Xing X, Yin G, Chan C, Qin C, Rao Z, Wang X, Sun F, Zhu Y. Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein. Proc Natl Acad Sci U S A 2021;118:e2112703118. [PMID: 34782481 DOI: 10.1073/pnas.2112703118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
541 Suleman S, Farooqui A, Sharma P, Malhotra N, Yadav N, Narang J, Hasnain MS, Nayak AK. Borderline microscopic organism and lockdown impacted across the borders-global shakers. Environ Sci Pollut Res Int 2021. [PMID: 34841487 DOI: 10.1007/s11356-021-17641-w] [Reference Citation Analysis]
542 Zhang Z, Cui F, Cao C, Wang Q, Zou Q. Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections. Comput Biol Med 2021;140:105092. [PMID: 34864302 DOI: 10.1016/j.compbiomed.2021.105092] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 21.0] [Reference Citation Analysis]
543 Dogra N, Ledesma-feliciano C, Sen R. Developmental Aspects of SARS-CoV-2, Potential Role of Exosomes and Their Impact on the Human Transcriptome. JDB 2021;9:54. [DOI: 10.3390/jdb9040054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
544 Li X, Hou P, Ma W, Wang X, Wang H, Yu Z, Chang H, Wang T, Jin S, Wang X, Wang W, Zhao Y, Zhao Y, Xu C, Ma X, Gao Y, He H. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol 2021. [PMID: 34845370 DOI: 10.1038/s41423-021-00807-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
545 Banga V, Jain S. D Dimer – Prognostic indicator for disease severity in patients hospitalised with COVID 19. IJPO 2021;8:461-464. [DOI: 10.18231/j.ijpo.2021.096] [Reference Citation Analysis]
546 Mehyar N, Mashhour A, Islam I, Alhadrami HA, Tolah AM, Alghanem B, Alkhaldi S, Somaie BA, Al Ghobain M, Alobaida Y, Alaskar AS, Boudjelal M. Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assay. SAR QSAR Environ Res 2021;32:963-83. [PMID: 34818959 DOI: 10.1080/1062936X.2021.1993995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
547 Henao-Kaffure L, Peñaloza G. A critical perspective on pandemics and epidemics: building a bridge between public health and science education. Cult Stud Sci Educ 2021;:1-17. [PMID: 34849176 DOI: 10.1007/s11422-021-10074-4] [Reference Citation Analysis]
548 Alshehri MH, Alsabaani AA, Alghamdi AH, Alshehri RA. Evaluation of Communicable Disease Surveillance System at Primary Health Care Centers in Jeddah, Saudi Arabia. Cureus 2021;13:e19798. [PMID: 34820251 DOI: 10.7759/cureus.19798] [Reference Citation Analysis]
549 Li Y, Jin Y, Kuang L, Luo Z, Li F, Sun J, Zhu A, Zhuang Z, Wang Y, Wen L, Liu D, Chen C, Gan M, Zhao J, Zhao J. The N-terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus. J Virol 2021;:JVI0184221. [PMID: 34817197 DOI: 10.1128/JVI.01842-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
550 Ujike M, Etoh Y, Urushiyama N, Taguchi F, Asanuma H, Enjuanes L, Kamitani W. Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus. J Virol 2021;:JVI0156121. [PMID: 34817201 DOI: 10.1128/JVI.01561-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
551 Khandker SS, Godman B, Jawad MI, Meghla BA, Tisha TA, Khondoker MU, Haq MA, Charan J, Talukder AA, Azmuda N, Sharmin S, Jamiruddin MR, Haque M, Adnan N. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines (Basel) 2021;9:1387. [PMID: 34960133 DOI: 10.3390/vaccines9121387] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
552 van Doremalen N, Letko M, Fischer RJ, Bushmaker T, Schulz J, Yinda CK, Seifert SN, Kim NJ, Hemida MG, Kayali G, Park WB, Perera RAPM, Tamin A, Thornburg NJ, Tong S, Queen K, van Kerkhove MD, Choi YK, Oh MD, Assiri AM, Peiris M, Gerber SI, Munster VJ. Surface‒Aerosol Stability and Pathogenicity of Diverse Middle East Respiratory Syndrome Coronavirus Strains, 2012‒2018. Emerg Infect Dis 2021;27:3052-62. [PMID: 34808078 DOI: 10.3201/eid2712.210344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
553 Gupta AM, Mandal S, Mandal S, Chakrabarti J. Immune escape facilitation by mutations of epitope residues in RdRp of SARS-CoV-2.. [DOI: 10.1101/2021.11.18.469065] [Reference Citation Analysis]
554 Saeed OS, El-Deeb AH, Hussein Ahmed HA. No evidence of SARS-CoV-2 infection in Rousettus aegyptiacus bat in Egypt. Int J Vet Sci Med 2021;9:59-61. [PMID: 34796231 DOI: 10.1080/23144599.2021.1991135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
555 Tai W, Zhang X, Yang Y, Zhu J, Du L. Advances in mRNA and other vaccines against MERS-CoV. Transl Res 2021:S1931-5244(21)00280-2. [PMID: 34801748 DOI: 10.1016/j.trsl.2021.11.007] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
556 Kayesh MEH, Kohara M, Tsukiyama-Kohara K. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants. Viruses 2021;13:2302. [PMID: 34835108 DOI: 10.3390/v13112302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
557 Umakanthan S, Chauhan A, Gupta MM, Sahu PK, Bukelo MM, Chattu VK. COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies. AIMS Public Health 2021;8:665-81. [PMID: 34786427 DOI: 10.3934/publichealth.2021053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
558 Iyer S, Yadav R, Agarwal S, Tripathi S, Agarwal R. Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clin Microbiol Rev 2021;:e0012321. [PMID: 34788128 DOI: 10.1128/CMR.00123-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
559 Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis 2021;1:5. [PMID: 34778878 DOI: 10.1186/s44149-021-00005-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
560 Eckstrand CD, Baldwin TJ, Rood KA, Clayton MJ, Lott JK, Wolking RM, Bradway DS, Baszler T. An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms. PLoS Pathog 2021;17:e1009952. [PMID: 34767598 DOI: 10.1371/journal.ppat.1009952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
561 Nematollahi P, Ashrafi F, Darakhshandeh A, Salmasi M. T-cell immunophenotyping in COVID-19 pneumonia. J Res Med Sci 2021;26:81. [PMID: 34759998 DOI: 10.4103/jrms.JRMS_598_20] [Reference Citation Analysis]
562 Al-Karmalawy AA, Soltane R, Abo Elmaaty A, Tantawy MA, Antar SA, Yahya G, Chrouda A, Pashameah RA, Mustafa M, Abu Mraheil M, Mostafa A. Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview. Vaccines (Basel) 2021;9:1317. [PMID: 34835248 DOI: 10.3390/vaccines9111317] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
563 He W, Hou X, Zhao J, Sun J, He H, Si W, Wang J, Jiang Z, Yan Z, Xing G, Lu M, Suchard MA, Ji X, Gong W, He B, Li J, Lemey P, Guo D, Tu C, Holmes EC, Shi M, Su S. Total virome characterizations of game animals in China reveals a spectrum of emerging viral pathogens.. [DOI: 10.1101/2021.11.10.467646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
564 Sluhanchuk EV, Bitsadze VO, Khizroeva JK, Tretyakova MV, Shkoda AS, Artyukov OP, Tsibizova VI, Mishchenko AL, Grigorieva KN, Gris J, Elalamy E, Makatsariya AD. COVID-19 and thrombotic microangiopathy. Akušerstvo, ginekologiâ i reprodukciâ 2021;15:639-657. [DOI: 10.17749/2313-7347/ob.gyn.rep.2021.265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
565 Zhou Y, Xu X, Wei H. Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment. Front Immunol 2021;12:716940. [PMID: 34745094 DOI: 10.3389/fimmu.2021.716940] [Reference Citation Analysis]
566 Cueno ME, Imai K. Structural Insights on the SARS-CoV-2 Variants of Concern Spike Glycoprotein: A Computational Study With Possible Clinical Implications. Front Genet 2021;12:773726. [PMID: 34745235 DOI: 10.3389/fgene.2021.773726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
567 Davenport BJ, Catala A, Weston SM, Johnson RM, Ardunay J, Hammond HL, Dillen C, Frieman MB, Catalano CE, Morrison TE. Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.. [DOI: 10.1101/2021.11.08.467648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
568 MotieGhader H, Safavi E, Rezapour A, Amoodizaj FF, Iranifam RA. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis. Sci Rep 2021;11:21872. [PMID: 34750486 DOI: 10.1038/s41598-021-01410-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
569 Parkhe P, Verma S. Evolution, Interspecies Transmission, and Zoonotic Significance of Animal Coronaviruses. Front Vet Sci 2021;8:719834. [PMID: 34738021 DOI: 10.3389/fvets.2021.719834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
570 Zhao YS, Yu YX. Lymphocyte count predicts the severity of COVID-19: Evidence from a meta-analysis. World J Clin Infect Dis 2021; 11(3): 49-59 [DOI: 10.5495/wjcid.v11.i3.49] [Reference Citation Analysis]
571 Doyle N, Simpson J, Hawes PC, Maier HJ. Coronavirus RNA synthesis takes place within membrane-bound sites.. [DOI: 10.1101/2021.11.04.467246] [Reference Citation Analysis]
572 Çağlayan E, Turan K. Mutations in the SARS CoV2 Spike Gene and Their Reflections on the Spike Protein. Clinical and Experimental Health Sciences. [DOI: 10.33808/clinexphealthsci.981816] [Reference Citation Analysis]
573 Yang Z, Wang Y, Jin Y, Zhu Y, Wu Y, Li C, Kong Y, Song W, Tian X, Zhan W, Huang A, Zhou S, Xia S, Tian X, Peng C, Chen C, Shi Y, Hu G, Du S, Wang Y, Xie Y, Jiang S, Lu L, Sun L, Song Y, Ying T. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants. Signal Transduct Target Ther 2021;6:378. [PMID: 34732694 DOI: 10.1038/s41392-021-00810-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
574 Bosaeed M, Balkhy HH, Almaziad S, Aljami HA, Alhatmi H, Alanazi H, Alahmadi M, Jawhary A, Alenazi MW, Almasoud A, Alanazi R, Bittaye M, Aboagye J, Albaalharith N, Batawi S, Folegatti P, Ramos Lopez F, Ewer K, Almoaikel K, Aljeraisy M, Alothman A, Gilbert SC, Khalaf Alharbi N. Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial. Lancet Microbe 2021. [PMID: 34751259 DOI: 10.1016/S2666-5247(21)00193-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
575 Bakhtazad A, Garmabi B, Joghataei MT. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies. J Neurovirol 2021. [PMID: 34727365 DOI: 10.1007/s13365-021-01014-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
576 Ftouh M, Kalboussi N, Abid N, Sfar S, Mignet N, Bahloul B. Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses. PPAR Res 2021;2021:6741290. [PMID: 34721558 DOI: 10.1155/2021/6741290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
577 Rando HM, Wellhausen N, Ghosh S, Lee AJ, Dattoli AA, Hu F, Byrd JB, Rafizadeh DN, Lordan R, Qi Y, Sun Y, Brueffer C, Field JM, Ben Guebila M, Jadavji NM, Skelly AN, Ramsundar B, Wang J, Goel RR, Park Y, Boca SM, Gitter A, Greene CS; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen. Identification and Development of Therapeutics for COVID-19. mSystems 2021;:e0023321. [PMID: 34726496 DOI: 10.1128/mSystems.00233-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
578 Maharjan S, Kang M, Kim J, Kim D, Park S, Kim M, Baek K, Lee Y, Kwon HJ. Apoptosis Enhances the Replication of Human Coronavirus OC43. Viruses 2021;13:2199. [PMID: 34835005 DOI: 10.3390/v13112199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
579 Jiao Y, Kong N, Wang H, Sun D, Dong S, Chen X, Zheng H, Tong W, Yu H, Yu L, Huang Y, Wang H, Sui B, Zhao L, Liao Y, Zhang W, Tong G, Shan T. PABPC4 Broadly Inhibits Coronavirus Replication by Degrading Nucleocapsid Protein through Selective Autophagy. Microbiol Spectr 2021;9:e0090821. [PMID: 34612687 DOI: 10.1128/Spectrum.00908-21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
580 Lundstrom K. The Current Status of COVID-19 Vaccines. Front Genome Ed 2020;2:579297. [PMID: 34713220 DOI: 10.3389/fgeed.2020.579297] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
581 Zhao S, Peng T, Liu Y, Wu G. Using Mathematical Model to Analyze COVID-19 Spreading. 2021 10th International Conference on Bioinformatics and Biomedical Science 2021. [DOI: 10.1145/3498731.3498751] [Reference Citation Analysis]
582 Wong ACP, Lau SKP, Woo PCY. Interspecies Jumping of Bat Coronaviruses. Viruses 2021;13:2188. [PMID: 34834994 DOI: 10.3390/v13112188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
583 Jiang Y, Chen Y, Sun H, Zhang X, He L, Li J, Zhao G, Sun S. MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation. J Gen Virol 2021;102. [PMID: 34704923 DOI: 10.1099/jgv.0.001667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
584 Yang J, Muhammad MH, Siddiqui MK, Hanif MF, Nasir M, Ali S, Liu J. Topological Co-indices of Hydroxyethyl Starch Conjugated with Hydroxychloroquine Used for COVID-19 Treatment. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2021.1996407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
585 Chrysostomou AC, Hezka Rodosthenous J, Topcu C, Papa C, Aristokleous A, Stathi G, Christodoulou C, Eleftheriou C, Stylianou DC, Kostrikis LG. A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2. Life (Basel) 2021;11:1146. [PMID: 34833022 DOI: 10.3390/life11111146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
586 Gutiérrez-Álvarez J, Honrubia JM, Sanz-Bravo A, González-Miranda E, Fernández-Delgado R, Rejas MT, Zúñiga S, Sola I, Enjuanes L. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Proc Natl Acad Sci U S A 2021;118:e2111075118. [PMID: 34686605 DOI: 10.1073/pnas.2111075118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
587 Liu X, Wu Q, Zhang Z. Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites. Front Microbiol 2021;12:649314. [PMID: 34690939 DOI: 10.3389/fmicb.2021.649314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
588 Wang L, Sola I, Enjuanes L, Zuñiga S. MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity. mBio 2021;12:e0131621. [PMID: 34517762 DOI: 10.1128/mBio.01316-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
589 Velusamy P, Kiruba K, Su CH, Arun V, Anbu P, Gopinath SCB, Vaseeharan B. SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines. J King Saud Univ Sci 2021;33:101648. [PMID: 34690467 DOI: 10.1016/j.jksus.2021.101648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
590 Nassar A, Ibrahim IM, Amin FG, Magdy M, Elgharib AM, Azzam EB, Nasser F, Yousry K, Shamkh IM, Mahdy SM, Elfiky AA. A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses. Molecules 2021;26:6455. [PMID: 34770863 DOI: 10.3390/molecules26216455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
591 Sarker MT, Hasan AQF, Rafi MO, Hossain MJ, El-mageed HRA, Elsapagh RM, Capasso R, Emran TB. A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention. Biologics 2021;1:357-83. [DOI: 10.3390/biologics1030021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
592 Bitterman R, Kumar D. Respiratory Viruses in Solid Organ Transplant Recipients. Viruses 2021;13:2146. [PMID: 34834953 DOI: 10.3390/v13112146] [Reference Citation Analysis]
593 Jiao D, Dong X, Yu Y, Wei C. Gene Presence/Absence Variation analysis of coronavirus family displays its pan-genomic diversity. Int J Biol Sci 2021;17:3717-27. [PMID: 34671195 DOI: 10.7150/ijbs.58220] [Reference Citation Analysis]
594 Calabrò L, Rossi G, Covre A, Morra A, Maio M. COVID and Lung Cancer. Curr Oncol Rep 2021;23:134. [PMID: 34677721 DOI: 10.1007/s11912-021-01125-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
595 Alzain AA, Elbadwi FA. Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies. Inform Med Unlocked 2021;26:100758. [PMID: 34667827 DOI: 10.1016/j.imu.2021.100758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
596 Ahsan H, Arif A, Ansari S, Khan FH. The emergence of Covid-19: evolution from endemic to pandemic. J Immunoassay Immunochem 2021;:1-11. [PMID: 34672900 DOI: 10.1080/15321819.2021.1991947] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
597 Fontal A, Bouma MJ, San-josé A, López L, Pascual M, Rodó X. Climatic signatures in the different COVID-19 pandemic waves across both hemispheres. Nat Comput Sci 2021;1:655-65. [DOI: 10.1038/s43588-021-00136-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
598 Biswas A, Rajan C, Samajdar DP. Sensitivity Analysis of Physically Doped, Charge Plasma and Electrically Doped TFET Biosensors. Silicon. [DOI: 10.1007/s12633-021-01461-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
599 Li X. Concerns on the multiple nomenclature systems for SARS-CoV-2. J Med Virol 2021. [PMID: 34672373 DOI: 10.1002/jmv.27406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
600 Butt RT, Janjua OS, Qureshi SM, Shaikh MS, Guerrero-Gironés J, Rodríguez-Lozano FJ, Zafar MS. Dental Healthcare Amid the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:11008. [PMID: 34769526 DOI: 10.3390/ijerph182111008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
601 Lauber C, Vaas J, Klingler F, Mutz P, Gorbalenya AE, Bartenschlager R, Seitz S. Deep mining of the Sequence Read Archive reveals bipartite coronavirus genomes and inter-family Spike glycoprotein recombination.. [DOI: 10.1101/2021.10.20.465146] [Reference Citation Analysis]
602 Sun X, Wandelt S, Zhang A. Delayed reaction towards emerging COVID-19 variants of concern: Does history repeat itself? Transp Res Part A Policy Pract 2021;152:203-15. [PMID: 34664004 DOI: 10.1016/j.tra.2021.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
603 Yuan S, Balaji S, Lomakin IB, Xiong Y. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition. Front Microbiol 2021;12:752214. [PMID: 34659188 DOI: 10.3389/fmicb.2021.752214] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
604 Nova N. Cross-Species Transmission of Coronaviruses in Humans and Domestic Mammals, What Are the Ecological Mechanisms Driving Transmission, Spillover, and Disease Emergence? Front Public Health 2021;9:717941. [PMID: 34660513 DOI: 10.3389/fpubh.2021.717941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
605 Yang X. SARS-COV-2 γ variant acquires spike P681H or P681R for improved viral fitness.. [DOI: 10.1101/2021.10.16.464641] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
606 Abuelizz HA, AlRasheed MM, Alhoshani A, Alhawassi T. Genetic Insights into the Middle East Respiratory Syndrome Coronavirus Infection among Saudi People. Vaccines (Basel) 2021;9:1193. [PMID: 34696302 DOI: 10.3390/vaccines9101193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
607 Srivastava VK, Kaushik S, Bhargava G, Jain A, Saxena J, Jyoti A. A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein. Biomed Res Int 2021;2021:7251119. [PMID: 34651048 DOI: 10.1155/2021/7251119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
608 Asghar M, Din M, Waris A, Yasin MT, Zohra T, Zia M. COVID-19 and the 1918 influenza pandemics: a concise overview and lessons from the past. Open Health 2021;2:40-9. [DOI: 10.1515/openhe-2021-0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
609 Tong Y, Liu W, Liu P, Liu WJ, Wang Q, Gao GF. The origins of viruses: discovery takes time, international resources, and cooperation. Lancet 2021;398:1401-2. [PMID: 34600605 DOI: 10.1016/S0140-6736(21)02180-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
610 Abbad A, Anga L, Faouzi A, Iounes N, Nourlil J. Effect of identified non-synonymous mutations in DPP4 receptor binding residues among highly exposed human population in Morocco to MERS-CoV through computational approach. PLoS One 2021;16:e0258750. [PMID: 34648601 DOI: 10.1371/journal.pone.0258750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
611 Zebardast A, Hosseini P, Hasanzadeh A, Latifi T. The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization. Mol Biol Rep 2021. [PMID: 34648139 DOI: 10.1007/s11033-021-06819-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
612 Khan J, Asoom LIA, Khan M, Chakrabartty I, Dandoti S, Rudrapal M, Zothantluanga JH. Evolution of RNA viruses from SARS to SARS-CoV-2 and diagnostic techniques for COVID-19: a review. Beni Suef Univ J Basic Appl Sci 2021;10:60. [PMID: 34642633 DOI: 10.1186/s43088-021-00150-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
613 Nunes DR, Braconi CT, Ludwig-begall LF, Arns CW, Durães-carvalho R. Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution.. [DOI: 10.1101/2021.10.14.21264474] [Reference Citation Analysis]
614 Debnath F, Chakraborty D, Deb AK, Saha MK, Dutta S. Increased human-animal interface & emerging zoonotic diseases: An enigma requiring multi-sectoral efforts to address. Indian J Med Res 2021;153:577-84. [PMID: 34643566 DOI: 10.4103/ijmr.IJMR_2971_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
615 Hristov DR, Gomez-Marquez J, Wade D, Hamad-Schifferli K. SARS-CoV-2 and approaches for a testing and diagnostic strategy. J Mater Chem B 2021;9:8157-73. [PMID: 34494642 DOI: 10.1039/d1tb00674f] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
616 Taoufik Y, de Goër de Herve MG, Corgnac S, Durrbach A, Mami-Chouaib F. When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak. Front Immunol 2021;12:692598. [PMID: 34630382 DOI: 10.3389/fimmu.2021.692598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
617 Santos FRDS, de Azevedo MSP, Bielavsky M, da Costa HHM, Ribeiro DG, Nascimento GGD, Marcondes GMP, de Castro BP, de Lima Neto DF, Prudencio CR. Mutational profile confers increased stability of SARS-CoV-2 spike protein in Brazilian isolates. J Biomol Struct Dyn 2022;40:13184-9. [PMID: 34633892 DOI: 10.1080/07391102.2021.1982775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
618 Ahmad I, Pawara R, Surana S, Patel H. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19. Top Curr Chem (Cham) 2021;379:40. [PMID: 34623536 DOI: 10.1007/s41061-021-00353-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
619 Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, Cervero M, Malo De Molina R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Alcamí J, Pérez-Olmeda M, Coiras M, López-Huertas MR. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU. Front Immunol 2021;12:742631. [PMID: 34616404 DOI: 10.3389/fimmu.2021.742631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
620 Göncüoğlu M, Ayaz N, Hacioglu S, Yeşil S, Yildirim Ö, Yarali C, Seçkin H, Pakdemirli B. The presence of SARS-CoV-2 on the surfaces and materials in supermarket social area in Turkey. Ankara Üniversitesi Veteriner Fakültesi Dergisi 2021. [DOI: 10.33988/auvfd.915360] [Reference Citation Analysis]
621 Banach BB, Cerutti G, Fahad AS, Shen CH, Oliveira De Souza M, Katsamba PS, Tsybovsky Y, Wang P, Nair MS, Huang Y, Francino-Urdániz IM, Steiner PJ, Gutiérrez-González M, Liu L, López Acevedo SN, Nazzari AF, Wolfe JR, Luo Y, Olia AS, Teng IT, Yu J, Zhou T, Reddem ER, Bimela J, Pan X, Madan B, Laflin AD, Nimrania R, Yuen KY, Whitehead TA, Ho DD, Kwong PD, Shapiro L, DeKosky BJ. Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses. Cell Rep 2021;37:109771. [PMID: 34587480 DOI: 10.1016/j.celrep.2021.109771] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
622 Ng JH, Zaidan M, Jhaveri KD, Izzedine H. Acute tubulointerstitial nephritis and COVID-19. Clin Kidney J 2021;14:2151-7. [PMID: 34603692 DOI: 10.1093/ckj/sfab107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
623 Tian D, Sun Y, Zhou J, Ye Q. The global epidemic of SARS-CoV-2 variants and their mutational immune escape. J Med Virol 2021. [PMID: 34609003 DOI: 10.1002/jmv.27376] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 15.5] [Reference Citation Analysis]
624 Wang Y, Zhao Y, Pan Q. Advances, challenges and opportunities of phylogenetic and social network analysis using COVID-19 data. Brief Bioinform 2021:bbab406. [PMID: 34601563 DOI: 10.1093/bib/bbab406] [Reference Citation Analysis]
625 Xu H, Zhang Y, Yuan M, Ma L, Liu M, Gan H, Liu W, Lum GGA, Tao F. Basic Reproduction Number of the 2019 Novel Coronavirus Disease in the Major Endemic Areas of China: A Latent Profile Analysis. Front Public Health 2021;9:575315. [PMID: 34595146 DOI: 10.3389/fpubh.2021.575315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
626 Meyers JM, Ramanathan M, Shanderson RL, Beck A, Donohue L, Ferguson I, Guo MG, Rao DS, Miao W, Reynolds D, Yang X, Zhao Y, Yang YY, Blish C, Wang Y, Khavari PA. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation. PLoS Pathog 2021;17:e1009412. [PMID: 34597346 DOI: 10.1371/journal.ppat.1009412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
627 Li Y, Wang T, Zhang J, Shao B, Gong H, Wang Y, He X, Liu S, Liu TY. Exploring the Regulatory Function of the N-terminal Domain of SARS-CoV-2 Spike Protein through Molecular Dynamics Simulation. Adv Theory Simul 2021;4:2100152. [PMID: 34901736 DOI: 10.1002/adts.202100152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
628 Gomes Noll JC, do Nascimento GM, Diel DG. Natural Transmission and Experimental Models of SARS CoV-2 Infection in Animals. Comp Med 2021;71:369-82. [PMID: 34702427 DOI: 10.30802/AALAS-CM-21-000046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
629 Drzewnioková P, Festa F, Panzarin V, Lelli D, Moreno A, Zecchin B, De Benedictis P, Leopardi S. Best Molecular Tools to Investigate Coronavirus Diversity in Mammals: A Comparison. Viruses 2021;13:1975. [PMID: 34696405 DOI: 10.3390/v13101975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
630 Mochalov K, Samokhvalov P, Nifontova G, Tsoi T, Sukhanova A, Nabiev I. Surface-enhanced Raman scattering of CoV-SARS-2 viral proteins in a strong coupling regime. J Phys : Conf Ser 2021;2058:012020. [DOI: 10.1088/1742-6596/2058/1/012020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
631 Pandey AK, Mohanty A, Hada V, Rath RS, Kumar S, Kishore S, Kant R. Comparison of the Rapid Antigen Testing Method With RT-qPCR for the Diagnosis of COVID-19. Cureus 2021;13:e17405. [PMID: 34589316 DOI: 10.7759/cureus.17405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
632 Diniz LRL, Elshabrawy HA, Souza MTS, Duarte ABS, Datta S, de Sousa DP. Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury. Molecules 2021;26:5951. [PMID: 34641495 DOI: 10.3390/molecules26195951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
633 ALkharashi NA. The consumption of nutritional supplements and herbal products for the prevention and treatment of COVID-19 infection among the Saudi population in Riyadh. Clin Nutr Open Sci 2021;39:11-20. [PMID: 34585172 DOI: 10.1016/j.nutos.2021.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
634 Wang N, Luo CM, Yang XL, Liu HZ, Zhang LB, Zhang W, Li B, Zhu Y, Peng C, Shi ZL, Hu B. Genomic Characterization of Diverse Bat Coronavirus HKU10 in Hipposideros Bats. Viruses 2021;13:1962. [PMID: 34696392 DOI: 10.3390/v13101962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
635 Sun X, Wandelt S, Zhang A. Technological and educational challenges towards pandemic-resilient aviation. Transp Policy (Oxf) 2021;114:104-15. [PMID: 34566279 DOI: 10.1016/j.tranpol.2021.09.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
636 Al Harthi S, Al Osali M, Al Ismaili R, Al Lawati S, Kamble B, Al Shaaibi M, Al Kindi N, Al Qasabi S, Alhinai M, Al Harthi H, Al Ghafri TS. Clinical Characteristics of Confirmed Cases of COVID-19 Admitted at Al Nahdha Hospital, Oman: A Cross-Sectional Descriptive Study. Cureus 2021;13:e17343. [PMID: 34567884 DOI: 10.7759/cureus.17343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
637 Parihar S, Kaur RJ, Singh S. Flashback and lessons learnt from history of pandemics before COVID-19. J Family Med Prim Care 2021;10:2441-9. [PMID: 34568118 DOI: 10.4103/jfmpc.jfmpc_2320_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
638 Miletic V, Nikolic P, Kinkela D. Structure-based Molecular Docking in the Identification of Novel Inhibitors Targeting SARS-CoV-2 Main Protease. 2021 44th International Convention on Information, Communication and Electronic Technology (MIPRO) 2021. [DOI: 10.23919/mipro52101.2021.9596660] [Reference Citation Analysis]
639 Mah MG, Linster M, Low DH, Yan Z, Jayakumar J, Samsudin F, Wong FY, Bond PJ, Mendenhall IH, Su YC, Smith GJ. Spike-independent infection of human coronavirus 229E in bat cells.. [DOI: 10.1101/2021.09.18.460924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
640 Mjokane N, Folorunso OS, Ogundeji AO, Sebolai OM. The Possible Role of Microbial Proteases in Facilitating SARS-CoV-2 Brain Invasion. Biology (Basel) 2021;10:966. [PMID: 34681064 DOI: 10.3390/biology10100966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
641 Fang M, Hu W, Liu B. Characterization of bat coronaviruses: a latent global threat. J Vet Sci 2021;22:e72. [PMID: 34553517 DOI: 10.4142/jvs.2021.22.e72] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
642 Afzal A, Iqbal N, Feroz S, Ali A, Ehsan MA, Khan SA, Rehman A. Rapid antibody diagnostics for SARS-CoV-2 adaptive immune response. Anal Methods 2021;13:4019-37. [PMID: 34555136 DOI: 10.1039/d1ay00888a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Islam A, Ferdous J, Islam S, Sayeed MA, Dutta Choudhury S, Saha O, Hassan MM, Shirin T. Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife. Viruses 2021;13:1908. [PMID: 34696338 DOI: 10.3390/v13101908] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
644 López-Cortés GI, Palacios-Pérez M, Zamudio GS, Veledíaz HF, Ortega E, José MV. Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2. Sci Rep 2021;11:18847. [PMID: 34552110 DOI: 10.1038/s41598-021-96950-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
645 Zandi M, Farahani A, Zakeri A, Akhavan Rezayat S, Mohammadi R, Das U, Dimmock JR, Afzali S, Nakhaei MA, Doroudi A, Erfani Y, Soltani S. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic COVID-19 Patients: A Systematic Literature Review. Int J Microbiol 2021;2021:5528786. [PMID: 34545287 DOI: 10.1155/2021/5528786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
646 Doody JS, Reid JA, Bilali K, Diaz J, Mattheus N. In the post-COVID-19 era, is the illegal wildlife trade the most serious form of trafficking? Crime Sci 2021;10:19. [PMID: 34540528 DOI: 10.1186/s40163-021-00154-9] [Reference Citation Analysis]
647 Arora K, Khurana P, Kumar D, Sharma B. Mathematical Insight of COVID‐19 Infection—A Modeling Approach. Enabling Healthcare 4.0 for Pandemics 2021. [DOI: 10.1002/9781119769088.ch14] [Reference Citation Analysis]
648 Verma P, Dumka A, Singh R, Ashok A, Singh A, Aljahdali HM, Kadry S, Rauf HT. A Deep Learning Based Approach for Patient Pulmonary CT Image Screening to Predict Coronavirus (SARS-CoV-2) Infection. Diagnostics (Basel) 2021;11:1735. [PMID: 34574076 DOI: 10.3390/diagnostics11091735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
649 Low ZY, Wen Yip AJ, Chow VTK, Lal SK. The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression. Rev Med Virol 2021;:e2300. [PMID: 34546610 DOI: 10.1002/rmv.2300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
650 Niu PH, Zhao X, Lu RJ, Zhao L, Huang BY, Ye F, Wang DY, Tan WJ. Full-Length Genome Sequencing of SARS-CoV-2 Directly from Clinical and Environmental Samples Based on the Multiplex Polymerase Chain Reaction Method. Biomed Environ Sci 2021;34:725-8. [PMID: 34530962 DOI: 10.3967/bes2021.100] [Reference Citation Analysis]
651 Shaban MS, Müller C, Mayr-Buro C, Weiser H, Meier-Soelch J, Albert BV, Weber A, Linne U, Hain T, Babayev I, Karl N, Hofmann N, Becker S, Herold S, Schmitz ML, Ziebuhr J, Kracht M. Multi-level inhibition of coronavirus replication by chemical ER stress. Nat Commun 2021;12:5536. [PMID: 34545074 DOI: 10.1038/s41467-021-25551-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
652 Shtro AA, Galochkina AV, Nikolaeva YV, Petukhova GD, Fedorova VA, Lioznov DA. Study of the medicine MestaMidin®-nos virucidal activity of against influenza and ARD pathogens. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-12-174-180] [Reference Citation Analysis]
653 Forni D, Cagliani R, Arrigoni F, Benvenuti M, Mozzi A, Pozzoli U, Clerici M, De Gioia L, Sironi M. Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host. Virus Evol 2021;7:veab061. [PMID: 34527284 DOI: 10.1093/ve/veab061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
654 Mehanna A, Elhadi YAM, Lucero-Prisno Iii DE. Public willingness to adhere to COVID-19 precautionary measures in Sudan: an application of the Health Belief Model. Pan Afr Med J 2021;39:135. [PMID: 34527151 DOI: 10.11604/pamj.2021.39.135.29171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
655 Chen GY, Pan YC, Wu TY, Yao TY, Wang WJ, Shen WJ, Ahmed A, Chan ST, Tang CH, Huang WC, Hung MC, Yang JC, Wu YC. Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay. J Tradit Complement Med 2021. [PMID: 34549024 DOI: 10.1016/j.jtcme.2021.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
656 Xu S, Liu Q, Lu X. Shock effect of COVID-19 infection on environmental quality and economic development in China: causal linkages (Health Economic Evaluation). Environ Dev Sustain 2021;:1-16. [PMID: 34539229 DOI: 10.1007/s10668-021-01814-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
657 Alaiya A, Alshukairi A, Shinwari Z, Al-Fares M, Alotaibi J, AlOmaim W, Alsharif I, Bakheet R, Alharbi L, Allam R, Asiri A, Memish Z, Alromaih K, Al-Mozaini M. Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients. J Inflamm Res 2021;14:4313-28. [PMID: 34511970 DOI: 10.2147/JIR.S322430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
658 Sengupta S, Bhattacharyya D, Kasle G, Karmakar S, Sahu O, Ganguly A, Addya S, Das Sarma J. Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses. Front Cell Infect Microbiol 2021;11:729622. [PMID: 34513735 DOI: 10.3389/fcimb.2021.729622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
659 Ding FM, Feng Y, Han L, Zhou Y, Ji Y, Hao HJ, Xue YS, Yin DN, Xu ZC, Luo S, Zhang PY, Zhang M. Early Fever Is Associated With Clinical Outcomes in Patients With Coronavirus Disease. Front Public Health 2021;9:712190. [PMID: 34513787 DOI: 10.3389/fpubh.2021.712190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
660 Xi B, Chen Z, Li S, Liu W, Jiang D, Bai Y, Qu Y, Lon JR, Huang L, Du H. AutoVEM2: A flexible automated tool to analyze candidate key mutations and epidemic trends for virus. Comput Struct Biotechnol J 2021;19:5029-38. [PMID: 34512928 DOI: 10.1016/j.csbj.2021.09.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
661 Elbadwi FA, Khairy EA, Alsamani FO, Mahadi MA, Abdalrahman SE, Ahmed ZAM, Elsayed I, Ibraheem W, Alzain AA. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Inform Med Unlocked 2021;26:100725. [PMID: 34514079 DOI: 10.1016/j.imu.2021.100725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
662 Arockia Raj AA, J. V. Natural Potential Inhibitors for Covid 19 – An Insilico Approach. RJPT 2021. [DOI: 10.52711/0974-360x.2021.00854] [Reference Citation Analysis]
663 Tan CCS, Owen CJ, Tham CYL, Bertoletti A, van Dorp L, Balloux F. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infect Genet Evol 2021;95:105075. [PMID: 34509646 DOI: 10.1016/j.meegid.2021.105075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
664 Mir JM, Khan MW, Shalla AH, Maurya RC. A Nonclinical Spectroscopic Approach for Diagnosing Covid-19: A Concise Perspective. J Appl Spectrosc 2021;:1-7. [PMID: 34538886 DOI: 10.1007/s10812-021-01238-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
665 Du L, Yang Y, Zhang X. Neutralizing antibodies for the prevention and treatment of COVID-19. Cell Mol Immunol 2021;18:2293-306. [PMID: 34497376 DOI: 10.1038/s41423-021-00752-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
666 Chérifi F, Laraba-Djebari F. Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19. Protein J 2021;40:799-841. [PMID: 34499333 DOI: 10.1007/s10930-021-10019-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
667 Kulkarni R, Chen WC, Lee Y, Kao CF, Hu SL, Ma HH, Jan JT, Liao CC, Liang JJ, Ko HY, Sun CP, Lin YS, Wang YC, Wei SC, Lin YL, Ma C, Chao YC, Chou YC, Chang W. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS One 2021;16:e0257191. [PMID: 34499677 DOI: 10.1371/journal.pone.0257191] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
668 Xu L, Shi J, Chen J, Li L. Estimating the effect of COVID-19 epidemic on shipping trade: An empirical analysis using panel data. Mar Policy 2021;133:104768. [PMID: 34493890 DOI: 10.1016/j.marpol.2021.104768] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
669 Liao MT, Wu CC, Wu SV, Lee MC, Hu WC, Tsai KW, Yang CH, Lu CL, Chiu SK, Lu KC. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients. Antioxidants (Basel) 2021;10:1440. [PMID: 34573071 DOI: 10.3390/antiox10091440] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
670 Ghasemzadeh M, Ghasemzadeh A, Hosseini E. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice. Hum Immunol 2021:S0198-8859(21)00230-5. [PMID: 34583856 DOI: 10.1016/j.humimm.2021.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
671 Singh P, Chauhan SS, Pandit S, Sinha M, Gupta S, Gupta A, Parthasarathi R. The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins. J Tradit Complement Med 2021. [PMID: 34513611 DOI: 10.1016/j.jtcme.2021.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
672 Beaudoin-bussières G, Chen Y, Ullah I, Prévost J, Tolbert WD, Symmes K, Ding S, Benlarbi M, Gong SY, Tauzin A, Gasser R, Chatterjee D, Vézina D, Goyette G, Richard J, Zhou F, Stamatatos L, Mcguire AT, Charest H, Roger M, Pozharski E, Kumar P, Mothes W, Uchil PD, Pazgier M, Finzi A. An anti-SARS-CoV-2 non-neutralizing antibody with Fc-effector function defines a new NTD epitope and delays neuroinvasion and death in K18-hACE2 mice.. [DOI: 10.1101/2021.09.08.459408] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
673 Schroeder S, Mache C, Kleine-Weber H, Corman VM, Muth D, Richter A, Fatykhova D, Memish ZA, Stanifer ML, Boulant S, Gultom M, Dijkman R, Eggeling S, Hocke A, Hippenstiel S, Thiel V, Pöhlmann S, Wolff T, Müller MA, Drosten C. Functional comparison of MERS-coronavirus lineages reveals increased replicative fitness of the recombinant lineage 5. Nat Commun 2021;12:5324. [PMID: 34493730 DOI: 10.1038/s41467-021-25519-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
674 Viganò C, Mulinacci G, Palermo A, Barisani D, Pirola L, Fichera M, Invernizzi P, Massironi S. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. World J Gastroenterol 2021; 27(33): 5520-5535 [PMID: 34588749 DOI: 10.3748/wjg.v27.i33.5520] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
675 Cui Y, Dong X, Zhang X, Chen C, Fu D, Li X, Liang X. Deciphering the O-Glycosylation of HKU1 Spike Protein With the Dual-Functional Hydrophilic Interaction Chromatography Materials. Front Chem 2021;9:707235. [PMID: 34485242 DOI: 10.3389/fchem.2021.707235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
676 Rani J, Bhargav A, Khan FI, Ramachandran S, Lai D, Bajpai U. In silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2. J Biomol Struct Dyn 2022;40:12118-34. [PMID: 34486935 DOI: 10.1080/07391102.2021.1968497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
677 Parthasarathi KTS, Munjal NS, Dey G, Kumar A, Pandey A, Balakrishnan L, Sharma J. A pathway map of signaling events triggered upon SARS-CoV infection. J Cell Commun Signal 2021. [PMID: 34487344 DOI: 10.1007/s12079-021-00642-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
678 Latifi M, Bagherpour F, Jafarian A, Hamidiyeh A, Javandoost E, Mansouri Z, Pourhosien M, Tirgar N, Amirkhani MA, Dehghani S. Evaluating the Impact of COVID-19 Pandemic on Organ Donation and Transplantation Activities in Iran. Shiraz E-Med J 2021;23. [DOI: 10.5812/semj.116048] [Reference Citation Analysis]
679 Dey D, Singh S, Khan S, Martin M, Schnicker NJ, Gakhar L, Pierce BG, Hasan SS. An Extended Motif in the SARS-CoV-2 Spike Modulates Binding and Release of Host Coatomer in Retrograde Trafficking.. [DOI: 10.1101/2021.09.03.458953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
680 S T PK, Lahiri B, Alvarado R. Multiple change point estimation of trends in Covid-19 infections and deaths in India as compared with WHO regions. Spat Stat 2021;:100538. [PMID: 34493970 DOI: 10.1016/j.spasta.2021.100538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
681 Ntumvi NF, Ndze VN, Gillis A, Doux Diffo JL, Tamoufe U, Takuo J, Mouiche MMM, Nwobegahay J, Lebreton M, Rimoin AW, Schneider BS, Monagin C, Mciver DJ, Roy S, Ayukekbong JA, Saylors K, Joly DO, Wolfe ND, Rubin EM, Lange CE. Wildlife in Cameroon harbor diverse coronaviruses including many isolates closely related to human coronavirus 229E.. [DOI: 10.1101/2021.09.03.458874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
682 Sharad S, Kapur S. Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks. Pathogens 2021;10:1130. [PMID: 34578161 DOI: 10.3390/pathogens10091130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
683 Fatima N, Kaushik V, Ayoub A. A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19. Iran J Med Sci 2021;46:151-68. [PMID: 34083848 DOI: 10.30476/ijms.2020.86417.1624] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
684 Swami SK, Chauhan NK, Goyal S, Verma A, Biyani S. ESTIMATION OF SARS COV 2 SPECIFIC ANTIBODIES SEROPREVALENCE IN HEALTHCARE WORKERS IN DISTRICT UDAIPUR, INDIA. IJAR 2021. [DOI: 10.36106/ijsr/8601137] [Reference Citation Analysis]
685 Uraki R, Yamayoshi S, Kawaoka Y. Basic Research Reveals the Unique Virologic Features of SARS-CoV-2. tits 2021;26:9_79-9_86. [DOI: 10.5363/tits.26.9_79] [Reference Citation Analysis]
686 Rezabeigi-davarani E, Bokaie S, Mashayekhi V, Sharifi L, Faryabi R, Alian Samakkhah S, Ashrafi Asgarabad A, Hushmandi K, Raei M, Daneshi S; Research Center for Health Services Management, Institute of Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran, Dept. of Food Hygiene and Quality Control, Division of Epidemiology and Zoonoses, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran., Deputy of Health, Jiroft University of Medical University, Jiroft, Iran., Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran., Dept of Public Health, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran., Dept. of Food Hygiene, Faculty of Veterinary Medicine, University of Special Modern Technologies, Amol, Iran., Dept. of Public Health, School of Health, Bam University of Medical Sciences, Bam, Iran., Dept. of Food Hygiene and Quality Control, Division of Epidemiology and Zoonoses, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran., Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran., Dept. of Public Health, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran. Epidemiological and Clinical Characteristics of COVID-19 Patients Studied by Jiroft University of Medical Sciences: Southeast of Iran. J Adv Med Biomed Res 2021;29:302-8. [DOI: 10.30699/jambs.29.136.302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
687 Seifi T, Reza Kamali A. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Med Drug Discov 2021;11:100099. [PMID: 34056572 DOI: 10.1016/j.medidd.2021.100099] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
688 Orfali R, Perveen S, Aati HY, Al-taweel AM. nCOVID-19 outcomes on curfews and lockdown: Precautionary decisions in Saudi Arabia. Health Policy and Technology 2021;10:100538. [DOI: 10.1016/j.hlpt.2021.100538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
689 Yan H, Sun J, Wang K, Wang H, Wu S, Bao L, He W, Wang D, Zhu A, Zhang T, Gao R, Dong B, Li J, Yang L, Zhong M, Lv Q, Qin F, Zhuang Z, Huang X, Yang X, Li Y, Che Y, Jiang J. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2. Acta Pharm Sin B 2021;11:2850-8. [PMID: 33723501 DOI: 10.1016/j.apsb.2021.02.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
690 Zocchi E, Terrazzano G. COVID-19: why not learn from the past? Front Med 2021;15:776-81. [PMID: 34463906 DOI: 10.1007/s11684-021-0883-0] [Reference Citation Analysis]
691 Mazzariol A, Benini A, Unali I, Nocini R, Smania M, Bertoncelli A, De Sanctis F, Ugel S, Donadello K, Polati E, Gibellini D. Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation. Front Cell Infect Microbiol 2021;11:683409. [PMID: 34458159 DOI: 10.3389/fcimb.2021.683409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
692 Valencak TG, Csiszar A, Szalai G, Podlutsky A, Tarantini S, Fazekas-Pongor V, Papp M, Ungvari Z. Animal reservoirs of SARS-CoV-2: calculable COVID-19 risk for older adults from animal to human transmission. Geroscience 2021;43:2305-20. [PMID: 34460063 DOI: 10.1007/s11357-021-00444-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
693 Xie XP, Sheng LP, Han CQ, Jin Y, Bai T, Lin R, Ding Z, Hou XH. Features of capsule endoscopy in COVID-19 patients with a six-month follow-up: A prospective observational study. J Med Virol 2022;94:246-52. [PMID: 34460118 DOI: 10.1002/jmv.27308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
694 Kayode AJ, Banji-Onisile FO, Olaniran AO, Okoh AI. An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks. Pathogens 2021;10:1108. [PMID: 34578140 DOI: 10.3390/pathogens10091108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
695 Benoni R, Krafcikova P, Baranowski MR, Kowalska J, Boura E, Cahová H. Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase. Viruses 2021;13:1722. [PMID: 34578302 DOI: 10.3390/v13091722] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
696 Ali Al Shehri S, Al-Sulaiman AM, Azmi S, Alshehri SS. Bio-safety and bio-security: A major global concern for ongoing COVID-19 pandemic. Saudi J Biol Sci 2021. [PMID: 34483699 DOI: 10.1016/j.sjbs.2021.08.060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
697 Hossain MI, Shahriar EB, Sarker A, Lubna N, Haque M, Khalil MI. Effects of COVID-19 on vital organs in patients infected with SARS-CoV-2. GHM Open 2021;1:12-19. [DOI: 10.35772/ghmo.2021.01010] [Reference Citation Analysis]
698 Mair T, Ivankovic M, Paar C, Salzer HJF, Heissl A, Lamprecht B, Schreier-Lechner E, Tiemann-Boege I. Processing Hundreds of SARS-CoV-2 Samples with an In-House PCR-Based Method without Robotics. Viruses 2021;13:1712. [PMID: 34578293 DOI: 10.3390/v13091712] [Reference Citation Analysis]
699 Moothedath M, Muhamood M, Bhosale YS, Bhatia A, Gupta P, Reddy MRH, Tiwari RVC. COVID and Animal Trials: A Systematic Review. J Pharm Bioallied Sci 2021;13:S31-5. [PMID: 34447038 DOI: 10.4103/jpbs.JPBS_749_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
700 Sun X, Wandelt S, Fricke H, Rosenow J. The Impact of COVID-19 on Air Transportation Network in the United States, Europe, and China. Sustainability 2021;13:9656. [DOI: 10.3390/su13179656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
701 Johari J, Hontz RD, Pike BL, Husain T, Chong CK, Rusli N, Sulaiman LH, Verasahib K, Mohd Zain R, Azman AS, Khor CS, Nor'e SS, Tiong V, Lee HY, Teoh BT, Sam SS, Khoo JJ, Abd Jamil J, Loong SK, Yaacob CN, Mahfodz NH, Azizan NS, Che Mat Seri NAA, Mohd-Rahim NF, Hassan H, Yahaya H, Garcia-Rivera JA, AbuBakar S. Multiyear prospective cohort study to evaluate the risk potential of MERS-CoV infection among Malaysian Hajj pilgrims (MERCURIAL): a study protocol. BMJ Open 2021;11:e050901. [PMID: 34446498 DOI: 10.1136/bmjopen-2021-050901] [Reference Citation Analysis]
702 Giovannoni F, Li Z, Remes-Lenicov F, Dávola ME, Elizalde M, Paletta A, Ashkar AA, Mossman KL, Dugour AV, Figueroa JM, Barquero AA, Ceballos A, Garcia CC, Quintana FJ. AHR signaling is induced by infection with coronaviruses. Nat Commun 2021;12:5148. [PMID: 34446714 DOI: 10.1038/s41467-021-25412-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
703 Yang SL, DeFalco L, Anderson DE, Zhang Y, Aw JGA, Lim SY, Lim XN, Tan KY, Zhang T, Chawla T, Su Y, Lezhava A, Merits A, Wang LF, Huber RG, Wan Y. Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions. Nat Commun 2021;12:5113. [PMID: 34433821 DOI: 10.1038/s41467-021-25357-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
704 Chen Y, Zhang YN, Yan R, Wang G, Zhang Y, Zhang ZR, Li Y, Ou J, Chu W, Liang Z, Wang Y, Chen YL, Chen G, Wang Q, Zhou Q, Zhang B, Wang C. ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduct Target Ther 2021;6:315. [PMID: 34433803 DOI: 10.1038/s41392-021-00740-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
705 Islam MS, Hasib FMY, Nath C, Ara J, Nu MS, Fazal MA, Chowdhury S. Coronavirus disease 2019 and its potential animal reservoirs: A review. Int J One Health. [DOI: 10.14202/ijoh.2021.171-181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
706 Palma M. Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2. Germs 2021;11:287-305. [PMID: 34422699 DOI: 10.18683/germs.2021.1264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
707 Yadav PK, Jaiswal A, Singh RK. In silico study on spice-derived antiviral phytochemicals against SARS-CoV-2 TMPRSS2 target. J Biomol Struct Dyn 2022;40:11874-84. [PMID: 34427179 DOI: 10.1080/07391102.2021.1965658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
708 Jin D, Wei J, Sun J. Analysis of the molecular mechanism of SARS-CoV-2 antibodies. Biochem Biophys Res Commun 2021;566:45-52. [PMID: 34116356 DOI: 10.1016/j.bbrc.2021.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
709 Arora M, Tuchen S, Nazemi M, Blessing L. Airport Pandemic Response: An Assessment of Impacts and Strategies after One Year with COVID-19. Transp Res Interdiscip Perspect 2021;:100449. [PMID: 34458721 DOI: 10.1016/j.trip.2021.100449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
710 Almanza-Reyes H, Moreno S, Plascencia-López I, Alvarado-Vera M, Patrón-Romero L, Borrego B, Reyes-Escamilla A, Valencia-Manzo D, Brun A, Pestryakov A, Bogdanchikova N. Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo. PLoS One 2021;16:e0256401. [PMID: 34411199 DOI: 10.1371/journal.pone.0256401] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
711 Tian F, Tong B, Sun L, Shi S, Zheng B, Wang Z, Dong X, Zheng P. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife 2021;10:e69091. [PMID: 34414884 DOI: 10.7554/eLife.69091] [Cited by in Crossref: 120] [Cited by in F6Publishing: 137] [Article Influence: 60.0] [Reference Citation Analysis]
712 Dixit A, Samajdar DP, Bagga N. Dielectric modulated GaAs 1−x Sb X FinFET as a label-free biosensor: device proposal and investigation. Semicond Sci Technol 2021;36:095033. [DOI: 10.1088/1361-6641/ac0d97] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
713 Ahn DG, Yoon GY, Lee S, Ku KB, Kim C, Kim KD, Kwon YC, Kim GW, Kim BT, Kim SJ. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses. Viruses 2021;13:1639. [PMID: 34452503 DOI: 10.3390/v13081639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
714 Li JF, He L, Deng YQ, Qi SH, Chen YH, Zhang XL, Hu SX, Fan RW, Zhao GY, Qin CF. Generation and Characterization of a Nanobody Against SARS-CoV. Virol Sin 2021. [PMID: 34403037 DOI: 10.1007/s12250-021-00436-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
715 Molina P, Torres Arias M. Herramientas biotecnológicas en el diagnóstico, prevención y tratamiento frente a pandemias. RB 2021;3:2091-2113. [DOI: 10.21931/rb/2021.06.03.33] [Reference Citation Analysis]
716 Pascual-Iglesias A, Canton J, Ortega-Prieto AM, Jimenez-Guardeño JM, Regla-Nava JA. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era. Pathogens 2021;10:1030. [PMID: 34451494 DOI: 10.3390/pathogens10081030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
717 Singh J, Pandit P, McArthur AG, Banerjee A, Mossman K. Evolutionary trajectory of SARS-CoV-2 and emerging variants. Virol J 2021;18:166. [PMID: 34389034 DOI: 10.1186/s12985-021-01633-w] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 31.5] [Reference Citation Analysis]
718 Atasever A, Mendil AS, Ekebaş G. LABORUTUVAR, EGZOTİK HAYVANLAR VE DOMUZLARDA CORONAVİRUS ENFEKSİYONLARI VE COVID-19. Sağlık Bilimleri Dergisi 2021. [DOI: 10.34108/eujhs.809210] [Reference Citation Analysis]
719 Saji R, Nishii M, Sakai K, Miyakawa K, Yamaoka Y, Ban T, Abe T, Ohyama Y, Nakajima K, Hiromi T, Matsumura R, Suzuki N, Taniguchi H, Otsuka T, Oi Y, Ogawa F, Uchiyama M, Takahashi K, Iwashita M, Kimura Y, Fujii S, Furuya R, Tamura T, Ryo A, Takeuchi I. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One 2021;16:e0256022. [PMID: 34379684 DOI: 10.1371/journal.pone.0256022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
720 Parmar M, Thumar R, Patel B, Athar M, Jha PC, Patel D. Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics Simulations.. [DOI: 10.1101/2021.08.11.455903] [Reference Citation Analysis]
721 Newman JA, Douangamath A, Yadzani S, Yosaatmadja Y, Aimon A, Brandão-Neto J, Dunnett L, Gorrie-Stone T, Skyner R, Fearon D, Schapira M, von Delft F, Gileadi O. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase. Nat Commun 2021;12:4848. [PMID: 34381037 DOI: 10.1038/s41467-021-25166-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 21.0] [Reference Citation Analysis]
722 El-Said WA, Al-Bogami AS, Alshitari W, El-Hady DA, Saleh TS, El-Mokhtar MA, Choi JW. Electrochemical Microbiosensor for Detecting COVID-19 in a Patient Sample Based on Gold Microcuboids Pattern. Biochip J 2021;:1-9. [PMID: 34394845 DOI: 10.1007/s13206-021-00030-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
723 Singh AK, Chaterjee A, Sirohi S, Sharma N, Kathuria A. Convalescent plasma therapy: A promising solution for SARS-CoV-2 outbreak. JCB 2021;7:11-17. [DOI: 10.3233/jcb-200024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
724 Panchal D, Kataria J, Patel K, Crowe K, Pai V, Azizogli AR, Kadian N, Sanyal S, Roy A, Dodd-O J, Acevedo-Jake AM, Kumar VA. Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV. Adv Ther (Weinh) 2021;:2100104. [PMID: 34514085 DOI: 10.1002/adtp.202100104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
725 Batista CM, Foti L. Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives. Int Immunopharmacol 2021;99:108036. [PMID: 34371330 DOI: 10.1016/j.intimp.2021.108036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
726 Kulkarni R, Chen W, Lee Y, Kao C, Hu S, Ma H, Jan J, Liao C, Liang J, Ko H, Sun C, Lin Y, Wang Y, Wei S, Lin Y, Ma C, Chao Y, Chou Y, Chang W. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.. [DOI: 10.1101/2021.08.03.454910] [Reference Citation Analysis]
727 Gunathilake TMSU, Ching YC, Uyama H, Chuah CH. Nanotherapeutics for treating coronavirus diseases. J Drug Deliv Sci Technol 2021;64:102634. [PMID: 34127930 DOI: 10.1016/j.jddst.2021.102634] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
728 Ding Y, Wandelt S, Sun X. TLQP: Early-stage transportation lock-down and quarantine problem. Transportation Research Part C: Emerging Technologies 2021;129:103218. [DOI: 10.1016/j.trc.2021.103218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
729 Williams ME, Fielding BC. Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders. AIDS Res Hum Retroviruses 2021;37:601-9. [PMID: 32993321 DOI: 10.1089/AID.2020.0136] [Reference Citation Analysis]
730 Swami SK, Chauhan NK, Goyal S, Verma A, Biyani S. ESTIMATION OF SARS-COV-2 SPECIFIC ANTIBODIES SEROPREVALENCE IN HEALTHCARE WORKERS IN DISTRICT UDAIPUR, INDIA. IJAR 2021. [DOI: 10.36106/ijar/8102221] [Reference Citation Analysis]
731 Williams EP, Spruill-Harrell BM, Taylor MK, Lee J, Nywening AV, Yang Z, Nichols JH, Camp JV, Owen RD, Jonsson CB. Common Themes in Zoonotic Spillover and Disease Emergence: Lessons Learned from Bat- and Rodent-Borne RNA Viruses. Viruses 2021;13:1509. [PMID: 34452374 DOI: 10.3390/v13081509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
732 Tardiolo G, Brianti P, Sapienza D, dell'Utri P, Dio VD, Rao G, Calabrò RS. Are We Paving the Way to Dig Out of the "Pandemic Hole"? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization. Med Sci (Basel) 2021;9:53. [PMID: 34449681 DOI: 10.3390/medsci9030053] [Reference Citation Analysis]
733 Wu L, Yang J, Wang D, Cheng Q, Lu W. Scientists’ response to global public health emergencies: A bibliometrics perspective. Journal of Information Science. [DOI: 10.1177/01655515211030866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
734 Ahmed S, Khan S, Imran I, Al Mughairbi F, Sheikh FS, Hussain J, Khan A, Al-Harrasi A. Vaccine Development against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use. Vaccines (Basel) 2021;9:836. [PMID: 34451961 DOI: 10.3390/vaccines9080836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
735 Gökçe A, Özer A, Söyiler V, Gündoğdu ME. Bingöl İlindeki 65 Yaş Üstü Covid 19 Hastalarının Epidemiyolojik Özelliklerinin İncelenmesi. Eskişehir Türk Dünyası Uygulama ve Araştırma Merkezi Halk Sağlığı Dergisi 2021. [DOI: 10.35232/estudamhsd.902272] [Reference Citation Analysis]
736 Liang J, Zhu C, Zhang L. Cospeciation of coronavirus and paramyxovirus with their bat hosts in the same geographical areas. BMC Ecol Evol 2021;21:148. [PMID: 34325659 DOI: 10.1186/s12862-021-01878-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
737 Al-Hemoud A, AlSaraf M, Malak M, Al-Shatti M, Al-Jarba M, Othman A, Al-Shammari H, Al-Shatti A. Analytical and Early Detection System of Infectious Diseases and Animal Health Status in Kuwait. Front Vet Sci 2021;8:676661. [PMID: 34395570 DOI: 10.3389/fvets.2021.676661] [Reference Citation Analysis]
738 Mahmud S, Rafi MO, Paul GK, Promi MM, Shimu MSS, Biswas S, Emran TB, Dhama K, Alyami SA, Moni MA, Saleh MA. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach. Sci Rep 2021;11:15431. [PMID: 34326355 DOI: 10.1038/s41598-021-92176-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
739 Malik YS, Kumar P, Ansari MI, Hemida MG, El Zowalaty ME, Abdel-Moneim AS, Ganesh B, Salajegheh S, Natesan S, Sircar S, Safdar M, Vinodhkumar OR, Duarte PM, Patel SK, Klein J, Rahimi P, Dhama K. SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development. Front Mol Biosci 2021;8:607886. [PMID: 34395515 DOI: 10.3389/fmolb.2021.607886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
740 Velazquez S, Madurga R, Castellano JM, Rodriguez-Pascual J, de Aguiar Diaz Obregon SR, Jimeno S, Montero JI, Wichner PSV, López-Escobar A. Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19. BMC Emerg Med 2021;21:89. [PMID: 34315437 DOI: 10.1186/s12873-021-00480-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
741 Schoeman D, Fielding BC. Human Coronaviruses: Counteracting the Damage by Storm. Viruses 2021;13:1457. [PMID: 34452323 DOI: 10.3390/v13081457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
742 Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, Larsson SG, Langer RD. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging 2017;27:342-9. [PMID: 29089687 DOI: 10.4103/ijri.IJRI_469_16] [Cited by in Crossref: 203] [Cited by in F6Publishing: 218] [Article Influence: 101.5] [Reference Citation Analysis]
743 Fodil S, Annane D. Complement Inhibition and COVID-19: The Story so Far. Immunotargets Ther 2021;10:273-84. [PMID: 34345614 DOI: 10.2147/ITT.S284830] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
744 Ebihara T, Masuda A, Takahashi D, Hino M, Mon H, Kakino K, Fujii T, Fujita R, Ueda T, Lee JM, Kusakabe T. Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System. Mol Biotechnol 2021. [PMID: 34304364 DOI: 10.1007/s12033-021-00373-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
745 Leli C, Di Matteo L, Gotta F, Cornaglia E, Vay D, Megna I, Pensato RE, Boverio R, Rocchetti A. Performance of a SARS-CoV-2 antigen rapid immunoassay in patients admitted to the emergency department. Int J Infect Dis 2021;110:135-40. [PMID: 34302961 DOI: 10.1016/j.ijid.2021.07.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
746 Morando N, Sanfilippo M, Herrero F, Iturburu M, Torti A, Gutson D, Pando MA, Rabinovich RD. [Evaluation of interventions during the COVID-19 pandemic: development of a model based on subpopulations with different contact rates]. Rev Argent Microbiol 2021:S0325-7541(21)00078-X. [PMID: 34509309 DOI: 10.1016/j.ram.2021.04.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
747 Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-Kuraishy HM, Qusti S, Alshammari EM, Ayikobua ET, Ssempijja F, Afodun AM, Kenganzi R, Usman IM, Ochieng JJ, Osuwat LO, Matama K, Al-Gareeb AI, Kairania E, Musenero M, Welburn SC, Batiha GE. The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections. Life (Basel) 2021;11:734. [PMID: 34440478 DOI: 10.3390/life11080734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
748 García-Granja PE, Veras C, Aparisi Á, Amat-Santos IJ, Catalá P, Marcos M, Cabezón G, Candela J, Gil JF, Uribarri A, Revilla A, Carrasco M, Gómez I, San Román JA. Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Engl Ed) 2021;157:58-63. [PMID: 34307884 DOI: 10.1016/j.medcle.2021.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
749 Gardner A, Ghosh S, Dunowska M, Brightwell G. Virucidal Efficacy of Blue LED and Far-UVC Light Disinfection against Feline Infectious Peritonitis Virus as a Model for SARS-CoV-2. Viruses 2021;13:1436. [PMID: 34452302 DOI: 10.3390/v13081436] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
750 Espino A, El Costa H, Tabiasco J, Al-Daccak R, Jabrane-Ferrat N. Innate Immune Response to Viral Infections at the Maternal-Fetal Interface in Human Pregnancy. Front Med (Lausanne) 2021;8:674645. [PMID: 34368184 DOI: 10.3389/fmed.2021.674645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
751 Anyfantakis D, Mantadaki AE, Mastronikolis S, Spandidos DA, Symvoulakis EK. COVID-19 pandemic and reasons to prioritize the needs of the health care system to ensure its sustainability: A scoping review from January to October 2020 (Review). Exp Ther Med 2021;22:1039. [PMID: 34373725 DOI: 10.3892/etm.2021.10471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
752 Akter S, Roy PC, Ferdaus A, Ibnat H, Alam ASMRU, Nigar S, Jahid IK, Hossain MA. Prevalence and stability of SARS-CoV-2 RNA on Bangladeshi banknotes. Sci Total Environ 2021;779:146133. [PMID: 33740558 DOI: 10.1016/j.scitotenv.2021.146133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
753 Moustafa A, Khalel RS, Aziz RK. Traces of SARS-CoV-2 RNA in Peripheral Blood Cells of Patients with COVID-19. OMICS 2021;25:475-83. [PMID: 34280038 DOI: 10.1089/omi.2021.0068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
754 Brant AC, Tian W, Majerciak V, Yang W, Zheng ZM. SARS-CoV-2: from its discovery to genome structure, transcription, and replication. Cell Biosci 2021;11:136. [PMID: 34281608 DOI: 10.1186/s13578-021-00643-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 25.0] [Reference Citation Analysis]
755 Petrie JG, Bazzi LA, McDermott AB, Follmann D, Esposito D, Hatcher C, Mateja A, Narpala SR, O'Connell SE, Martin ET, Monto AS. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses. J Infect Dis 2021;224:49-59. [PMID: 33755731 DOI: 10.1093/infdis/jiab161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
756 Shrestha A, Thapa TB, Giri M, Kumar S, Dhobi S, Thapa H, Dhami PP, Shahi A, Ghimire A, Rathaur ES. Knowledge and attitude on prevention of COVID-19 among community health workers in Nepal-a cross-sectional study. BMC Public Health 2021;21:1424. [PMID: 34281512 DOI: 10.1186/s12889-021-11400-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
757 Ren W, Zhu Y, Lan J, Chen H, Wang Y, Shi H, Feng F, Chen D, Close B, Zhao X, Wu J, Tian B, Yuan Z, Zhou D, Saeed M, Wang X, Zhang R, Ding Q. Susceptibilities of human ACE2 genetic variants in coronavirus infection.. [DOI: 10.1101/2021.07.18.452826] [Reference Citation Analysis]
758 Abi Nassif T, Fakhri G, Younis NK, Zareef R, Al Amin F, Bitar F, Arabi M. Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population. Can J Infect Dis Med Microbiol 2021;2021:5518979. [PMID: 34326911 DOI: 10.1155/2021/5518979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
759 Erausquin E, López-sagaseta J. A single de novo substitution in SARS-CoV-2 spike informs enhanced adherence to human ACE2.. [DOI: 10.1101/2021.07.16.452441] [Reference Citation Analysis]
760 Rolta R, Salaria D, Sharma P, Sharma B, Kumar V, Rathi B, Verma M, Sourirajan A, Baumler DJ, Dev K. Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach. Curr Pharmacol Rep 2021;:1-15. [PMID: 34306988 DOI: 10.1007/s40495-021-00259-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
761 Guo W, Lakshminarayanan H, Rodriguez-Palacios A, Salata RA, Xu K, Draz MS. Glycan Nanostructures of Human Coronaviruses. Int J Nanomedicine 2021;16:4813-30. [PMID: 34290504 DOI: 10.2147/IJN.S302516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
762 Wang Z, Zhou M, Fu Z, Zhao L. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion? Front Immunol 2021;12:693579. [PMID: 34335604 DOI: 10.3389/fimmu.2021.693579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
763 Chazal N. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes? Front Microbiol 2021;12:682603. [PMID: 34335504 DOI: 10.3389/fmicb.2021.682603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
764 Zahan MN, Habibi H, Pencil A, Abdul-Ghafar J, Ahmadi SA, Juyena NS, Rahman MT, Parvej MS. Diagnosis Of Covid-19 In Symptomatic Patients: An Updated Review. Vacunas 2021. [PMID: 34276268 DOI: 10.1016/j.vacun.2021.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
765 Shapiro JT, Víquez-R L, Leopardi S, Vicente-Santos A, Mendenhall IH, Frick WF, Kading RC, Medellín RA, Racey P, Kingston T. Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy. Viruses 2021;13:1356. [PMID: 34372562 DOI: 10.3390/v13071356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
766 Morris DH, Yinda KC, Gamble A, Rossine FW, Huang Q, Bushmaker T, Fischer RJ, Matson MJ, Van Doremalen N, Vikesland PJ, Marr LC, Munster VJ, Lloyd-Smith JO. Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses. Elife 2021;10:e65902. [PMID: 33904403 DOI: 10.7554/eLife.65902] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 35.5] [Reference Citation Analysis]
767 Kaadan MI, Abdulkarim J, Chaar M, Zayegh O, Keblawi MA. Determinants of COVID-19 vaccine acceptance in the Arab world: a cross-sectional study. Glob Health Res Policy 2021;6:23. [PMID: 34253254 DOI: 10.1186/s41256-021-00202-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
768 Salleh MZ, Derrick JP, Deris ZZ. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion. Int J Mol Sci 2021;22:7425. [PMID: 34299045 DOI: 10.3390/ijms22147425] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
769 Stoddard SV, Wallace FE, Stoddard SD, Cheng Q, Acosta D, Barzani S, Bobay M, Briant J, Cisneros C, Feinstein S, Glasper K, Hussain M, Lidoski A, Lingareddy P, Lovett G, Matherne L, Mcintosh J, Moosani N, Nagge L, Nyamkondiwa K, Pratt I, Root E, Rutledge MR, Sawyer M, Singh Y, Smith K, Tanveer U, Vaghela S. In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains. Biophysica 2021;1:311-27. [DOI: 10.3390/biophysica1030023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
770 Nallusamy S, Mannu J, Ravikumar C, Angamuthu K, Nathan B, Nachimuthu K, Ramasamy G, Muthurajan R, Subbarayalu M, Neelakandan K. Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening. Front Pharmacol 2021;12:667704. [PMID: 34305589 DOI: 10.3389/fphar.2021.667704] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
771 Canal B, Fujisawa R, McClure AW, Deegan TD, Wu M, Ulferts R, Weissmann F, Drury LS, Bertolin AP, Zeng J, Beale R, Howell M, Labib K, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J 2021;478:2465-79. [PMID: 34198324 DOI: 10.1042/BCJ20210199] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
772 Canal B, McClure AW, Curran JF, Wu M, Ulferts R, Weissmann F, Zeng J, Bertolin AP, Milligan JC, Basu S, Drury LS, Deegan TD, Fujisawa R, Roberts EL, Basier C, Labib K, Beale R, Howell M, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. Biochem J 2021;478:2445-64. [PMID: 34198326 DOI: 10.1042/BCJ20210198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
773 Chen Z, Lv Y, Xu H, Deng L. Herbal Medicine, Gut Microbiota, and COVID-19. Front Pharmacol 2021;12:646560. [PMID: 34305582 DOI: 10.3389/fphar.2021.646560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
774 Kang L, He G, Sharp AK, Wang X, Brown AM, Michalak P, Weger-Lucarelli J. A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation. Cell 2021:S0092-8674(21)00833-3. [PMID: 34289344 DOI: 10.1016/j.cell.2021.07.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
775 Rollano-peñaloza OM, Barrera CD, Michel AV. SARS-CoV-2 genome sequencing with Oxford Nanopore Technology and Rapid PCR Barcoding in Bolivia.. [DOI: 10.1101/2021.07.06.451357] [Reference Citation Analysis]
776 Abdul Ashik K, Tanmoy D, Palas M, Manab M, Swapan Kumar C, Minhajuddin A, Nabajyoti B, Sourav M, Narendra Nath G. Novel Coronavirus Disease (COVID-19): An extensive study on evolution, global health, drug targets and vaccines. Int J Clin Virol 2021;5:054-069. [DOI: 10.29328/journal.ijcv.1001036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
777 Xu J, Wu Z, Zhang M, Liu S, Zhou L, Yang C, Liu C. The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2. Front Neurosci 2021;15:694446. [PMID: 34276298 DOI: 10.3389/fnins.2021.694446] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
778 Shah H, Khan MSH, Dhurandhar NV, Hegde V. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19. Acta Diabetol 2021;58:831-43. [PMID: 33587177 DOI: 10.1007/s00592-020-01636-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
779 Wang Q, Liu Z. Recent progress of surface plasmon resonance in the development of coronavirus disease-2019 drug candidates. Eur J Med Chem Rep 2021;1:100003. [PMID: 36304139 DOI: 10.1016/j.ejmcr.2021.100003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
780 Yadav S, Gedam A, Tirkey S. A Dielectric Modulated Biosensor for SARS-CoV-2. IEEE Sensors J 2021;21:14483-90. [DOI: 10.1109/jsen.2020.3019036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
781 Qamar SUR. Nanocomposites: Potential therapeutic agents for the diagnosis and treatment of infectious diseases and cancer. Colloid and Interface Science Communications 2021;43:100463. [DOI: 10.1016/j.colcom.2021.100463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
782 Mahmoudi S, Balmeh N, Mohammadi N, Sadeghian-Rizi T. The Novel Drug Discovery to Combat COVID-19 by Repressing Important Virus Proteins Involved in Pathogenesis Using Medicinal Herbal Compounds. Avicenna J Med Biotechnol 2021;13:107-15. [PMID: 34484639 DOI: 10.18502/ajmb.v13i3.6370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
783 S. Tade R, Nangare SN, M. Sangale P, R. Patil M, G. Patil A, O. Patil P. Historical Dilemmas of Coronavirus Disease (COVID-19): Public health emergency, Management perspectives and Global impacts. IJNER 2021. [DOI: 10.52711/2454-2660.2021.00080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
784 Sarkar S, Das D, Borsingh Wann S, Kalita J, Manna P. Is diabetes mellitus a wrongdoer to COVID-19 severity? Diabetes Res Clin Pract 2021;178:108936. [PMID: 34217771 DOI: 10.1016/j.diabres.2021.108936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
785 Maidana-kulesza MN, Poma HR, Sanguino-jorquera DG, Reyes SI, Said-adamo MDM, Remis MM, Gutiérrez-cacciabue D, Cristóbal HA, Cruz MC, González MA, Rajal VB. Tracking SARS-CoV-2 in rivers as a tool for epidemiological surveillance.. [DOI: 10.1101/2021.06.17.21259122] [Reference Citation Analysis]
786 Goldstein SA, Brown J, Pedersen BS, Quinlan AR, Elde NC. Extensive recombination-driven coronavirus diversification expands the pool of potential pandemic pathogens. bioRxiv 2021:2021. [PMID: 33564759 DOI: 10.1101/2021.02.03.429646] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
787 Hernández-Aguilar I, Lorenzo C, Santos-Moreno A, Naranjo EJ, Navarrete-Gutiérrez D. Coronaviruses in Bats: A Review for the Americas. Viruses 2021;13:1226. [PMID: 34201926 DOI: 10.3390/v13071226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
788 Vazquez C, Swanson SE, Negatu SG, Dittmar M, Miller J, Ramage HR, Cherry S, Jurado KA. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS One 2021;16:e0253089. [PMID: 34166398 DOI: 10.1371/journal.pone.0253089] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 21.5] [Reference Citation Analysis]
789 Eckstein S, Ehmann R, Gritli A, Ben Yahia H, Diehl M, Wölfel R, Ben Rhaiem M, Stoecker K, Handrick S, Ben Moussa M. Prevalence of Middle East Respiratory Syndrome Coronavirus in Dromedary Camels, Tunisia. Emerg Infect Dis 2021;27:1964-8. [PMID: 34152977 DOI: 10.3201/eid2707.204873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
790 Gultom M, Licheri M, Laloli L, Wider M, Strässle M, V'kovski P, Steiner S, Kratzel A, Thao TTN, Probst L, Stalder H, Portmann J, Holwerda M, Ebert N, Stokar-Regenscheit N, Gurtner C, Zanolari P, Posthaus H, Schuller S, Vicente-Santos A, Moreira-Soto A, Corrales-Aguilar E, Ruggli N, Tekes G, von Messling V, Sawatsky B, Thiel V, Dijkman R. Susceptibility of Well-Differentiated Airway Epithelial Cell Cultures from Domestic and Wild Animals to Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis 2021;27:1811-20. [PMID: 34152956 DOI: 10.3201/eid2707.204660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
791 Takayama S, Namiki T, Odaguchi H, Arita R, Hisanaga A, Mitani K, Ito T. Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Front Pharmacol 2021;12:656246. [PMID: 34248620 DOI: 10.3389/fphar.2021.656246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
792 Zhu L, Gao T, Fu Y, Han X, Yue J, Liu Y, Liu H, Dong Q, Yang W, Hu Y, Jin Y, Li P, Liu X, Cao C. The MERS-CoV N Protein Regulates Host Cytokinesis and Protein Translation via Interaction With EF1A. Front Microbiol 2021;12:551602. [PMID: 34248858 DOI: 10.3389/fmicb.2021.551602] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
793 Babarinsa IA, Okunoye GO, Odukoya O. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy - An overview. Eur J Obstet Gynecol Reprod Biol 2021;263:171-5. [PMID: 34218204 DOI: 10.1016/j.ejogrb.2021.06.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
794 Kohl C, Nitsche A, Kurth A. Update on Potentially Zoonotic Viruses of European Bats. Vaccines (Basel) 2021;9:690. [PMID: 34201666 DOI: 10.3390/vaccines9070690] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
795 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
796 Lazarevic I, Pravica V, Miljanovic D, Cupic M. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Viruses 2021;13:1192. [PMID: 34206453 DOI: 10.3390/v13071192] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 48.0] [Reference Citation Analysis]
797 Bogarapu K, P A. IgM and IgG Antibody Levels in Patients with COVID-19 in South Andhra Pradesh. jebmh 2021;8:2216-2221. [DOI: 10.18410/jebmh/2021/414] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
798 Najafi Fard S, Petrone L, Petruccioli E, Alonzi T, Matusali G, Colavita F, Castilletti C, Capobianchi MR, Goletti D. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses. Biomed Res Int 2021;2021:8856018. [PMID: 34239932 DOI: 10.1155/2021/8856018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
799 Tabprasit S, Saipin K, Siriwatthanakul K, Kramyoo M, Yokanit W, Rodkvamtook W, Kana K, Imwattana P, Chotanaphuti T. REAL TIME RT-PCR ASSAY TO DETECT SARS-COV-2 IN THAILAND. J Southeast Asian Med Res 2021;5:21-25. [DOI: 10.55374/jseamed.v5i1.77] [Reference Citation Analysis]
800 da Silva SJR, do Nascimento JCF, dos Santos Reis WPM, da Silva CTA, da Silva PG, Germano Mendes RP, Mendonça AA, Rodrigues Santos BN, de Magalhães JJF, Kohl A, Pena L. Widespread Contamination of SARS-CoV-2 on Highly Touched Surfaces in Brazil During the Second Wave of the COVID-19 Pandemic.. [DOI: 10.1101/2021.06.14.21258894] [Reference Citation Analysis]
801 Aydillo T, Rombauts A, Stadlbauer D, Aslam S, Abelenda-Alonso G, Escalera A, Amanat F, Jiang K, Krammer F, Carratala J, García-Sastre A. Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun 2021;12:3781. [PMID: 34145263 DOI: 10.1038/s41467-021-23977-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 37.5] [Reference Citation Analysis]
802 Volkan E. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era. Mol Biotechnol 2021. [PMID: 34145550 DOI: 10.1007/s12033-021-00353-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
803 Brentville V, Vankemmelbeke M, Metheringham R, Symonds P, Cook K, Urbanowicz R, Tsoleridis T, Coleman C, Chang K, Skinner A, Dubinina E, Daniels I, Shah S, Dixon J, Pockley A, Adams S, Paston S, Daly J, Ball J, Durrant L. A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants.. [DOI: 10.1101/2021.06.18.448932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
804 Beyrampour-Basmenj H, Milani M, Ebrahimi-Kalan A, Ben Taleb Z, Ward KD, Dargahi Abbasabad G, Aliyari-Serej Z, Ebrahimi Kalan M. An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know? Public Health Rev 2021;42:1604061. [PMID: 34381626 DOI: 10.3389/phrs.2021.1604061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
805 Berber E, Sumbria D, Çanakoğlu N. Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19. J Infect Public Health 2021;14:1051-64. [PMID: 34174535 DOI: 10.1016/j.jiph.2021.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
806 Ning S, Yu B, Wang Y, Wang F. SARS-CoV-2: Origin, Evolution, and Targeting Inhibition. Front Cell Infect Microbiol 2021;11:676451. [PMID: 34222046 DOI: 10.3389/fcimb.2021.676451] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
807 Mulabbi EN, Tweyongyere R, Wabwire-Mangen F, Mworozi E, Koehlerb J, Kibuuka H, Millard M, Erima B, Tugume T, Aquino UQ, Byarugaba DK. Seroprevalence of human coronaviruses among patients visiting hospital-based sentinel sites in Uganda. BMC Infect Dis 2021;21:585. [PMID: 34134656 DOI: 10.1186/s12879-021-06258-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
808 Hardmeier I, Aeberhard N, Qi W, Schoenbaechler K, Kraettli H, Hatt JM, Fraefel C, Kubacki J. Metagenomic analysis of fecal and tissue samples from 18 endemic bat species in Switzerland revealed a diverse virus composition including potentially zoonotic viruses. PLoS One 2021;16:e0252534. [PMID: 34133435 DOI: 10.1371/journal.pone.0252534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
809 Chu H, Shuai H, Hou Y, Zhang X, Wen L, Huang X, Hu B, Yang D, Wang Y, Yoon C, Wong BH, Li C, Zhao X, Poon VK, Cai JP, Wong KK, Yeung ML, Zhou J, Au-Yeung RK, Yuan S, Jin DY, Kok KH, Perlman S, Chan JF, Yuen KY. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity. Sci Adv 2021;7:eabf8577. [PMID: 34134991 DOI: 10.1126/sciadv.abf8577] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
810 Almayahi ZK, Alswaidi F, Alzahrani A. Perception of the health surveillance users on the health electronic surveillance network (HESN), Saudi Arabia, 2016. J Egypt Public Health Assoc 2021;96:17. [PMID: 34150342 DOI: 10.1186/s42506-021-00074-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
811 Weidner L, Nunhofer V, Jungbauer C, Hoeggerl AD, Grüner L, Grabmer C, Zimmermann G, Rohde E, Laner-Plamberger S. Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors. Infection 2021. [PMID: 34132990 DOI: 10.1007/s15010-021-01639-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
812 Zhou Z, Hui KPY, So RTY, Lv H, Perera RAPM, Chu DKW, Gelaye E, Oyas H, Njagi O, Abayneh T, Kuria W, Walelign E, Wanglia R, El Masry I, Von Dobschuetz S, Kalpravidh W, Chevalier V, Miguel E, Fassi-Fihri O, Trarore A, Liang W, Wang Y, Nicholls JM, Zhao J, Chan MCW, Poon LLM, Mok CKP, Peiris M. Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential. Proc Natl Acad Sci U S A 2021;118:e2103984118. [PMID: 34099577 DOI: 10.1073/pnas.2103984118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
813 Wong LR, Zheng J, Sariol A, Lowery S, Meyerholz DK, Gallagher T, Perlman S. Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence. Proc Natl Acad Sci U S A 2021;118:e2102983118. [PMID: 34099556 DOI: 10.1073/pnas.2102983118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
814 Yan K, Yan H, Gupta R. The predicted trend of COVID-19 in the United States of America under the policy of "Opening Up America Again". Infect Dis Model 2021;6:766-81. [PMID: 34124417 DOI: 10.1016/j.idm.2021.05.005] [Reference Citation Analysis]
815 Koike H, Chiba A, Katsuno M. Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review. Neurol Ther 2021. [PMID: 34117994 DOI: 10.1007/s40120-021-00261-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
816 Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, Yu F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther 2021;6:233. [PMID: 34117216 DOI: 10.1038/s41392-021-00653-w] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 50.5] [Reference Citation Analysis]
817 Afroze S, Reza MS, Cheok Q, Islam SN, Abdalla AM, Taweekun J, Azad AK, Khalilpoor N, Issakhov A, Soonmin H. Advanced Applications of Fuel Cells during the COVID-19 Pandemic. International Journal of Chemical Engineering 2021;2021:1-9. [DOI: 10.1155/2021/5539048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
818 Pires de Souza GA, Osman IO, Le Bideau M, Baudoin JP, Jaafar R, Devaux C, La Scola B. Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells. Front Cell Infect Microbiol 2021;11:639177. [PMID: 34178717 DOI: 10.3389/fcimb.2021.639177] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
819 Eckstrand C, Baldwin T, Torchetti MK, Killian ML, Rood KA, Clayton M, Lott JK, Wolking RM, Bradway DS, Baszler T. An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms.. [DOI: 10.1101/2021.06.09.447754] [Reference Citation Analysis]
820 Kulus J, Kulus M, Stefańska K, Sobolewski J, Piotrowska-Kempisty H, Mozdziak P, Kempisty B. SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach. Vaccines (Basel) 2021;9:639. [PMID: 34200951 DOI: 10.3390/vaccines9060639] [Reference Citation Analysis]
821 Berruga-Fernández T, Robesyn E, Korhonen T, Penttinen P, Jansa JM. Risk Assessment for the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) on Aircraft: A Systematic Review. Epidemiol Infect 2021;:1-51. [PMID: 34108058 DOI: 10.1017/S095026882100131X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
822 Xia B, Shen X, He Y, Pan X, Liu FL, Wang Y, Yang F, Fang S, Wu Y, Duan Z, Zuo X, Xie Z, Jiang X, Xu L, Chi H, Li S, Meng Q, Zhou H, Zhou Y, Cheng X, Xin X, Jin L, Zhang HL, Yu DD, Li MH, Feng XL, Chen J, Jiang H, Xiao G, Zheng YT, Zhang LK, Shen J, Li J, Gao Z. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res 2021;31:847-60. [PMID: 34112954 DOI: 10.1038/s41422-021-00519-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 17.0] [Reference Citation Analysis]
823 Kumakamba C, Niama FR, Muyembe F, Mombouli JV, Kingebeni PM, Nina RA, Lukusa IN, Bounga G, N'Kawa F, Nkoua CG, Atibu Losoma J, Mulembakani P, Makuwa M, Tamufe U, Gillis A, LeBreton M, Olson SH, Cameron K, Reed P, Ondzie A, Tremeau-Bravard A, Smith BR, Pante J, Schneider BS, McIver DJ, Ayukekbong JA, Hoff NA, Rimoin AW, Laudisoit A, Monagin C, Goldstein T, Joly DO, Saylors K, Wolfe ND, Rubin EM, Bagamboula MPassi R, Muyembe Tamfum JJ, Lange CE. Coronavirus surveillance in wildlife from two Congo basin countries detects RNA of multiple species circulating in bats and rodents. PLoS One 2021;16:e0236971. [PMID: 34106949 DOI: 10.1371/journal.pone.0236971] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
824 Chrysostomou AC, Vrancken B, Koumbaris G, Themistokleous G, Aristokleous A, Masia C, Eleftheriou C, Iοannou C, Stylianou DC, Ioannides M, Petrou P, Georgiou V, Hatziyianni A, Lemey P, Vandamme AM, Patsalis PP, Kostrikis LG. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic. Viruses 2021;13:1098. [PMID: 34207490 DOI: 10.3390/v13061098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
825 Alshammari MA, Alshammari TK. COVID-19: A new challenge for mental health and policymaking recommendations. J Infect Public Health 2021;14:1065-8. [PMID: 34174536 DOI: 10.1016/j.jiph.2021.05.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
826 Milanetti E, Miotto M, Di Rienzo L, Nagaraj M, Monti M, Golbek TW, Gosti G, Roeters SJ, Weidner T, Otzen DE, Ruocco G. In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2. Front Mol Biosci 2021;8:690655. [PMID: 34179095 DOI: 10.3389/fmolb.2021.690655] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
827 Alnuqaydan AM, Almutary AG, Sukamaran A, Yang BTW, Lee XT, Lim WX, Ng YM, Ibrahim R, Darmarajan T, Nanjappan S, Chellian J, Candasamy M, Madheswaran T, Sharma A, Dureja H, Prasher P, Verma N, Kumar D, Palaniveloo K, Bisht D, Gupta G, Madan JR, Singh SK, Jha NK, Dua K, Chellappan DK. Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech 2021;22:173. [PMID: 34105037 DOI: 10.1208/s12249-021-02062-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
828 Peng R, Wu LA, Wang Q, Qi J, Gao GF. Cell entry by SARS-CoV-2. Trends Biochem Sci 2021:S0968-0004(21)00118-3. [PMID: 34187722 DOI: 10.1016/j.tibs.2021.06.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 27.5] [Reference Citation Analysis]
829 Ropa J, Trinh T, Aljoufi A, Broxmeyer HE. Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters. Curr Opin Hematol 2021;28:231-42. [PMID: 33656463 DOI: 10.1097/MOH.0000000000000645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
830 Liu S, Li Q, Chu X, Zeng M, Liu M, He X, Zou H, Zheng J, Corpe C, Zhang X, Xu J, Wang J. Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools. Front Public Health 2021;9:672215. [PMID: 34164371 DOI: 10.3389/fpubh.2021.672215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
831 Yoo HM, Kim IH, Kim S. Nucleic Acid Testing of SARS-CoV-2. Int J Mol Sci 2021;22:6150. [PMID: 34200331 DOI: 10.3390/ijms22116150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
832 Chen J, Cheng YR, Wen W, Wang C, Ni J, Jiang J, Fu X, Zhou M, Ye L, Ge ZJ, Tan HX, Wang M, Feng ZH, Zhang X. The Dilemma of Masks During the COVID-19 Outbreak. Risk Manag Healthc Policy 2021;14:2369-75. [PMID: 34135649 DOI: 10.2147/RMHP.S305748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
833 Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front Aging Neurosci 2021;13:662786. [PMID: 34149397 DOI: 10.3389/fnagi.2021.662786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
834 Abolaban FA, Djouider FM. Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development. Open Life Sci 2021;16:558-70. [PMID: 34131589 DOI: 10.1515/biol-2021-0051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
835 Sajjad H, Majeed M, Imtiaz S, Siddiqah M, Sajjad A, Din M, Ali M. Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review. Biologia (Bratisl) 2021;:1-19. [PMID: 34092799 DOI: 10.1007/s11756-021-00792-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
836 Hazeldine J, Lord JM. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets. Front Immunol 2021;12:680134. [PMID: 34149717 DOI: 10.3389/fimmu.2021.680134] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
837 Low ZY, Yip AJW, Sharma A, Lal SK. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors. Virus Genes 2021;57:307-17. [PMID: 34061288 DOI: 10.1007/s11262-021-01846-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
838 Sauer MM, Tortorici MA, Park YJ, Walls AC, Homad L, Acton OJ, Bowen JE, Wang C, Xiong X, de van der Schueren W, Quispe J, Hoffstrom BG, Bosch BJ, McGuire AT, Veesler D. Structural basis for broad coronavirus neutralization. Nat Struct Mol Biol 2021;28:478-86. [PMID: 33981021 DOI: 10.1038/s41594-021-00596-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 51.0] [Reference Citation Analysis]
839 Crisan Dabija R, Antohe I, Trofor A, Antoniu SA. Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice. Expert Rev Anti Infect Ther 2021;:1-10. [PMID: 34015985 DOI: 10.1080/14787210.2021.1933437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
840 Rasheed MA, Raza S, Zohaib A, Riaz MI, Amin A, Awais M, Khan SU, Ijaz Khan M, Chu Y. Immunoinformatics based prediction of recombinant multi-epitope vaccine for the control and prevention of SARS-CoV-2. Alexandria Engineering Journal 2021;60:3087-97. [DOI: 10.1016/j.aej.2021.01.046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
841 Saunders KO, Lee E, Parks R, Martinez DR, Li D, Chen H, Edwards RJ, Gobeil S, Barr M, Mansouri K, Alam SM, Sutherland LL, Cai F, Sanzone AM, Berry M, Manne K, Bock KW, Minai M, Nagata BM, Kapingidza AB, Azoitei M, Tse LV, Scobey TD, Spreng RL, Rountree RW, DeMarco CT, Denny TN, Woods CW, Petzold EW, Tang J, Oguin TH 3rd, Sempowski GD, Gagne M, Douek DC, Tomai MA, Fox CB, Seder R, Wiehe K, Weissman D, Pardi N, Golding H, Khurana S, Acharya P, Andersen H, Lewis MG, Moore IN, Montefiori DC, Baric RS, Haynes BF. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature 2021;594:553-9. [PMID: 33971664 DOI: 10.1038/s41586-021-03594-0] [Cited by in Crossref: 141] [Cited by in F6Publishing: 140] [Article Influence: 70.5] [Reference Citation Analysis]
842 Jardine J, Morris E. COVID-19 in Women's health: Epidemiology. Best Pract Res Clin Obstet Gynaecol 2021;73:81-90. [PMID: 33906791 DOI: 10.1016/j.bpobgyn.2021.03.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
843 Low ZY, Yip AJW, Sharma A, Lal SK. SARS coronavirus outbreaks past and present-a comparative analysis of SARS-CoV-2 and its predecessors. Virus Genes 2021;57:307-17. [PMID: 34061288 DOI: 10.1007/s11262-021-01846-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
844 Bhardwaj VK, Singh R, Sharma J, Rajendran V, Purohit R, Kumar S. Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2. Front Med (Lausanne) 2021;8:684020. [PMID: 34136511 DOI: 10.3389/fmed.2021.684020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Refe